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ABSTRACT
The majority of chloroplast proteins are nuclear-encoded and post-translationally
imported into the chloroplast. These newly imported proteins are translocated from the
cytosolic compartment to the stroma by the Translocons of the Outer/Inner membranes of
Chloroplast (TOC/TIC). In order to understand protein transport across the chloroplast outer
membrane, it is crucial to investigate the structure and function of these complexes. The TOC
complex is composed of the beta-barrel channel protein Toc75 and the GTPase receptors Toc34
and Toc159.
Toc75 is a member of the OMP85 (Outer Member Protein, 85 kDa) superfamily. Other
proteins of the OMP85 superfamily also exist in Gram-negative bacteria and mitochondria. The
members of this family contain a C-terminal transmembrane beta-barrel and a soluble Nterminus with a varying numbers of POTRA (POlypeptide TRansport Associated) domains. The
recent crystal structures of the POTRA domains of Gram-negative bacteria reveal that these
domains are localized in the periplasmic side. This thesis identifies the orientation of the POTRA
domains as being localized in the cytosol and provides initial evidence for their involvement in
the protein import.
Three POTRA domains of psToc75 were identified, purified in E. coli and characterized
by MALDI-TOF mass spectrometry and circular dichroism. Using variety of immunofluorescence
methods, such as flow cytometry and LSCM, the topology of the POTRA domains was
investigated. Chloroplast agglutination assays were used to assess the location of immunoreactive fragments of the POTRA domains, which supported the results from the flow
cytometry and LSCM. Finally, thermolysin was used to probe the surface of the isolated intact
chloroplasts. Proteolytic digestion along with the data obtained from flow cytometry, LSCM and
agglutination assays suggested the orientation of the N-terminal POTRA domains facing the
cytosol, followed by a C-terminal beta-barrel domain. The import competence of individual
POTRA domains was determined by in vitro chloroplast import and binding competition assays.
POTRA1 inhibited the binding of the precursor of the small subunit of ribulose-1,5-bisphosphate
carboxylase/oxygenase to intact chloroplasts, while POTRA3 inhibited the import of
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radiolabeled precursors into isolated chloroplasts; however, in both assays, the inhibition of
precursor binding and import was to a lesser extent than non-labeled prSSU.
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CHAPTER 1 Introduction
1.1 Background and General Information
1.1.1 Chloroplast Information
The research to unravel the mechanism of protein import into the chloroplast, the
mechanism of gene transfer from organelles to the nucleus, evolution of plastids and the
evolution of organelle genomes gained considerable attention in past couple of decades (1).
Chloroplasts are the best studied and the most prominent members of the family of plant
organelles called plastids. They carry out essential processes such as fatty acid and amino acid
biosynthesis in addition to their involvement in photosynthesis (2). The process of
photosynthesis utilizes the sun’s energy to convert solar energy into carbohydrates and ATP, on
which all the life on the earth either directly or indirectly depends. The chloroplast is a complex
organelle which is surrounded by an envelope containing outer and inner membranes. The two
membranes of the chloroplasts, which are separated by only 5-10 nm, serve as a physical
barrier to separate the interior of the organelle from the cytoplasm and play a key role in
communication between the cytoplasm and the organelle (2). An internal thylakoid membrane
and three aqueous compartments of the intermembrane space, the stroma and the thylakoid
lumen, give six possible sites for targeting of proteins (3). Because of this complex structure of
the chloroplasts, the internal routing of the destined proteins becomes a crucial and complex
process. This thesis focuses on proteins located in the outer membrane and will not discuss
proteins located in the inner membrane or those destined for thylakoid membrane or lumen.
Toc75, which forms the channel of the outer envelope membrane complex, will be discussed in
detail in this Chapter 1.

1.1.2 Origin of Plastids and gene Transfer
In 1883, Schimper observed the resemblance of chloroplasts to the free-living
cyanobacteria. Based on this observation, Mereschkowsky was the first to articulate the theory
of endosymbiosis concerning the origin of plastids which later included the endosymbiotic
origin of mitochondria (4). Chloroplasts originated as a result of a primary endosymbiotic event
(1.5 to 1.6 billion years ago) involving enslavement of free-living photosynthetic organism,
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ancestral to the present-day cyanobacteria, by a heterotrophic plant/algal cell containing
mitochondria (from a previous single endosymbiotic event > 2 billion years ago) (5-7). The
endosymbiont permanently retained in the host cell for production of essential metabolites
which gave rise to the fully integrated organelle called the plastids capable of photosynthesis
(8). Over the course of the evolution, the endosymbiont lost its independence by massive gene
transfer to the host cell nucleus. More than 95% of chloroplastic proteins were transferred to
the nucleus of the host cell (9). During the establishment of permanent relationship between
the endosymbiont and the host cell, in the case of the chloroplasts, they lost some functions
related to autonomous life. However, they still retained a small number of genes and a large
degree of their biochemistry (10). Modern day chloroplasts encode only around 60-200
proteins, while the total chloroplast proteome of Arabidopsis thaliana is estimated to be
comprised of approximately 2100-4500 proteins (11). Thus chloroplasts must import more than
95% of their proteins encoded by genes in the nucleus (9, 12).

1.2 Protein Import into Chloroplasts
These nuclear encoded proteins are synthesized on 80S ribosomes in the cytoplasm and
post-translationally translocated into the chloroplasts (10). The proteins are synthesized as
larger molecular weight proteins or preproteins with cleavable N-terminal targeting sequences
which contain information necessary for the targeting of proteins to the correct organelles (See
Section 1.3) (1, 3). Although it is not clear how the “sorting” occurs, it has been well established
that receptors specific to organelles recognize the signal peptides and transport the proteins
through the outer and inner membrane complexes (13-14).
One of the first proteins to demonstrate the post-translational preprotein import across
the chloroplast membranes was the small subunit of RuBisCO (Ribulose 1,5 Bisphosphate
Carboxylase/Oxygenase) (15). It catalyzes the first step of photosynthetic CO2 fixation and
photorespiratory carbon oxidation. It is composed of eight large and eight small subunits (MW
of 490 kDa) (16). The small subunits are synthesized as large molecular weight precursor called
prSSU (precursor to the Small SubUnit of RuBisCO). The preprotein is targeted for import into
the chloroplasts for assembly with the large subunits of the hexadecamic holoenzyme (16).

2

The hetero-oligomeric molecular machine involved in the specific recognition and
translocation of the precursor proteins across the chloroplast envelope is called the TOC and
TIC for Translocon at the Outer/Inner envelope membrane of chloroplasts (17). In
mitochondria, similar processes are accomplished by translocons of the outer (TOM) and inner
(TIM) complexes, but the main components are not closely related (3). The binding and import
of precursor proteins across the envelope is an irreversible and an energy dependent process
(18-19). So far in garden pea (Pisum sativum) chloroplasts, many components have been
biochemically identified as preprotein receptors, channel proteins and molecular chaperones
(3).
Five outer and eight inner membrane proteins have been identified to be involved in the
process of protein import: Toc75, the two GTPases Toc159 and Toc34, Toc64 and Toc12 and
Tic110, Tic20, Tic22, Tic40, Tic55, Tic62, Tic32 and Tic21 (3). The proteins are named with the
Toc/Tic, depending on the membrane association, followed by their molecular mass in
kilodaltons and the two letter prefix of the species of origin (P. sativum is implied if no prefix is
used) (20). Early studies involving chloroplasts from pea seedling by chemical cross-linking
during various stages of protein import with precursor proteins, solubilization of the
membranes using mild detergents, and other immunoprecipitation methods identified the main
components of the TOC core complex, including Toc34, Toc159 and Toc75 (9). Toc64 and Toc12
have been added more recently and proposed to have roles in recruitment of chaperones
delivering preproteins (3, 21-22). The components of the TIC complex, Tic110, Tic40, Tic22, and
Tic20, are involved in the translocation of incoming preproteins across the inner membrane
into the stroma (4). Once the precursor import is completed, the targeting signal is cleaved by
the stromal (chloroplast)/mitochondrial processing peptidase (mitochondria) at a weakly
conserved processing site leaving the mature form of protein, which may undergo sorting and
assembly (without transit peptide) (3, 23).

1.3 Transit Peptide
1.3.1 Modular Organization of Transit Peptide
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During the life of a typical plant, more than 3500 nuclear encoded proteins are imported
into the chloroplasts. This is achieved by an N-terminal targeting sequence, called the ‘transit
peptide’ in the chloroplasts (13, 24). Transit peptides are both necessary (a protein without
transit peptide does not associate with chloroplasts) and sufficient (they can direct foreign
proteins into chloroplasts) for transport into the chloroplast (19). After translocation, transit
peptides are cleaved by the Stromal Processing Peptidase (SPP) (25). The proteins destined for
thylakoid lumen contain bipartite transit peptides, which contain stromal targeting information
in the N-terminal and thylakoid targeting information in the C-terminal of the peptides (26). The
majority of preproteins containing transit peptides follow the general import pathway,
although other pathways do exist (14). Preproteins synthesized without cleavable transit
peptides (most OMPs and one of the inner membrane protein) contain their targeting
information in the mature part of the protein (22).
Transit peptides are the largest class of targeting sequences in plants and are highly
divergent in length, composition and organization (1, 23). They range from 20 to 150 residues in
length and are largely unstructured in aqueous solution (22, 27). Upon insertion into micelle or
exposure to hydrophobic solvent, they tend to become α-helical, which has been postulated to
play a role in recognition by the TOC complex (1, 28). They are rich in hydrophobic residues
such as Ala, Leu, Phe, Val; hydroxylated residues – Ser, Thr and positively charged resides, Arg,
and Lys and deficient in acidic resides (29-30). Hydroxylated residues, such as Ser and Thr, of
transit peptides form loose phosphorylation motifs, which allows phosphorylated preproteins
to interact with the guidance complex containing chaperones like 14-3-3 proteins and an
Hsp70, Heat-Shock Protein, 70 kilodalton (31-32). Transit peptides do not contain the regions of
highly conserved amino acids, but three distinct regions were identified from the early study of
the primary sequences of stromal-targeting transit peptides of LHCPII, RuBisCO small subunit
and ferredoxin (1, 15): (1) A central domain rich in hydroxylated Serine/Threonine residues but
lacking acidic residues. This region works as a flexible connector containing Proline, turn
promoting resides G and N as well as the semi-conserved FGLK motif, (2) an uncharged Nterminal domain of ~10 resides beginning with Methionine followed by Alanine and lacking
Glycine or Proline. The N-terminal is involved in the interaction between transit peptide and
4

envelope lipid MGDG, and (3) A C-terminal domain rich in Arginines forming amphiphilic βstrand. These positively charged regions may interact with membrane lipids through
electrostatic interaction (1, 33).

1.3.2 Processing of Transit Peptides
Upon the arrival of precursor proteins in the stroma, they are proteloytically processed
for the removal of their transit peptides by the SPP enzyme located in the stroma (15). The SPP
protein, a metalloendopeptidase containing a signature zinc binding motif, releases transit
peptide in its intact form (24, 34). However, in order to prevent the aggregation of transit
peptides into the stroma, another ATP and metal dependant protease, the presequence
protease (PreP1 and 2), is involved in degradation of cleaved transit peptides (3, 24). Once the
mature protein is released, it is folded and assembled or targeted to the thylakoid membrane
or lumen (24).

1.4 General Import Pathway into Chloroplast
In eukaryotic cells, two-thirds of all proteins have to traverse cellular membranes (35).
The process of protein import into chloroplasts is facilitated by the actions of components of
the outer (TOC) and inner (TIC) chloroplast membranes (22). Although TOC/TIC-independent
pathways for chloroplast protein targeting have been identified, the components of these
pathways have not yet been identified (3).
A few possibilities exist for preproteins targeting from the cytosol to the chloroplast
surface and interacting with the TOC complex. Shown in Fig 1-1 (1a) is the first possibility of the
formation of the guidance complex by interaction of phosphorylated transit peptide with 14-3-3
protein and an Hsp70 chaperone, delivering the transit peptide mostly to Toc34 since Toc159
recognizes only non-phosphorylated proteins (32, 36). Phosphorylation and binding to the
guidance complex import proteins 4-5 fold higher rates than non-phosphorylated proteins (18).
Another reason for phosphorylation could be that it induces the secondary structure formation
in transit peptide sequence (usually forms random coil in aqueous solution), which is important
in recognition by the TOC complex (18). The second possibility is denoted as (1b) when soluble
form of Toc159 recognizes the transit peptide of preprotein. Toc159 then presumably binds
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Figure 1- 1 General import pathway for chloroplast preprotein import
The preprotein is synthesized on the free ribosomes in the cytoplasm with an N-terminal transit
peptide sequence, shown here in red, green and yellow. Different possibilities of interactions
are shown in steps 1 to 6. (1a) Shows the interaction of the phosphorylated transit peptide
(black dot) with a guidance complex containing a 14-3-3 protein and Hsp70. (1b) Interaction of
the preprotein and soluble Toc159. (2a) Nucleotide-independent interaction of the transit
peptide with chloroplast outer membrane lipids, such as MGDG, SL and PG. (2b, 2c, 2d)
Precursor directly interacts with the TOC subunits, with an Initial interaction with the full-length
Toc159 (2b), Toc64 (2c), or the hetero-oligomeric TOC translocon (2d), and (2e) guidance by
soluble Toc159 to the translocon. (3) Protein-lipid interactions cause changes in the transit
peptide helical structure (shown in green) and the lipid phase preference of the envelope
(shown as an inverted micelle). (4) Recognition and interaction of membrane-associated transit
peptide with Toc86/159 receptor. (5, 6) Transfer of the transit peptide from an initial
association with Toc86/159 and and/or Toc64 to interact with Toc34 and Toc75, resulting in the
assembly of a TOC translocon, localized at a contact site of both the inner and outer envelopes.
This also illustrates (6) the GTP-dependent insertion of transit peptide into Toc75. (7)
Preprotein translocation across the outer membrane in a nucleotide-dependent manner using
molecular motors. (8) Complete translocation of preprotein across the inner membrane
requires higher levels of nucleotide using stromal molecular motors. (9,10) Upon import, the
transit peptide is cleaved by SPP, followed by complete degradation of the transit peptide by
PreP1 and 2 and proper folding of the mature domain. This figure is adapted from (15).
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Toc34 and assembles into the TOC complex (37). Another possibility is denoted as (1c) in which
preproteins are recognized via Toc64 interaction with chaperone Hsp90, which is then
transferred onto to Toc34 in a GTP-dependant association of Toc64 (2f) with Toc34 (38). The
fourth possibility is denoted as (2a) showing the direct interaction of preproteins with
chloroplast specific lipids (such as MGDG, SL and PG), which induces the α-helical structure
which facilitates the recognition by one of the GTPase receptors of the TOC complex (1, 28, 39).
Finally, a preprotein may not require any of these aids and bind directly to the TOC complex.
Different classes of preproteins use distinct TOC complexes, such as Arabidopsis Toc159 and
Toc33 recognize photosynthetic proteins while non-photosynthetic or ‘house-keeping’ proteins
are recognized via other classes of the TOC complex (discussed in section 1.8.2.2) (40-41).
Once a preprotein reaches the chloroplast surface, the translocation is completed via
the actions of components of TOC and TIC machinery at the contact sites between the two
complexes (19). The rest of the process consumes energy at different stages, so the stages of
envelope translocation can be divided into three steps depending on the amount of energy
consumed at each stage (42). The first is an energy independent reversible binding step which
occurs at the chloroplast surface (Fig 1-1, steps 5 & 6). At this stage, no energy is consumed
when a transit peptide initiates the reversible contacts with the components of the TOC
complex, preferably Toc159 (19, 43). The translocation is believed to involve the ‘contact site’
formed between the inner and outer membrane where they are held in close proximity (19,
44). In the second step, preprotein is deeply embedded into the TOC complex and makes
contact with Toc75 and TIC complex (45-46). In the second step, the formation of an “early
import intermediate” takes place, which is irreversible and requires low concentration of ATP
(≤100 µM) as well as GTP in the intermembrane space (Fig 1-1, step 7) (47-49). At this stage,
the preprotein is translocated across the outer membrane and now in contact with the TIC
apparatus in the inner membrane. The final stage of protein translocation or formation of “late
intermediate stage” is depicted in Fig 1-1 step 8. The complete simultaneous translocation of
preprotein across both envelope membranes requires high concentration ATP (>1 mM) in the
stroma probably due to involvement of stromal chaperones in the import process (3, 50-51).
Once into the stroma, transit peptide is cleaved off via stromal processing peptidase and
7

presequence protease, shown in Fig 1-1, steps 9 and 10, respectively. The mature protein takes
its final conformation at this point (25, 52).

1.5 Cytosolic Factors
Protein import into chloroplasts occurs post-translationally. Cytosolically synthesized
proteins may interact with soluble, cytosolic chaperone-like factors before binding and
translocating into the chloroplasts (18). The cytosolic chaperones are involved in the transport
of large, hydrophobic preproteins in extended conformation. Some of these chaperones include
cytoplasmic and stromal Hsp70 proteins, stromal Hsp100 and Hsp60 proteins, and 14-3-3
proteins (3, 50). According to the chloroplast transit peptide (CHLPEP: contains sequences for
over 300 transit peptides) database, more than 75% of the N-terminal transit peptides possess
binding domains for 14-3-3 proteins and/or Hsp70 molecular chaperones (1). The preproteins
associated with the guidance complex have been shown to import more rapidly than the ones
without (31). In order to be recognized by 14-3-3 guidance complex, the preproteins have to be
phosphorylated in their transit peptides which enables the subsequent delivery of preprotein to
the TOC complex (30). The targeting signals are phosphorylated by a cytosolic protein kinase on
a serine or threonine residue, which results in the interaction of 14-3-3 and Hsp70 proteins of
the guidance complex (31, 53). Since around 25% of chloroplast targeted proteins lack these
consensus domains, the presence of these binding domains may be indicative of the need to
target highly expressed preproteins to the correct organelle and thus preventing their
aggregation in the cytosol (3). Another targeting mechanism involves non-phosphorylated
preproteins. These proteins may bind to cytosolic Hsp90 with Toc64 serving as a co-receptor for
the Hsp90-bound precursor complex. In turn, Toc64 most likely engages in interaction with
Toc34 delivering the preprotein to the Toc75 channel (38, 54-55).

1.6 Lipids of the Outer Envelope
Due to its endosymbiotic origin, the chloroplast is surrounded by two membranes.
Density-gradient centrifugation of the outer envelope of chloroplast membrane from
chloroplasts revealed unique feature in lipid and protein composition (56-57). The lipid: protein
ratio in the outer envelope is 2.5-3.0 which is 3 times higher than the inner envelope (0.8-1)

8

and 6-8 times higher than the thylakoids (2, 57). The chloroplast is the only plant membrane
containing galactolipids (MGDG and DGDG) at the cytosolic surface (15). The outer membrane
of chloroplasts contain large amount of glycolipids and low amount of phospholipids, with
phosphotydyl

choline

(PC)

(32%)

as

major

outer

envelope

phospholipid

and

phosphatidylglycerol (PG) (10%) as the major chloroplast phospholipid (58). Additionally, it
contains

the

major

chloroplast

glycolipids

which

are

neutral

galactolipids,

monogalactosyldiacylglyceride (MGDG) (17%), digalactosyldiacylglyceride (DGDG) (29%), and
negatively charged sulfolipids (SL) (58). PC is mainly located in the outer envelope, whereas PG
is exclusively located in the inner leaflet. The asymmetric distribution of PC in the outer
envelope may be relevant to lipid metabolism. The role of lipids in protein import was shown by
Arabidopsis mutant deficient in the DGDG which was unable to import preprotein targeted to
the chloroplast (59). The ferredoxin and small subunit of RuBisCO have been shown to interact
with chloroplast outer envelope lipids, in particular with MGDG, and in return adopt a more αhelical conformation when interacting with lipids, which is important in recognition by the TOC
complex (18, 28, 39).

1.7 The TIC Complex
The TIC complex is responsible for preprotein translocation across the inner envelope of
the chloroplast. The most basic function of the TIC apparatus is the formation of an aqueous
pore for preprotein conduction across the inner membrane of the chloroplast (3). So far, eight
components have been identified: Tic110, Tic40, Tic22, Tic20, Tic62, Tic55, Tic32, Tic21;
however, little is known about the roles they play in protein import in part due to their dynamic
behavior (34). Although the TIC complex has the ability to retrieve and translocate proteins
entered into the intermembrane space by TOC complex independently, in most cases, the
translocation at the TIC and TOC complexes occur simultaneously at the contact sites (formed
by the close association of outer and inner chloroplast envelope) of these complexes (19, 22,
60).
Tic110 is the major component of the TIC machinery and forms the main pore of the TIC
complex (3). The translocation across the inner membrane requires hydrolysis of ATP which
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provides the driving force for molecular chaperones of the stroma to complete the import of
preproteins into the chloroplast (22, 61-62). In the inner membrane, Tic40 and the stromal
chaperone Hsp93 form the “motor complex”, providing the ATP-dependent driving force for
import (50-51). Once the protein enters the stroma, with the help from the translocation
channel and motor complex, the transit peptide is cleaved off by the SPP (15). Tic22 is involved
in mediating the association of TIC and TOC complexes at the contact site because of its
location in the intermembrane space (63). Tic20 is deeply embedded within the inner
membrane and has been suggested to form a channel in the inner membrane, but the
experiments confirming its channel activity are still missing (63-64). Together with Tic110, Tic20
and Tic22 form the TOC/TIC supercomplex by interacting with the components of the TOC
complex (43, 64). While Tic62, Tic55, Tic32, and Tic21 do not form the major components of the
TIC complex, they enable redox regulation of the import via their Rieske-type iron sulphur
groups (65-67). Tic21 may be a possible candidate for forming a channel in the inner membrane
and involved in the later stages of leaf development (68). The major components of the TIC
apparatus will not be described in detail in this thesis.

1.8 The TOC Complex
1.8.1 Oligomeric Composition of the TOC Complex
The initial evidence for the existence of a proteinaceous import apparatus came from
the treatment of isolated chloroplast with a protease, thermolysin, which degrades only
cytosolically exposed proteins (3, 69). The identification of import apparatus (three components
of the outer and one of the inner membranes) became possible with the application of protein
cross-linking techniques and the isolation of translocation complexes (19, 70). The specific
binding of precursor to the small subunit of RuBisCO (prSSU) led to the identification of the
receptor of the TOC complex, Toc159/86 and the chaperone Hsp70 in isolated pea chloroplasts
(70). The analysis of cDNA clones and the inhibition of preprotein translocation by nonhydrolyzable GTP analogs led to the identification of Toc34 and Toc 159/86 proteins as GTP
binding proteins of the TOC complex (48). The identification of the receptor Toc159/86 and
channel protein Toc75 was accomplished by label-transfer cross-linking from prSSU to an
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arrested early import complex (19). Toc159 is proteloytically sensitive and was first identified as
Toc86, due to proteolytic degradation of a larger protein (71). Toc34 and Toc159, which belong
to the class of GTP-binding proteins sharing significant homology with the Ras superfamily of
GTPases, serve as receptors for preproteins containing N-terminal transit peptides (3, 6, 72).
They both might act cooperatively, forming a GTPase gate for channel protein Toc75. Toc75, a
member of OMP85 (Outer Membrane Protein, 85 kDa) superfamily, is the most abundant outer
membrane pore forming -barrel channel protein in isolated chloroplasts (73). The N-terminal
contains POlypeptide TRanport Associated (POTRA) domains, and C-terminal is involved in the
pore formation for preprotein translocation (73-74). When these three proteins were
reconstituted into lipid vesicle, they appear to be sufficient for in vitro translocation of a
precursor protein (75). Toc64 another component of the TOC complex is a proposed receptor
that interacts with Hsp90-bound precursor and delivers it to Toc34, but the actual function in
protein translocation is still debated because the deletion showed a very little effect on import
(38, 54, 76). Toc12 is oriented in the intermembrane space and may play a role in recruitment
of Hsp70 proteins and keeping them in close proximity with the TOC complex to bind incoming
preproteins in irreversible manner (6, 77). Toc64 and Toc12 do not form TOC core complex and
will not be discussed in detail.

1.8.2 Oligomeric Structure of the TOC core Complex
In 2003, Schleiff et al. identified the stoichiometry of the pea TOC core complex using
low resolution cryoelectron microscopy at 14 Å (Fig 1-2). The mass of the TOC core complex has
been estimated at between 500 kDa – 1 MDa in pea and approximately 1 MDa in Arabidopsis
(55, 78). The structural analysis suggested that the pea TOC core complex forms roughly circular
particles with the diameter of 13 nm surrounded by solid ring and height of 10-12 nm. A threedimension map suggested a central finger-like domain, which divides the cavity into four porelike domains. The stoichiometry of the TOC core complex was identified to be in ratio of 4-5:4:1
for Toc34, Toc75 and Toc159, respectively, with four units of Toc34 and Toc75 each identical
with the observed pore-like domain structure and the unique Toc159 identical with the central
finger-like structure (55).
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Figure 1- 2 Reconstructed EM image of Toc core complex and proposed Stoichiometry
The Toc complex is composed of the translocation channel Toc75 and two GTPases: Toc159 and
Toc34. To gain an insight into the structural organization, Scheiff et al., 2003 purified The core
compled was purified from pea chloroplast outer membranes and EM studies were performed.
The isolated complex revealed a stoichiometry of 1:4:4-5 between the molecules of Toc 159,
Toc 75, and Toc34, respectively with an apparent molecular mass of 500 kDa. EM studies
revealed that the Toc complex forms four independent channels, which might be connected
inside the complex by a central finger like core region. The cytosolic face is shown on the top
view and the intermembrane space face is shown at the bottom. The image on the left is
adapted from (55).
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1.8.2.1 Toc34
Toc34 is anchored in the outer membrane by a short transmembrane helix near the Cterminus leaving the rest of the protein cytosolically exposed (predominantly hydrophilic) (48).
Toc34 was originally identified in the cross-linking experiments in association with preprotein
during an energy independent binding or in the early import intermediate state in the presence
of low levels of ATP (43). Sveshnikova et al. provided evidence for the role of Toc34 as
nucleotide-regulated preprotein receptor, and Becker et al. showed that the cytosolic domain
interacts specifically with transit peptides of prSSU in addition to binding and hydrolyzing GTP
(36, 79). The cytosolic domain of Toc34 from P. sativum, which lacks the C-terminal α-helical
transmembrane anchor, termed psToc34ΔTM was crystallized (80). In the absence of the
reported structures of other TOC proteins, the crystal structure can be used as a guide to the
mechanism of each of the TOC GTPases since the G-domains of both Toc34 and Toc159 are
significantly homologous (80-82). The crystal structure shows that the Toc34 forms dimer and
the interface serves as a nucleotide binding sites on each monomers (80, 83).
In Arabidopsis, two different Toc34 homologues, atToc33 and atToc34, exist sharing
61% and 64% amino acid identity with psToc34, respectively (34); with atToc33 being the
ortholog of psToc34 since it is the most abundantly expressed of the two proteins (84-85).
These homologues have also been identified in other species including spinach, poplar, tomato,
potato, maize, rapeseed and moss (86). The expression studies indicated that atToc33
expression is much higher in young leaves compared to atToc34, whereas atToc34 is uniformly
expressed at low levels in all organs (84, 87). Furthermore, it has been shown that atToc33, and
not atToc34, is able to inhibit the import of prSSU in isolated chloroplasts, suggesting some
degree of functional specialization (87). An Arabidopsis mutant lacking atToc33, termed plastid
protein import 1 (ppi1), was identified and provided the first in vivo evidence for the role of an
envelope protein in the chloroplast protein import (88). The ppi1 mutant chloroplasts imported
proteins with reduced efficiency and expression of nuclear-encoded proteins especially those
involved in the photosynthesis significantly decreased. The expression of non-photosynthetic
proteins was not changed, suggesting the preference of non-photosynthetic or house-keeping
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proteins by atToc34 (84, 88). Ppi1 mutants showed weak yellow-green chlorotic phenotype and
abnormal chloroplasts with smaller and less developed thylakoids; however, these plants
partially recovered and were able to survive to maturity (84, 87-88). The mutant lacking
atToc34 function, termed plastid protein import 3, ppi3, did not exhibit any severe visible
phenotype other than decrease in root length; however, the ppi1-ppi3 double knockout mutant
resulted in an embryo-lethal phenotype (89). The above observations suggest that atToc33 and
atToc34 play partially overlapping roles with distinct preprotein recognition specificities of
import pathways (89).
The association of Toc34 with preprotein is enhanced by phosphorylation of the transit
peptide. GTP increases the affinity of Toc34 for preproteins, while GDP-bound Toc34 has a
decreased ability to bind preproteins (79, 90). The phosphorylation of Toc34, regulated by a
kinase, results in the decreased affinity of Toc34 for GTP and preprotein and inhibits association
of Toc34 with other members of the TOC complex (79, 91-92). On the other hand, GTP-bound
non-phosphorylated Toc34 binds phosphorylated preproteins with higher affinity (79, 90). Thus,
the affinity of Toc34 for preprotein is modulated by the phosphorylation state of the receptor
protein which regulates the GTP binding properties of Toc34.
1.8.2.2 Toc159
The first member of the Toc159 family was identified as an 86-kDa protein, giving it the
name Toc86 (71). Toc86 was originally identified in isolated chloroplasts through the binding of
the preproteins and characterized as an integral membrane protein with ability to bind GTP (48,
70). It was later identified as a proteolytic fragment of a much larger protein, Toc159, without
its N-terminal A-domain (acidic), since this domain is sensitive to the endogenous proteases
(71). Three domain structures complete this protein: an N-terminal acidic A-domain which faces
the cytosol, a central GTPase G-domain sharing significant homology with Toc34, and a 52-kDa
C-terminal membrane associated M-domain (42, 82). The G- and M- domains are conserved
between members of the family representing more catalytic properties of the translocon
subunit; while the A-domain may be involved in protein-protein interactions due to the
repetitive nature of acidic domain and lack of sequence conservation (42, 93-94). Label-transfer
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cross-linking experiments of Toc86 showed that it interacts with preproteins either in the
presence or absence of ATP (19). Later, Smith et al. identified the involvement of G-domain,
and not the A-domain, of Toc159 in preprotein interaction (41). However, the chloroplasts
lacking the A- domain of Toc159 import proteins with less efficiency compared with those with
the intact protein implying that the acidic domain of Toc159 may be important although not
essential in the import mechanism (34, 71). Toc159 is inserted into the membrane directly via
its M-domain (95). The M-domain of Toc159 is hydrophilic and does not have transmembrane
helices. Furthermore, in isolated chloroplasts, the M-domain is insensitive to the protease
treatment or extraction with salt or alkaline confirming that it might be deeply embedded in
the membrane (34). Crosslinking studies identified Toc159-M domain to be in close proximity
with the mature-region of translocating preproteins suggesting that the C-terminal of Toc159
play roles in preprotein conductance as well as membrane anchorage (34, 43).
In vitro and in vivo experiments have provided evidence for two main functions of
Toc159: As a major protein-import receptor recognizing preproteins in GTP-dependent manner,
and in translocation possibly providing the driving force (43, 75). Initial experiments showed
that Toc159 cross-links preproteins at the preprotein binding phase and associated with the
early import intermediates, suggesting that Toc159 may be the primary receptor of the TOC
complex for preproteins. Later, Becker et al. suggested that Toc159 only binds nonphosphorylated proteins (19, 36, 46). Although Toc159 is shown to form a stable complex with
other translocons of the TOC complex, such as Toc34 and Toc75, even in the absence of
preproteins, there has been much debate regarding the stability with which it remains
integrated into the membrane (46, 55, 70, 96). Some studies suggest that Toc159 shuttles
between the cytosol, where it recognizes and picks up preproteins, and the chloroplast surface,
where it delivers the cargo to the TOC translocon, possibly while interacting with Toc34 and
handing preproteins to Toc75 (41, 94, 97). The cytosolic form of Toc159 was shown to dock
with Toc34 and insert into the membrane in a GTP-dependent manner of G-domain mediated
interaction of Toc159 with Toc34 (98). However, Becker et al. showed that the observations of
the soluble Toc159 is likely an experimental artifact of Toc159 associated with improper
fractionation methods (36). In contrast, a cross-linking study by Kouranov et al. provided
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evidence for Toc34 as initial site of preprotein interaction as preproteins interact with Toc34
transiently in an energy-independent manner, while Toc159 can be cross-linked to preproteins
throughout the early stage of translocation (43). Another study of reconstituted
proteoliposomes suggested that Toc159 provides driving force for the translocation of
preproteins because in the absence of Toc159, another GTPase Toc34 and the channel protein
Toc75 did not import preproteins but in the absence of Toc34, Toc159 and Toc75 were import
competent, suggesting that Toc34 may only be involved in the initial binding while Toc159 may
serve as motor driving the translocation of preproteins (75).
In Arabidopsis, four homologues of pea Toc159 have been identified as atToc159,
atToc132, atToc120 and atToc90 (the prefix ‘at’ refers to the organism of origin followed by the
predicted molecular masses) (94). The proteins atToc159, atToc132, atToc120 share 48%, 37%
and 39% amino acid sequence identity with psToc159, respectively, and each has the same
domain organization as psToc159 (34). Although the homologues of atToc159 share high
similarity to one another, atToc159 is the most abundantly expressed of the three proteins
probably because it is the major receptor while others play minor roles in preprotein import
(94). Arabidopsis null mutant called plastid protein import 2 (ppi2), created with a T-DNA
insertion into Toc159 gene, has a seedling lethal, albino phenotype when the mutant is grown
on soil which indicates that Toc159 is essential for chloroplast development (93). The
expression of photosynthetic genes was down-regulated in ppi2, while the expression of nonphotosynthetic genes was normal and import-competent (41, 93, 99). This supports role of
Toc159 as a main import receptor for photosynthetic proteins and indicate that some other
receptor systems are present for import of the non-photosynthetic or ‘house-keeping’ proteins,
suggesting the involvement of other isoforms of atToc159, such as atToc132 and atToc120 (40).
atToc90 may be involved in the import of photosynthetic proteins because double knockout
mutant for atToc90 and atToc159 severely impaired biogenesis of ppi2 plants (40, 100). Ivanova
et al. showed that the homologues of atToc159, atToc120 and atToc132 were associated in the
complexes containing Toc34, and not necessarily in complexes with atToc159. On the other
hand, atToc33 was associated with complexes containing atToc159 (99). These findings suggest
that more than one substrate-specific pathway of protein import exists involving different
16

subunits of specialized functions in Arabidopsis TOC GTPases. This could explain some of the
conflicting data concerning the order of TOC interactions with preproteins (40, 99).
1.8.2.3 Toc75
Toc75, the 75 kDa component of the complex of the outer membrane of chloroplasts of
P. sativum (psToc75), is a β-barrel channel protein involved in the translocation of proteins
across the outer membrane together with the actions of other components of the TOC
apparatus, such as Toc34 and Toc159 (75, 101). Toc75 is the only chloroplast outer membrane
protein containing cleavable N-terminal ‘bipartite’ transit peptide sequence for intraorganellar
targeting of Toc75 to the outer membrane (26). Originally it was thought that the entire length
of Toc75 contributed to the pore formation until the comparison with other evolutionaryrelated proteins of mitochondria and bacterial OMP85 superfamily which led to the
identification of Toc75 as a member of the OMP85 superfamily (73-74). All members of the
OMP85 family contain a conserved C-terminal transmembrane β-barrel and a soluble Nterminal region containing one or more POTRA (Polypeptide-TRansport Associated domains)
repeats (74). Toc75 contains three POTRA repeats at the N-terminal. The N-terminus region
may be involved in the complex formation with other TOC subunit(s) and/or have a chaperonelike function, binding to the transit peptides before their translocation through the channel
(102). However, the orientation of these N-terminal POTRA domains with respect to the outer
membrane is still unknown (74). The focus of this thesis is to elucidate the topological
orientation of the N-terminal POTRA domains of psToc75. A later part of Chapter 1 focuses on
the detailed discussion about the biogenesis, properties and homologues of Toc75 and OMP85
superfamily. The observations presented in the published crystal structures of bacterial outer
membrane proteins are conserved across other members of OMP85 family and therefore can
be applied to reconcile the organization and mode of action of the three psToc75 POTRA
domains as well.
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1.9 Toc75 and OMP85 Superfamily
The research on insertion of α-helically anchored membrane proteins gained much
attention in the past 10-20 years. It was not until recently that the β-barrel shaped transporters
gained considerable attention. This was followed by the discovery of a specific pathway for the
insertion of β-barrel outer membrane proteins identified in both mitochondria and Gramnegative bacteria (73, 103). The outer membranes of Gram-negative bacteria and eukaryotic
membranes of mitochondria and chloroplasts are unique because of the presence of β-barrel
proteins, while most biological membranes contain exclusively α-helical transmembrane
proteins (104). The presence of β-barrel proteins in mitochondria and chloroplasts is also
indicative of their evolutionary origin from an α-proteobacterium and a cyanobacterium,
respectively (103).
Toc75 is the β-barrel protein-conducting channel involved in the translocation of
preprotein across the outer membranes of chloroplasts (101, 105). Some of the features unique
to β-barrel proteins include the presence of even numbers of (usually 8 to 22) amphipathic,
antiparallel β-strands connected by loops of different sizes, forming a cylindrical barrel-like
structure across the membrane bilayer. Each strand usually comprises of 8 to 11 residues, long
enough to span the biological membrane (103, 106). Recent studies have indicated the
involvement of β-barrel proteins in polypeptide translocation (chloroplasts), in the assembly of
other outer membrane proteins of endosymbiotic organelle (such as in mitochondria) or in the
assembly of outer membrane proteins of bacteria (106). Bacterial outer membrane β-barrel
proteins function as virulence factors, metabolite and protein transporters and receptors of
polypeptides, while β-barrel from eukaryotic organelles are thought to facilitate the import of
preproteins across the membranes as well as assembly of other outer membrane proteins.
More than 60 bacterial β-barrel proteins have been identified, while 3 putative β-barrel
proteins in the mitochondria, and five porin-like β-barrels in the chloroplasts have been
identified (OEP7, OEP16, OEP21, OEP24, OEP37, Toc75) (22, 103).
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1.10 Origin of the Toc75
1.10.1

Origin of Toc75 from a Cyanobacterial Endosymbiont
Toc75 is one of the most abundant proteins in the isolated outer membrane complex

(2). It is a member of the polypeptide-transporting family found in endosymbiotic organelles
and acts as a protein translocation channel (106). The completion of the genome sequence of
cyanobacterium Synechocystis sp. PCC 6803 provided insight into the evolutionary origin of the
chloroplast translocation apparatus and indicated that proteins such as Toc75, Tic22 and Tic20
evolved from the existing cyanobacterial proteins (1, 107). A putative cyanobacterial
homologue of Toc75, referred to as SynToc75 or Synechocystis Toc75 (encoded by slr1227
gene), was identified and presumed to be the first one to be transferred to the host cell nucleus
yet retaining its function as a transport protein (107). One hypothesis suggested that prior to
engulfment of Synechocystis by a heterotrophic eukaryotic cell, the β-barrel SynToc75 protein
was organized such that it recognized and exported virulence factors from an ‘in to out’
direction. Upon being inserted into the plastid outer membrane (following engulfment),
SynToc75 inserted into the membrane with an inverted topology such that it now imported the
proteins into the organelle from an ‘out to in’ direction as shown in Fig 1-3 (1). This
topologically inverted protein - with its previously periplasmic precursor binding site now
exposed to the cytosol - is now referred to as the Toc75 or psToc75 of P. sativum and
recognizes and imports proteins into the chloroplasts in the same manner SynToc75 once
exported them (4). The difference in the directionality of the protein translocation across the
outer envelope of chloroplast through Toc75 distinguishes it from other outer membrane
proteins of OMP85 superfamily relatives, such as mitochondrial Sam50 (mitochondrial Sorting
and Assembly Machinery, 50 KDa)/Tob55 (Topogenesis of mitochondrial Outer membrane βbarrel protein, 55 kDa) and the TPS (Two-partner secretion) system, which transport proteins
from an ‘in to out’ direction (22, 73). The other components of the TOC core complex, such as
Toc159 and Toc34 do not show any prokaryotic origin and might have been added later to the
translocon during the conversion of an endosymbiont to an organelle (22, 108).
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Figure 1- 3 Model demonstrating possible evolutionary origin of the Toc75 channel from
cyanobacterial endosymbiont, SynToc75
(A) Panel A shows the involvement of SynToc75 in Synechocystis in facilitating the secretion of
virulence factors, shown in yellow and green, from periplasm to extracellular moiety. The
virulence factor substrates gave rise to the modern day transit peptides. (B) Panel B shows the
transfer of genes encoding both SynToc75 and substrates from cyanobacteria to the nucleus of
plant/algal cell. The Toc75 protein is now inserted back into the outer membrane in an inverted
topology such that that it now facilitates protein import back into the organelle. This model is
adapted and reconstructed from (1) by Dr. L. Evan Reddick .
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1.10.2

Toc75 and its Structural Homologue, SynToc75
Cyanobacterial SynToc75 is part of a group of prokaryotic secretion channels. It exports

virulence factors across the outer membrane and is essential for the viability of the organism
(107, 109). Cyanobacterial SynToc75 and pea Toc75 share 21% overall sequence identity (24%
identity and 41% similarity) and can be aligned over the entire sequence of the two proteins,
which are similar in size (psToc75: 809 residues; SynToc75: 861) (107). Both proteins are
integral outer membrane proteins, containing N-terminal cleavable transit peptide sequences
and a high number of amphiphilic β-strands especially in the C-terminus indicating that these
two proteins are structural homologues (17, 107, 109). Furthermore, electrophysiological
studies with SynToc75 reconstituted in proteoliposomes mimetic of the chloroplast outer
membrane displayed properties which were similar to the properties of Toc75 as both were
shown to form cation selective channels, supporting the transport function for SynToc75 and
Toc75 (109-110). Another homologue of psToc75 was identified in Nostoc PCC7120 (Anabena)
named alr2269 which shares 19.4% identity and 25.4% sequence similarity with psToc75 (102).
Pea Toc75 homologues are also conserved among different plant species of both monocots and
dicots including Arabidopsis, barley, cotton, maize, legume, potato, rice, rye, soybean, tomato
and wheat (111).

1.11 Biogenesis of peaToc75
1.11.1

Role of ‘Bipartite’ Transit Peptide in Processing of Toc75
Generally nuclear encoded proteins destined for the outer membrane lack N- terminal

transit peptides and contain their targeting information within their mature domain (23). The
targeting of precursor of Toc75 (prToc75) to the outer membrane is interesting because it is the
only outer membrane protein which is synthesized as a higher molecular weight protein with a
cleavable ‘bipartite’ N-terminal transit peptide sequence (26, 112). The N-terminus of the Toc75
transit peptide contains a usual stromal targeting sequence which is cleaved off by Stromal
Processing Peptidase (between residues 35 and 36) when it reaches the stroma. Whereas the Cterminus of the transit peptide contains information necessary to direct the protein to the
outer envelope membrane and contains a plastidic type I signal peptidase (Plsp1) cleavage site
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between residues 131 and 132, generating the mature form of the protein (26, 112-113) (Fig 14).

1.11.2

Role of ‘Bipartite’ Transit Peptide in Targeting of Toc75
In vitro import assays with isolated chloroplast and experiment with stromal extracts

provided information regarding the processing of prToc75 and insertion of the mature form of
Toc75 into the chloroplastic outer membrane (26). The action of SPP generates the
intermediate form (iToc75) of prToc75 and subsequently its mature form (mToc75) by the
action of Plsp1 (26) (Fig 1-4). The precursor of Toc75 is divided in three regions: N (n75) and C
(c75) terminals of the transit peptide and mature region of the Toc75 (m75) (26) (Fig 1-4).
When the n75 is cleaved off by the SPP, the c75 region of the transit peptide interacts with the
inner membrane, preventing translocation of the protein into the stroma and diverging the rest
of the protein to follow the general chloroplastic import pathway as m75 does not contain
information about intraorganellar targeting. Once the translocation is halted, the mature form
of Toc75 (m75) then folds and assembles into the outer membrane (26, 112). The final topology
of the mature form of Toc75 in the membrane is currently under investigation; however,
several models have been proposed (110, 114-115).
The C-terminus of the transit peptide of Toc75 (c75) consists of 96 amino acids and can
be divided into two regions: N-terminus rich in conserved hydrophobic residues and a region
towards the C-terminus of the peptide containing a polyglycine stretch of 17-22 glycine
residues separated by four consecutive serine residues, dividing this region into two polyglycine
stretches over 24-29 amino acids (Fig 1-4). By employing deletion and site-directed
mutagenesis followed by in vitro import assays, the importance of the transit peptide of Toc75
(especially the C-terminus) was shown in the biogenesis of Toc75. The first polyglycine stretch
located in the C-terminus (and not the conserved hydrophobic domain or the second
polyglycine stretch) was found to be necessary for correct targeting of psToc75 to the outer
membrane as replacement of this region with polyalanine stretch resulted in mistargeting of
the protein into the stroma (113, 116). One of the hypotheses proposed to explain this
observed phenomenon is that the polyglycine stretch could prevent the association of Toc75
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Figure 1- 4 Biogenesis of Toc75
The precursor of Toc75 is shown on the top with the transit peptide. Two domains of the transit
peptide are shown in red (N-terminus) and green (C-terminus) leaving the mature domain of
Toc75. The full-length precursor, intermediate, and mature forms of Toc75 are indicated as
prToc75, iToc75, and mToc75, respectively. The stromal targeting sequence (SPP) is shown as
black box at amino acid residue 36. The C-terminus of the transit peptide containing
hydrophobic block and polyglycine stretch are indicated as white and gray boxes, respectively.
Plastidic type I signal peptidase 1 (Plsp1) cleavage site is shown at amino acid 132 leaving the
mature form of Toc75. The blocks are not drawn to scale.
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with other envelope components, such as Toc12, Hsp70 and Tic22, which direct the proteins to
the stroma, thus assuring that the correct folding of Toc75 occurs at the outer envelope (113,
116). The similar insertion and topogenesis in mitochondrial outer membrane is mediated by
the SAM apparatus and the more precisely, the Sam50 protein (3).

1.12 Channel-Forming Properties of Toc75
Initial patch-clamp analysis provided compelling evidence for the role of Toc75 as a
channel forming protein (110). Toc75 formed narrow, voltage-gated, cation-selective
transmembrane channels with a predicted hydrophilic pore of approximately 8-9 Å in diameter;
the Toc75 protein also possessed a precursor binding site (110). With a pore of this diameter, it
was suggested that preproteins had to be unfolded in order to translocate across the
membrane. However, this observation was not in agreement with the diameters of other
translocation pores (101, 110). The electrophysiological studies of heterologously-expressed
Toc75 with an improved reconstitution procedure showed a resemblance to the β-barrel pores.
This study revealed that Toc75 has a wide pore of approximately 26 Å at the entrance and a
narrow restriction zone of about 14 Å serving as a selectivity filter for partially folded proteins
(101). The same study also demonstrated that the precursor binding site of Toc75 was able to
differentiate between a genuine transit peptide, a synthetic peptide resembling a transit
peptide, and a mitochondrial presequence based on both conformational and electrostatic
interactions (101, 110). Toc75 was resistant to thermolysin treatment, salt and high pH
extraction and therefore was identified as an integral outer membrane protein (17).

1.13 Role of Toc75 in Protein Import
Toc75 is a component of the chloroplastic protein import apparatus. It is the best
characterized component in its function among the TOC core complex (9). It was identified as
an outer membrane component associated with envelope-bound import intermediates, stably
associated with Toc159, Toc34 and other components of the translocon, even in the absence of
precursor proteins (17, 34). The investigation of the interactions of the outer membrane import
components with an early import intermediate using a label transfer cross-linking approach led
to the identification of Toc75 interaction with radiolabled prSSU bound to the TOC complex in
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intact chloroplasts of P. sativum in the presence of low ATP levels (<75 µM) (19), whereas
labeling of Toc159/86 was ATP independent (19). Although both proteins were identified as
components of the outer membrane, the labeling of Toc75 was only detected in the fractions
containing mixed envelope membranes (inner and outer membranes), suggesting a mechanism
of energy-independent binding from the receptor to the contact site between the inner and
outer membrane of the chloroplast envelope (19). In contrast, Ma et al. suggested that these
proteins act as part of a multiunit complex that mediates the initial energy-independent
recognition of the transit sequence and subsequent energy-dependent insertion of the
precursor across the outer membrane instead of sequential recognition by Toc159/86 and
Toc75 as suggested by Perry et al. (19, 46). The same cross-linking studies also showed that
Toc75 remained in close physical proximity to the transit sequence of preproteins during
protein import across the membrane (46). Moreover, the Fab fragments isolated from
antiserum against Toc75 inhibited the subsequent import of precursor proteins into
chloroplasts (112). This supported its role as a component of the outer member import
apparatus. The N-terminal region of psToc75 was shown to act as a specific receptor for
proteins containing N-terminal transit sequences; this was in agreement with postulated transit
peptide binding sites within the protein (102, 110). The N-terminus of psToc75 interacted with
the receptor Toc34, while the C-terminus was shown to be involved in the assembly of the pore
(102). Furthermore, Toc75 along with another subunit of the TOC complex, Toc34, were shown
to mediate the docking and insertion of Toc159 to the outer membrane (37).
Another interesting label-transfer cross-linking study demonstrated the dual role of
Toc75 in the targeting of proteins both to the outer and interior of chloroplast membranes. It
demonstrated that an α-helical Outer Envelope Protein, 14 kDa (OEP14, P. sativum) directly
cross-linked to Toc75 during its insertion into the membrane. OEP14 inserted with high
efficiency into proteoliposomes reconstituted with Toc75, whereas no insertion was observed
into liposomes devoid of Toc75. This indicated that Toc75 played a dual role in the targeting of
protein into and across the chloroplast envelope (117). However, this is the only study
demonstrating Toc75’s involvement in the insertion of another outer membrane protein into
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the membrane. Mitochondria (TOM40) and bacteria (SecYEG) also have been shown to use
similar pathway for the insertion of inner and outer-membrane proteins (117-118).

1.14 The Toc75 family
1.14.1

atToc75-I
So far two genes encoding Toc75 have been identified in the pea genome: Toc75 coding

for the protein conducting channel of the outer membrane, and psToc75-V identified based on
the sequence similarity with SynToc75 (109). psToc75-V shares 22% identity with psToc75 and
presumed to form a channel like psToc75 (108, 110). It was named as psToc75-V due to the
presence of the similar protein encoded on chromosome V in Arabidopsis, atToc75-V (108). It
has been proposed that psToc75-V could be an ortholog of the cyanobacterial ancestor and
Toc75, a paralog (108, 119).
In Arabidopsis, four genes that encode homologues of Toc75 have been identified as
atToc75-I, atToc75-III, atToc75-IV, atToc75-V according their location in chromosomes I, III, IV
and V, respectively (85, 108). All Arabidopsis Toc75 homologues are expressed proteins, with
the exception of atToc75-I (120). atToc75-I is a pseudogene containing a transposon and
numerous multiple nonsense mutations and stop codons (55% identity with psToc75) (120).

1.14.2

atToc75-III
Of the remaining three homologues, atToc75-III (approximately 75 kDa) is the only

functional homologue to Toc75 sharing 73% identity to the pea ortholog and it is the only
homologue containing a bipartite transit peptide similar to psToc75 (113, 120). It is the most
abundant integral outer membrane protein in the isolated chloroplast outer membrane
complex and is proposed to form the protein conducting channel in Arabidopsis TOC complexes
(55, 114, 120). atToc75-III is expressed at much higher levels than atToc75-IV and exhibits
similar expression patterns to those described for psToc75 (112, 120). Like psToc75, the
expressions of atToc75-III was the strongest in young, rapidly dividing photosynthetic tissues
and considerably lower in less rapidly growing tissues such as roots (112, 120). This suggested
that it encoded the main ortholog of psToc75 in Arabidopsis. T-DNA insertional mutants of
homozygous atToc75-III are embryo-lethal indicating its fundamental role in the chloroplast
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biogenesis and is consistent with the notion that it is the most direct functional ortholog of
psToc75 (120-121).

1.14.3

atToc75-IV
Another homologue of Toc75, named atToc75-IV, is the truncated form of atToc75-III

(44-kDa protein, 60% sequence identity with psToc75) without the N-terminal portion
(containing only 8 of the 16 β-strands, lacking the POTRA domains) and an integral protein of
the chloroplast outer envelope (85, 115).
It is expressed uniformly throughout the development but at much more lower level
than atToc75-III (120). Homozygous atToc75-IV knockout plants did not display any visible
phenotype indicating that it is not essential for protein import under normal growth conditions;
however, structural abnormalities were observed in the etioplasts of atToc75-IV seedlings
suggesting that atToc75-IV plays a specific role in the development of plastids in the dark (119120).

1.14.4

atOEP80
The fourth homologue of pea Toc75 named atOEP80 (formerly known as atToc75-V) is

encoded as 80-kDa protein and shares 22% sequence identity to pea Toc75 and 31% identity to
SynToc75 (9, 108). A pea ortholog of atOEP80 is synthesized as a 66 kDa protein and does not
isolate with the TOC complex (108). Based on this observation along with the prediction by
ChloroP (a network-based method for predicting chloroplast transit peptides), it was originally
assumed that atOEP80 (or atToc75-V) was synthesized as a precursor protein with a transit
peptide of 11 kDa and processed to a mature form of 69 kDa; however, this idea was
contradicted by Inoue et al. who demonstrated that the size of atOEP80 is in fact 80 kDa based
on immunoblotting and in vitro import data and suggested that it was targeted to the outer
membrane (not processed upon insertion) in a manner different from that for Toc75/atToc75-III
(9). It was renamed to atOEP80 instead of ‘atToc75-V’ or ‘atToc80’ since there was not enough
experimental evidence to support its function at that time (9, 108). Unlike atToc75-III, it is not
processed into its mature form during membrane insertion and the expression level of atOEP80
is approximately 25% of that for atToc75-III throughout development but substantially higher in
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the embryo (40% higher than atToc75-III) suggesting a possible role during seed development
(9, 122). Moreover, T-DNA insertions in Arabidopsis gene resulted in embryo lethality at a stage
later than that affected by atToc75-III knockout indicating that both Toc75 homologues are
essential for the viability of plants from very early stage of development but may have distinct
functions (122). It is present in the outer membrane with an abundance of less than 10% that of
atToc75-III (108).
atOEP80 has been predicted to form a porin-like channel with 16 β-strands and
hypothesized to be involved in the insertion of other β-barrel proteins into the outer
membrane (9, 108, 114). atOEP80 is distantly related to Toc75 but most closely related to
Omp85 and Tob55/Sam50 (mitochondria) (108, 122). Phylogenic analysis of Toc75 from various
organisms led to the conclusion that both Toc75 and atOEP80 represent two independent gene
families mostly derived from cyanobacterial sequences but diverged prior to the endosymbiotic
event (followed by more recent gene duplication to atToc75-I, atToc75-III, and atToc75-IV)
representing the most ancestral form of Toc75 and thus developed different roles in protein
targeting (9, 108).

1.15 Orientation of Toc75
Structural studies to determine the topology and composition of Toc75 using various
methods such as proteolytic digestion, amino acid sequencing, hydrophobicity, computation
predictions and proteoliposomal studies led to the identification of β-barrel structure
comprising 16 β-strands. Based on these studies, two topology models of the Toc75 orientation
within the membrane were proposed (110, 114). Hinnah et al. proposed a model of Toc75
containing 16 β-strands, clustered in three domains, with a stretch of 229 amino acids
composed of shorter hydrophobic β-strands (Fig 1-5 A) (110). Using proteolytic digestion of
proteoliposomes combined with amino acid sequencing and computer modeling, Sveshnikova
et al. proposed a different model of Toc75 with an N in-Cin orientation of Toc75 (Fig 1-5 B) (114).
In contrast to the previously proposed model, this model contained large loop regions at both
the N- and C-terminal regions most likely facing the intermembrane space between the outer
and inner envelope membrane (110, 114). Despite the differences, both models agree on the
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Figure 1- 5 Comparison between the two predicted topological models of Toc75
(A) The putative secondary structure of Toc75 was derived using a program based on the
hydrophobicity (110). The stretch of 229 residues from 305 to 534 (corresponds to residues
436-665 with transit peptide) is cytosolically exposed at the C-terminus. (B) Panel B shows the
topological model of toc75 derived using rules for β-barrel proteins and treatment using
proteases such as endoproteinase Glu-C, trypsin, chymotrypsin and thermolysin (114). The
models are adapted and reconstructed from (114).
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number of predicted transmembrane stands. Identification of other homologues of pea Toc75
in Arabidopsis, atOEP80 in particular, and improved prediction methods, provided better tools
to reinvestigate the topology of the Toc75 protein family, since previously proposed models
were constructed from Toc75 and SynToc75 (110, 114-115).
This topology model of atOEP80 is proposed to contain 18 transmembrane β-sheets
and two large cytosolic exposed domains at the N-terminus. The C-terminus is not exposed to
the cytosol but forms the core of the membrane channel (data not shown) (115). This was in
disagreement with the previous model by Hinnah et al. who proposed that that the cytosolic
domain is localized at the C-terminus containing short loops and dense package of sheets (110,
115). However, the proposed model was in line with the observations established by
Sveshnikova et al. in that the large regions are localized at the N-terminus and exposed to the
intermembrane space based on the observation that protease treatment and membrane
solubilization resulted in degradation of the protein to 45 kDa (114-115). Since these models
were based on the pea Toc75 homologues present in Synechocystis (synToc75) and Arabidopsis
(atToc75-III, atOEP80), its orientation still remains to be resolved.
The comparison of the evolutionarily related proteins in bacteria and mitochondria shed
some light to the domain organization of the outer membrane β-barrel proteins of the OMP85
family (73). In 2003, Sanchez-Pulido and colleagues characterized N-terminal regions of outer
membrane proteins of the OMP85 superfamily at the sequence level and named them POTRA
domains (discussed in detail in Section 1.17). The C-terminus is a highly conserved β-barrel
domain comprising 10-16 β-strands (74). The domains were identified by generating
independent profiles by searching global hidden Markov models which produced statistical
significant E-values that connected all POTRA-domain containing families (74). A typical POTRA
domain consists of 70 to 95 amino acids and contains three β-strands and two α-helices (74).
The second helix and strand are usually separated by a loop of conserved ‘GXF’ motif. The
number of POTRA domains found in members of Gram-negative bacteria and eukaryotic
organelles varies from one organism to another. The multiple sequence alignment of POTRA
domain is fairly low as shown in Fig 1-6. In the case of bacterial and mitochondrial outer
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Figure 1- 6 Multiple alignment of POTRA domains from different members of OMP85
superfamily
This figure shows the representative multiple alignments of the POTRA domains from different
families ranging from psToc75 to T. elongatus. The alignment was produced with blastP and TCoffee by searching for sequences closely related to psTOC75. The alignment was extended to
include distantly related families such as T. elangatus, P. patens, C. reinhardtii, and H. influenza.
The sequences showing similarity with psToc75 POTRA domains were identified as POTRA
domains of that family to include in the alignment. Two POTRA domains from B. pertussis
(FhaC) and four from E. coli (YaeT) as well as psTOC75 domains identified with HMMer profile
searches have been included. Sequences of human, yeast, and H. influenzae have been adapted
from (74). The alignment shows low sequence similarity between different POTRA domains.
Shown below in the alignment is a consensus secondary structure prediction predicted by the
T-Coffee alignment program. POTRA domains are predicted to have three β-strands (in green)
separated by two α-helices (in red). The second helix and β-strand is separated by a loop
conserved at the ‘GXF’ motif (74). The species abbreviations are: D151_HAE, Haemophilus
influenza; AtToc75, Arabidopsis thaliana; psToc75, Pisum sativum, OryzaJapo, Oryza sativa
japonica; Physcop, Physcomitrella patens; Yaet (BamA), Escherichia coli; Fhac, Bordetalla
pertussis; Te, Thermosynechococcus elongatus; Synec, Synechocystis; Nostoc, Anabena sp
PCC7120.; DrosophilaDROM, Drosophila melanogaster; Chlamy, Chlamydomonas reinhardtiiI,
Human and Yeast.
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membrane proteins, these domains are postulated to localize in the periplasmic and
intermembrane space, respectively. However, the topology of these domains is still unknown in
chloroplastic Toc75. Although not much was known about POTRA domains, they have been
implicated in the membrane biogenesis (123-124). They are involved in the secretion of
virulence proteins and play a key role in protein transport (74, 123); however, the mechanism
by which they transport proteins into or across membranes is unclear. This research focuses on
investigating the topology of the N-terminal POTRA domains of the psToc75. The topology of
these domains will shed light on determining the role(s) of these domains in preprotein
recognition and translocation across the chloroplast outer membranes.

1.16 The OMP85 Superfamily
1.16.1

Members of OMP85 Superfamily
Phylogenic relatedness, secondary structure predictions and roles in protein

translocation define the wide spread nature of the OMP85 superfamily of proteins in many
diverse organisms such as bacteria, fungi, plant and animals (125). The OMP85 superfamily
includes a group of proteins found in the outer membranes of Gram-negative bacteria,
mitochondria and chloroplasts (73, 126). Other members of the gram-negative bacterial
proteins, Serratia marcescens ShlB and Bordetella pertussis FhaC (and other members of the
TPS pathway), are involved in protein translocation/export across the outer membrane (125).
Omp85 was first characterized in Neisseria meningitidis and confirmed in Escherichia coli to play
a key role in OMP assembly machinery. The function of OMP assembly has been conserved
during evolution in both Gram-negative bacteria and mitochondria (126-127). OMP85-like
proteins are divided into two functional classes based on the specific roles they play in protein
transport. Class I proteins are involved in polypeptide translocation across membranes, such as
FhaC protein from B. pertussis (128). Toc75 also belongs to Class I based on its involvement in
protein translocation across the envelope membranes of the chloroplasts. Class II is defined by
the proteins involved in the assembly of β-barrel proteins into the outer membranes such as
BamA - (formerly known as YaeT) for β-barrel assembly machinery component A (E. coli),
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Omp85 (N. menignitidis), TeOmp85 (thermophilic cyanobacterium Thermosynechococcus
elongatus), AnaOmp85 (Anabena sp. PCC7120) and Sam50/Tob55 (mitochondria) (73, 106).

1.16.2

Molecular Architecture of OMP85 Superfamily
The highly conserved molecular architecture common in the members of this family of

proteins distinguishes OMP85 from other family of transport proteins. All the members of this
family share a common domain organization. Their N-termini contain a characteristic set of
POTRA domains, and C-termini is composed of a conserved β-barrel domain (74). These
domains are also present in the FtsQ/DivIB bacterial division protein family (POTRA domains
not associated with a transmembrane β-barrel) as well as other less characterized proteins such
as YtfM (E. coli BamA homologue) and eukaryotic CGI51 (human) (74). The number of POTRA
domains may range from one up to seven and different numbers might be related to the
selectivity of the transporters (74, 129). For example, one POTRA repeat is present in
mitochondrial Sam50 and in the members of FtsQ/DivIB, ShlB, CGI51, whereas three POTRA
repeats are present in YtfM, five repeats in D15 of Haemophilus influenza, N. meningitidis and
other bacterial Omp85s, and as many as seven repeats in Mxan5763 of Myxococcus Xanthus
(Fig 1-7) (74, 129). A recent study provided a possible explanation for larger POTRA structures.
It was suggested that the higher number of POTRA domains may be required for connecting the
periplasm (such as five in proteobacteria); however, cyanobacterial Omp85 periplasmic space is
even larger than that of proteobacteria and yet it contains only three POTRA domains. This can
be explained by a necessity for an adaptation to different sets of accessory proteins (128).
Another study of homologues relationships between 567 POTRA-domain containing proteins
demonstrated that regardless of different number of POTRA domains found in different
species, the most C-terminal POTRA domain is the most conserved followed by the most Nterminal POTRA domain (129). Toc75 contains three POTRA domains at the N-terminus
followed by characteristic β-barrel transmembrane domain (74). Toc75 POTRA domains may
have lost POTRA-containing sequences to adapt an altered functional requirement such as
protein translocation across the membranes rather than protein insertion into membranes
(128).
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Figure 1- 7 Schematic representation of the domain architectures of representative OMP85
homologues
The characteristic set of conserved domain architecture found in the members of the OMP85
superfamily is illustrated in this figure. The most N-terminal contains transit peptide (except in
OEP80 and Sam50) followed by POTRA domains and a conserved C-terminal transmembrane
domain. The proteins are drawn approximately to scale. The transit/signal peptide is indicated
with gray bar; POTRA domains are indicated with green and transmembrane β-barrel domain is
shown in blue. The number of POTRA domains found in different members of OMP85
superfamily ranges from one to as many as seven. Toc75 contains three POTRA domains
followed by a pore forming C-terminal transmembrane domain. FtsQ/DivIB is the only family of
proteins not associated with the β-barrel domain. The class I proteins involved in the transport
of polypeptides across the membranes are Toc75, OEP80, FhaC and ShIB. The proteins belong
to Class II include cyanobacterial, proteobacterial and mitochondrial OMPs involved in the
assembly and insertion of outer membrane β-barrel proteins. The conserved domains are
commonly found in Myxococcus Xanthus, Fusobacterium Nucleatum, Thermosynechococcus
elongates, Anabena sp. PCC7120, Escherichia coli, Bordetalla pertussis, chloroplasts and
mitochondria. This image is modified and reconstructed from (74) and (129).
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Although the domain organization is well conserved in OMP85 superfamily, how these
domains mediate the assembly of OMPs and polypeptide translocation was not clear until now.
The recent crystal structure of several members of this POTRA domain-containing family of
proteins shed some light on this issue. The structures of two POTRA domains of FhaC (B.
pertussis - Class I), the first four POTRA domains of BamA (Class II), and three POTRA domains of
AnaOmp85 (Class II) and TeOmp85 (Class II) provided a better understanding of the assembly
and molecular mechanism by which these proteins incorporate proteins into and across the
outer membranes (123-124, 128-130).

1.17 The POTRA Domains
1.17.1

psToc75-POTRA Domains (Class I)
Although no structural information is available for eukaryotic Toc75 and Sam50, several

studies have implicated the roles of N-terminal regions of these proteins. Biochemical studies
on mitochondrial Sam50 revealed that the N-terminus containing one POTRA repeat of
Sam50/Tob55 faces the intermembrane space (132). In vitro import experiment suggested that
this domain specifically interacted with the β-barrel protein VDAC and inhibited its import into
the organelle (131). Deletion of the part of the N-terminus of the POTRA domain disrupted the
function of Tob55/Sam50 causing a growth defect in yeast suggesting that mitochondrial
POTRA domain plays a critical role in recognizing and guiding the β-barrel proteins from IMS to
the outer membrane of mitochondria (132).
Interestingly, the biochemical studies of the N-terminus of psToc75 truncations
suggested that the N-terminus of psToc75 serve as binding sites to the transit peptides of
preproteins to be targeted to or across the chloroplast outer membrane (102). The same study
showed that the most N-terminal region is involved in hetero-oligomerization with Toc34 and
C-terminus is involved in the pore formation. It is clear that Toc75 is involved in protein
translocation and thus the domains might function in protein recognition, translocation and
gating the pore or might be involved in the complex formation with other TOC subunits as
discussed above depending on the orientation of these domains within the membrane, which is
currently unknown (102). However, based on the proposed topology models (See Section 1.15
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and Fig 1-5), phylogenic and structural relatedness with cyanobacterial proteins (SynToc75,
AnaOmp85, TeOmp85), and most importantly the evolution from the endosymbiotic
cyanobacterial channel protein SynToc75, confident prediction of the topology of Toc75 can be
made (1, 110, 115, 128-129, 133). Prior to engulfment by a heterotrophic eukaryotic cell,
SynToc75 exported proteins from an ‘in to out’ orientation.
Because the topology of any membrane protein is determined by the direction by which
it is inserted into the membrane, the exposure of a previously periplasmic binding site of Toc75
would now have to face the cytosol to facilitate the import of proteins into the chloroplasts (4).
In mitochondria and Gram-negative bacteria, the process of polypeptide recognition and
insertion is mediated by N-terminal POTRA domains localized on the periplasmic side, which
would correspond to the putative cytosolic side of eukaryotic chloroplast outer membrane.
Because domain architecture is a conserved characteristic of OMP85 family members, their
arrangement and mode of function(s) found in recent crystal structures can also apply towards
gaining more understanding about their function and orientation in the chloroplasts (See
Sections 1.17.2 – 1.17.6).

1.17.2

Omp85 - N. meningitidis (Class II)
The role of five POTRA domains of the outer membrane Omp85 of N. meningitidis in

assembly and function was demonstrated by serial POTRA deletion studies. In contrast to the
serial deletion study of E. coli BamA reported by Kim et al. (See Section 1.17.4), this mutation
analysis showed that only POTRA5 was required for the functioning of the outer membrane
assembly (124, 134). This was evidenced through the deletion of the first four POTRA domains
which resulted in only slightly reduced cell viability and some defects in folding of large OMPs
(130). It was suggested that the functional core of Omp85 consists of its β-barrel membrane
domain and one (out of five) POTRA domain: POTRA5 (130). This discrepancy might be due to
the relative position of the individual POTRA domains or due to different OMP assembly
pathways in the two organisms. POTRA5 in bacteria in both the organisms (E. coli and N.
meningitidis) is of particular importance because both studies suggest a role for POTRA5 in
either directly interacting with substrates (in the periplasm) or in binding to the essential
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accessory lipoproteins (YfiO) (124, 130). Such observation suggests that the most C-terminal
POTRA domain may play an important role in the OMP assembly across all the members of
Gram-negative bacteria.

1.17.3

FhaC - B. pertussis (Class I)
POTRA1 domain of FhaC (Class II) is involved in the secretion of FHA across the outer

membrane of B. pertussis. Clantin et al. reported the full-length structure of the outer
membrane transporter of Omp85-TpsB superfamily of protein FhaC at a resolution of 3.15 Å.
This protein mediates the translocation of filamentous hemagglutinin (FHA), the major adhesin
of the whooping cough agent B. pertussis to the bacterial surface of (135). The C-terminal
domain of FhaC forms a transmembrane pore comprised of 16 anti-parallel β-strands. The Nterminal periplasmic module consists of two globular POTRA domains composed of 75 residues
each with three β-strands and 2 α-helices, forming hydrophobic core. POTRA domains share
very low (~14%) sequence identity; however, they share well conserved structure. Both POTRA
domains of FhaC superimpose with an r.m.s.d of 1.6 Å (74, 123). The β-barrel is occluded by an
N-terminal 20-residue long α-helix (H1) and a C-terminal extracellular loop (L6). In silico
analyses of this superfamily demonstrated conserved motifs within the β-barrel, referred to as
motifs 3 and 4, also seen in FhaC (L6 of motif 3) (106, 123). These motifs are also found with
the homologues of Toc75 and defined by two conserved transmembrane β-sheets and suggest
similar gating and translocation behavior of the other proteins of this family (106). Finally, the
role and precise orientation of the POTRA domains in secretion was demonstrated by deletion
of either of POTRA domains and insertion of Gly134 at the junction of the POTRA, which resulted
in abolishment of secretion; however, FhaC was still able to form the channel suggesting that
the POTRA domains are required for the secretion but not pore formation (123). Based on the
planar lipid bilayer conductance assay, as well as mutation and deletion studies, the model of
the FHA translocation by FhaC was proposed (123). The model proposes that the POTRA1
domain of FhaC (furthest from the pore, at periplasmic moiety) binds to the N-terminal domain
of the FHA in the periplasm which opens the β-barrel channel removing the occluding elements
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(L6) (123). FHA is then translocated through the channel in an extended hairpin conformation.
The N-terminus dissociates from POTRA1 and subsequent folding takes place at the cell surface.
This model serves as a general model of secretion by other outer membrane proteins of this
family. Fig 1-8 A shows the full-length structure of FhaC. The substrate binding site of POTRA1
faces the periplasmic site and translocates the polypeptide across the membrane of B.
pertussis. The N-terminal H1 helix and L6-loop are folded inside the pore.

1.17.4

BamA - E. coli (Class II)
Kim et al. reported the 2.2 Å structure of a periplasmic region of the E. coli outer-

membrane protein BamA (formerly known as YaeT/Omp85) (Fig 1-8 B). BamA contains five
POTRA domains, although only four and a fragment of the fifth POTRA domain was crystallized.
The overall structure of the four BamA POTRA domains revealed a curved ‘fishhook’ like
arrangement; however, small-angle X-ray scattering (SAXS) and NMR data revealed that the
POTRA domains are less rigid and form an extended (Z-shaped) conformation in solution (136).
Another crystal structure of BamA POTRA domains contained four of five POTRAs in an
extended conformation (137). Both structures highlight conformational flexibility with a hinge
between the POTRA domains allowing flexibility in solution (124, 128, 136-137). Although the
primary sequence similarity of the POTRA domains is relatively low, the structural folds in each
domain reveal a high level of similarity as suggested previously by Sanchez-Pulido et al.,
comprising three stranded sheets and two helices. Superimposed images of the two FhaCPOTRA domains and four BamA-POTRA domains reveal high structural similarity between
different POTRA domains (Fig 1.8 C). The order of the secondary structure is β-α-α-β-β with the
first and second β-strand forming the two edges of the sheet with the third strand sandwiched
between them. Also, the most conserved residues were shown to be in the hydrophobic core or
the loop regions, suggesting their role in maintaining structural integrity. BamA is reported to
bind C-terminal peptides of OMPs. Deletion studies of BamA POTRA domains suggest that these
domains play a critical roles in substrate recognition and perhaps folding (138). Targeted deletion of five
BamA POTRA domains revealed that all five POTRA domains of E. coli BamA are important in complex
formation (124). Deletion of these domains severely altered intramembrane assembly and resulted in a
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Figure 1- 8 Crystal structures of the POTRA domains of FhaC and BamA
Panel A shows the full-length crystal structure of the two POTRA domains and β-barrel of FhaC
in B.pertussis. The N-terminal H-1 helix and L6-loop of the β-barrel are folded inside the pore.
Two POTRA domains face the periplasmic site and POTRA1 binds the N-terminal of FHA
removing occluding L6-loop from the barrel. FHA is translocated across the membrane in an
extended hairpin-like conformation. (B) Panel B shows the four (of five) POTRA domains of
BamA in E. coli. (C) Panel C indicates a high degree of structural similarity when these six POTRA
domains, two of FhaC and four of BamA, were superimposed using STAMP alignment program.
The β-strands are labeled in yellow and the helices are labeled in purple; the loops are shown in
light blue. The PDB structures were available from NCBI database and (123-124).
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significant increase of misfolded β-barrels in the periplasm as well as a decrease in the amount
of correctly inserted β-barrel OMPs (124, 137). POTRA1 and POTRA2 deletion mutants retained
partial function, while POTA3-5 domains were essential for cell viability. This observation
suggested that the POTRA domains closest to the pore might play a critical role. Moreover, the
POTRAs formed a dimer in the crystal structure most likely through interactions between βstrands. Although the dimer formation was probably not physiologically relevant, the possibility
of the formation of β-strand augmentation, an interaction between a β-sheet with a β-strand of
a second protein, in the dimer interface in mediating the assembly of other OMPs or interaction
with other OMP components was also suggested (124). Similar scenario was observed at the
dimer interface of the AnaOmp85 and TeOmp85 crystal structures and in complexes that bind
and clear misfolded OMPs from the periplasm (124, 128-129) (See Sections 1.17.5-1.17.6).
These observations may shed some light on the mechanism by which Toc75 POTRA domains
interact and translocate preproteins across the chloroplast membranes.

1.17.5

AnaOmp85 – Anabena (Class II)
Until now all bacterial homologues of OMP85 were thought to contain five POTRA

domains. Recent studies showed that the cyanobacterial Omp85s (of T. elongatus and
Anabena) differ in structure and composition from proteobacterial Omp85 and more closely
related to its chloroplast homologues, Toc75 containing only three POTRA domains instead of
five (128-129, 137). Three POTRA domains of a cyanobacterial homologue Anabena sp.
PCC7120 was recently crystallized, and the domains were named P1 to P3 from the N-terminus
(128). Residues 217 to 296 were identified as POTRA1, 297 to 377 as POTRA2 and 378 to 467 as
POTRA3. The POTRA domains of AnaOmp85 share a common fold of a three stranded β-sheet
packed against two helices with these variations: POTRA1 contains small two stranded β-sheet
near to its N-terminal; In POTRA2, helix α1 and strand β2 are interrupted and in POTRA3: an
extended structure loop (L1) is observed between β2 and α2 forming two β-turns. The L1-loop
is well conserved between chloroplasts Toc75 family, mitochondrial Sam50 and proteobacterial
proteins and acts in the pore gating function of the protein (128). Based on the variations in the
folds of these domains, each of the POTRA domains were assigned functions. As implied
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previously, the most C-terminal POTRA domain and thus closest to the pore, POTRA3, is
involved in regulation of protein transport via its conserved L1-loop. POTRA1 and POTRA2 can
be involved in the substrate recognition and hetero-oligomerization as shown by the presence
of β-augmentation (also seen in BamA) in mediating protein-protein interaction in POTRA1,
while POTRA2 has two potential protein interfaces to the sides of its β sheets. Moreover, the
structure revealed the presence of a hinge between POTRA1 and POTRA2 corresponds to the
flexibility between P2 and P3 domains of E. coli BamA, suggesting an equivalent hinge region,
while POTRA2 and POTRA3 were fixed in orientation (124, 128).
The hinge between the two proteins may allow change in orientation between POTRA1
and POTRA2 caused by protein-protein interactions. Thus the presence of flexible linker regions
might be of importance for substrate-recognizing POTRA domains. The arrangement of the
most C-terminal POTRA domain was closely similar to that observed with FhaC and TeOmp85
(See Sections 1.17.3 and 1.17.6), further suggesting the orientation is a conserved feature of
this family of proteins (123, 128). The crystal structure of these three POTRA domains is shown
in Fig 1-9 A. The regions involved in the protein-protein interactions are highlighted in the
figure. The structural features observed in this study also apply to the members of
cyanobacterial Omp85 and chloroplastic Toc75 (128).

1.17.6

TeOmp85 - T. elongatus (Class II)
Recently, Arnold et al. reported the first structure of the periplasmic part containing all

POTRA domains of cyanobacterium T. elongatus (TeOmp85) at 1.97 Å resolution (without first
45 residues) (Fig 1-9 B) (129). Unlike BamA and Omp85 of E. coli and N. meningitidis,
respectively, TeOmp85 contains three POTRA domains, like Toc75, followed by a C-terminal
pore containing 16 β-strands and an unstructured proline-rich region located N-terminal to the
POTRA domains. The domains were named P1 to P3 from the N-terminus, P3 being closest to
the pore and forming a banana-shaped scaffold. Residues 67 to 141 were identified as POTRA1,
142 to 217 as POTRA2 and 218 to 301 as POTRA3. These POTRA domains formed the usual β-αα-β-β fold with a small three stranded β-sheet covered by two helices and formed a conserved
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Figure 1- 9 Crystal structures of the POTRA domains of AnaOmp85 and TeOmp85
(A) Panel A shows the crystal structure of the three POTRA domains of AnaOmp85 in Anabena
sp. PCC 7120. The L1-loop of POTRA3 is shown at the top which is involved in regulation of
protein transport being closest to the pore. The N-terminal POTRAs might be involved in
substrate recognition and hetero-oligomerization by β-augmentation. (B) Panel B shows the
three POTRA domains of TeOmp85 in T. elongatus. (C) Panel C indicates a high degree of
structural similarity when POTRA domains, three of AnaOmp85 and three of TeOmp85, were
superimposed using STAMP alignment program. The POTRA superimposed with an r.m.s.d. of
3.71 Å. The β-strands are labeled in yellow and the helices are labeled in purple; the loops are
shown in light blue. The PDB structures were available from NCBI database and (128-129).
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hydrophobic core, as seen previously in FhaC and BamA (123-124, 129). Furthermore, when
POTRA domains of AnaOmp85 and TeOmp85 were aligned, they superimposed with an r.m.s.d.
of 3.41 Å as shown in Fig 1-9 C. Therefore, some of the features observed in AnaOmp85 POTRA
domains can be applied to other cyanobacterial OMP proteins as well. The deletion of POTRA
domains led to a destabilization of the pore at higher voltage, which suggested a role of the
soluble N-terminus in stabilizing the channel. The stabilization is mediated by the interactions
of the C-terminal POTRA domain (POTRA3) with the periplasmic turns connecting the β-strands
of the pore (129). A similar scenario is observed in FhaC by the presence of H1 helix inside the
pore and the most C-terminal POTRA domain (POTRA2 of FhaC) is in the close proximity (123);
however, deletion of either of FhaC POTRA domains did not have any effect on the pore
formation. On the other hand, the unstructured proline-rich N-terminus can also fold inside the
channel (like H1 helix of FhaC) leading to a decreased conductance of the full-length protein,
although this was not observed. Finally, the presence of a long L6 loop of motif 3 of β-barrel
which folds inside the pore is well conserved between FhaC and TeOmp85 (129). This indicates
that this loop may be responsible for the assembly of OMPs in other cyOmp85 (cyanobacterial
Omp85) as well. The electrophysiological measurements of conductance of TeOmp85 was in
the range of other cyanobacterial Omp85s, plant Toc75 and TPS proteins and higher than that
of proteobacteria and Sam50 (129). This indicated a closer relation to its chloroplast homologue
Toc75 than to proteobacterial Omp85s. Another piece of evidence for a close relationship
between TeOmp85 and Toc75 came from sequence analysis and clustering methods. When
POTRA1 and POTRA3 of TeOmp85-N were superimposed individually, they aligned better than
POTRA1/POTRA2 or POTRA2/POTRA3. Cluster analysis of POTRA domains also revealed that
POTRA1 and 3 clustered much closer than either does with POTRA2. When these POTRA
domains were superimposed with two POTRA domains of FhaC, they aligned well with an
overall r.m.s.d. of 3.4 Å, further suggesting well-conserved structural similarity. The cluster
analysis of N-terminal POTRA domains of Sam50, Toc75-III, Toc75-V, cyOmp85s, proteobacterial
Omp85, and TPS-Omp85 proteins revealed that the most N-terminal (furthest from the pore,
usually POTRA1) and most C-terminal (closest to the pore, POTRA5 of Omp85, BamA, POTRA1
of Sam50, and POTRA3 of Toc75, cyanobacterial Omp85) are clustered close together. The most
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C-terminal POTRA domains are the most conserved, followed by the most N-terminal POTRA
domains, regardless of presence of different number of POTRA domains between them. It was
concluded that the most complex OMP85 proteins contain as many as seven POTRA domains
(M. xanthus) and may have evolved from a relatively simple ancestor (such as Sam50 containing
one POTRA repeat) (129). This study also showed that the proteins of the TPS family containing
two POTRA repeats did not cluster close together with other cyanobacterial or proteobacterial
POTRAs, but it could represent an intermediate in the evolution of these more complex
proteins. Based on the electrophysiological experiments, cluster analysis and structure analyses
two main conclusions were made: (1) Cyanobacterial TeOmp85-POTRA domains are more
closely related to Toc75 than to the proteobacterial proteins, and (2), the most N and Cterminus POTRA domains are the most conserved along with the β-barrel representing the
most central functions of these proteins, in substrate recognition and membrane insertion
(129).

1.18 Summary
One of the most important characteristics that distinguishes the photosynthetic
eukaryotes (plants) from animals is their ability to convert sunlight into chemical energy in the
process of photosynthesis, supporting almost all life on earth (21). Chloroplasts contain the
sites of photosynthesis and are believed to have originated from a primary endosymbiotic
event from photosynthetic prokaryote related to modern cyanobacteria. Over the course of 1.5
billion years of evolution, plastid genome went under a large genome reduction where most of
their genetic information was transferred to the host cell nucleus necessitating a mechanism
for the import of now nuclear-encoded proteins back into the chloroplasts for chloroplast
biogenesis. These proteins are synthesized in the cytosol and post-translationally translocated
across outer and inner envelope membranes of the chloroplast with actions of components
associated with TOC and TIC hetero-oligomeric complexes, respectively.
The channel forming β-barrel protein of the TOC core complex, Toc75, is a member of
OMP85 superfamily and shares significant homology with it ancestral cyanobacterial
homologue. Members of this family share signature characteristic: C-terminal involved in the β-
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barrel pore formation and N-terminal containing POTRA repeats. From the studies of the
POTRA domains in other organisms, it is clear that regardless of the different number of POTRA
domains present in each family, the arrangement and structural folds of POTRA domains are
conserved within different organisms. Thus, the molecular mechanism by which POTRA
domains facilitate the substrate recognition and insertion into and/or across the membranes
can apply to the rest of the OMP85 family of proteins. In bacterial outer membranes, these
domains localize in the periplasm and facilitate the transport of polypeptides to the
extracellular space, and in mitochondria from intermembrane space to outer membrane.
The focus of this thesis is to elucidate the topological orientation of N-terminal POTRA
domains of psToc75. Methodology is presented in Chapter 2. Chapter 3 and 4 present the
evidence for the orientation of psToc75-POTRA domains within the outer chloroplast
membrane and present initial evidence for their involvement in protein import, followed by
concluding remarks, and potential future directions addressed in Chapter 5.

1.19 Proposed research
This thesis focuses on investigating the orientation of the N-terminal POTRA domains of
psToc75. We hypothesize that POTRA domains of psToc75 face the cytosol and are involved in
preprotein interaction and targeting to the chloroplast. Two topological models were proposed
for full-length Toc75 and were utilized as a first step to re-investigate the topological
orientation of this protein (110, 133). Seven predicted Toc75 inter-β-strand loops were selected
and named as ‘Toc75 Loop Domains’ (TLDs). These loops were cloned, expressed, and purified
for the ultimate production of antibodies. Recent reports of crystal structures of FhaC, BamA,
AnaOmp85 and TeOmp85 POTRA domains provided valuable insight into the topology studies
of Toc75.
Three POTRA domains of psToc75 were identified, cloned, and purified for antibody
production and to test the hypothesis that these domains may interact with other TOC
component(s) or preproteins. To this end, in vitro chloroplast import and binding assays were
designed. The data obtained from these assays can be used to infer the topological organization
of these Toc75 POTRA domains. Furthermore, Flow cytometry or fluorescence activated cell
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sorting (FACS) and chloroplast agglutination assays can be used to confirm the topology of
POTRA domains by decorating intact chloroplasts with the antibodies raised against these
domains. Finally, Laser Scanning Confocal Microscopy along with proteolytic digestion with
thermolysin can be used to confirm the localization of POTRA domains. Utilizing data obtained
from these experiments, we propose that Toc75 POTRA domains are localized in the cytosol
and POTRA domain(s) interact with translocating preprotein(s) evidence by the import and
binding assays.
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CHAPTER 2 Methods and Materials
2.1 Homology Modeling
Toc75 contains three copies of POTRA domains according to identification by (74).
Identification of POTRA domains of psToc75 provided adequate information to build a
reasonable homology model of the psToc75-POTRA domains. Using HMMer to perform Hidden
Markov Profile searches and the HMM profiles of POTRA1 and the related Bacterial Surface
Antigen (both downloaded from the pFam database, Sanger Institute), the POTRA domains of
psToc75 were identified as POTRA1, POTRA2 and POTRA3 and the homology model of psToc75
was generated by a former student, Mr. Michael Vaughn (105). The crystal structure of a
recently published protein containing POTRA domains, FhaC, was used as a model to generate
the homology model of psToc75-POTRA domains. The alignments were generated by align2d
program, and Modeller 9v2 package was used to properly align the structures of FhaC and
psToc75-POTRA domains (105, 123). The alignment was slightly adjusted for proper alignment.
The crystal structures and homology model of psToc75 were viewed with Visual Molecular
Dynamics 1.8.6 (VMD) available online at http://www.ks.uiuc.edu/Research/vmd/. The
identified POTRA domains were cloned and expressed for characterization (See Sections 2.2
and 2.3). For the alignment of Toc75 with the AnaOmp85 and TeOmp85 POTRA domains,
SwissModel Alignment Mode
(http://swissmodel.expasy.org/workspace/index.php?func=modelling_simple1) was used along
with the alignments generated by ClustulW. The alignment of POTRA domains was performed
with MultiSeq, which uses the program STAMP (Structural Alignment of Multiple Proteins) to
align protein molecules. STAMP is a tool for aligning protein sequences based on a three
dimensional structure.

2.1.1 Multiple Sequence Alignment
The protein sequence alignments of full-length psToc75, Toc75 Loop Domains (TLD –
Toc Small Peptide) and POTRA domain containing proteins were produced with a BLAST (Basic
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Local Alignment Search Tool) program, blastP 2.2.24, against database specification of nonredundant proteins which were available at the National Center for Biotechnology Information
(NCBI) http://www.ncbi.nlm.nih.gov/blast/ by searching for sequences closely related to
psToc75. Multiple sequence alignments were performed using T-Coffee available at the
European

Bioinformatic

Institute

(EBI)

Web

server

(http://www.ebi.ac.uk/Tools/t-

coffee/index.html) and viewed with JalView (version 8.93), a multiple alignment editor available
at http://www.jalview.org/ (139). The alignment of psToc75 full-length generated by the blastP
also resulted in the phylogenic tree of relationship found within psToc75 homologues. The
alignment of POTRA domains was extended to include distantly related families such as T.
elongatus, P. patens, C. reinhardtii, and H. influenza. The residues of the linker regions between
each POTRA domain and between the last (POTRA3) and β-barrel of the psToc75 were aligned
against the sequences containing POTRA domains found in other organisms. The list of all the
organisms containing POTRA repeats can be found in the ‘Results’ section. The resulting
alignment was slightly adjusted in order to identify conserved regions found within POTRA
domains. The highly conserved residues were selected for redesigning of various sizes of POTRA
domains, which would include the most conserved residues of the linker regions (See section
below).

2.1.2 Secondary Structure Prediction
To analyze and confirm the secondary structure folds of individual POTRA domains (β-αα-β-β), which contain two α-helices packed against three β-sheets, different secondary
structure prediction programs were used (available for free online). psToc75 sequence of 809
amino acids was submitted for prediction of secondary structure to the following programs:
PredictProtein (http://www.sdsc.edu/predictprotein/)
PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/)
PROF (http://www.aber.ac.uk/~phiwww/prof/)
jufo (http://www.meilerlab.org/web/view.php)
JPred3 (http://www.compbio.dundee.ac.uk/www-jpred/)
123D+ (http://www.123d.ncifcrf.gov/123D+)
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PORTER (http://distill.ucd.ie/porter/) (140)
APSSP (http://imtech.res.in/raghava/apssp/) (141) and others available at ExPASy Web Server
(http://www.expasy.ch/tools/) (see ‘Supplementary data’). The secondary structure prediction
outcome was analyzed for the conserved secondary folds found in each psToc75 POTRA
domains.

2.2 Cloning of Codon Optimized POTRA domain into psToc75pET23(a)
Analysis of the outcome of prediction programs (β-α-α-β-β) along with the multiple
sequence alignment of primary amino acid sequence of the intra-POTRA linker regions led to
the identification of a few conserved residues between POTRA domains of psToc75. By
designing forward and reverse primers corresponding to the conserved primary and secondary
sequence folds of POTRA domains, various lengths of cloned POTRA domains were generated.
Although many primers were designed which would generate different sizes of POTRA domains,
only those yielding different sizes of POTRA2 and POTRA1-2-3 (all three POTRAs) are shown in
Table 1. Three sizes: small, intermediate, and large of POTRA2 and small, intermediate, and
large of POTRA1-2-3 were cloned into an expression vector; however, only the expression of
small, intermediate, and large POTRA2 and intermediate POTRA1-2-3 was achievable. Since
these domains were difficult to purify, a codon optimize gene encoding these proteins was
designed. Purification of POTRA1 and POTRA3 did not require codon optimization. The list of all
the primers generated during redesign of the POTRA primers are provided in Chapter 3.
In order to improve the heterologous protein expression of psToc75-POTRA2 and fulllength POTRA1-2-3, the target gene of psToc75 was codon optimized to increase the level of
bacterial expression level. The target sequence was selected and modified using E. coli codon
usage table using the Synthetic Gene Designer
(https://www.dna20.com/tools/genedesigner.php) and JCat (Java Codon Adaptation Tool)
(http://www.prodoric.de/JCat) (142) by a fellow graduate student, Mr. Prakitchai
Chotewutmontri. The programs allowed codon manipulation resulting in a graphical
presentation of the relative adaptiveness (wij) of the codons in psToc75-POTRA domain gene
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based on the codon usage of E. coli (see Chapter 3). The DNA sequence of the adapted and
unadapted psToc75 gene is provided in the ‘Supplementary data’.
The codon optimized synthetic gene was synthesized by Epoch Biolabs (Sugar Land, TX)
and cloned into SmaI digested pBluescript II SK derivative lacking its multiple cloning site. It was
flanked by the 5’-NsiI, 3’-SacII restriction sites, which are also present in the Toc75-pET23(a)
template (unadapted) to be used to insert the codon optimized gene. The synthetic codon
optimized gene was sequence confirmed and transformed into NovaBlue competenet cells. The
synthetic DNA was midi prepped and digested with 5’- NsiI and 3’- SacII restriction sites. The
target psToc75-pET23(a) template, digested with the same restriction enzymes, was used to
set-up digestion reactions at 37°C for 3 hr followed by heat inactivation at 80°C for 20 min. The
digested products were run on a 0.7% agarose gels, the digested bands were excised and
purified with GeneClean PCR Cleanup kit. The purified digested insert and vector DNA were
ligated at 22°C for 3.5 hr and heat activated at 60 °C for 20 min. The ligated products were
transformed into GC-5 super competent cells for the colony PCR. For colony screens, 10 small
colonies were picked and PCR colony screen was performed per general colony screen protocol
with T7 forward and reverse primers resulting in 2666 bp product. Since it was difficult to
distinguish the before- and after- codon optimized Toc75, another restriction enzyme, EcoR1,
was used which would result in the presence of three bands if the codon optimized gene was
successfully present in psToc75-pET23(a). Since wild type psToc75-pET23 only contains one
EcoR1 site, only two bands will show up on the gel. The positive DNA was transformed into
NovaBlue for midi prep. The final construct resulted in codon optimized whole of POTRA2 and
partial POTRA3 into the Toc75-pET23(a) template. Once the codon optimized POTRA domains
were cloned into psToc75-pET23(a), primers were designed to amplify the now-codon
optimized POTRA domains.

2.2.1 Subcloning of Toc75 Loop Domains and POTRA Domains
In order to express various loops of psToc75 as soluble peptides, the pET23(a)-psToc75
DNA was used as PCR template DNA. Primers were designed by hand and synthesized by IDT
(Coralville, IA) for various cytosolic and intermembrane space loops ranging from 35-70
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residues and selected by analysis of two previously published topological models shown in Fig
1-5. The loops were digested and sub cloned into pTYB2 vector (New England BioLabs, Beverly,
MA, USA). These constructs were transformed into an ER2566 E. coli expression line for the
purpose of purification. Primers were designed similarly for POTRA1, POTRA2, POTRA3 and
codon optimized POTRA2 and POTRA1-2-3 except the design of primers included an addition of
three residues forward and reverse of the HMMer identified POTRA domains (S, Inter., L).
Original residues were identified as 161-237 for POTRA1, 266-255 for POTRA2 and 366-439 for
POTRA3.
Lyophilized primers were resuspended to 500 ng/µl in distilled, autoclaved H 2O and
stored as 5X stocks at -20°C. To prevent contamination of primer stocks, working stocks of 100
ng/ µl were prepared by diluting 5 X stocks in water. To ensure that the PCR products had ends
that were sufficiently long for restriction enzyme binding/cutting, the forward primer
restriction site NdeI was preceded by an irrelevant basepair (5`-GGTGGT). NdeI recognition site
was used in the design of the forward primer to restore the start codon ATG. 3’ GC clamp was
included to promote proper annealing of primers to the DNA sequence. The reverse primer was
designed with the XmaI (an isoschizomer of SmaI) restriction site using similar guidelines for
proper annealing and specificity. Amplifying the target gene with the XmaI recognition site
would generate a sticky 3’ end PCR product, which can be ligated with XmaI-digested pTYB2
vector which would introduce a C-terminal cleavable Intein tag and a chitin-binding domain.
This construct would permit one-step purification of the protein using a chitin column as
described elsewhere in this chapter. Tables 1 and 2 list all the primers used to generate POTRA
and TLDs constructs. The digested inserts and vector were ligated at temperature controlled
closed RM6 Lauda Brinkman water bath at 22°C for 3 hr following heat inactivation of ligase at
65°C for 15-20 min and transformed into DH5-α or GC5- supercompetent cells for colony
screening. The list of all the primers created or used is shown in the ‘Supplementary data’.

2.2.2 Colony Screen of Ligation Product
PCR amplification of TLDs and POTRAs was set up as shown in Table 3 and the
parameters were slightly adjusted depending on the length of the region to be amplified. Initial
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Amino acid sequence
and residue numbers

Protein name

Primer name

Strand

Length

Sequence 5’ -> 3’

POTRA1

P1 FORWARD

+

34

GGT GGT CAT ATG TTT AAG AAA TAC AAA ATC TCA G

P1 REVERSE

-

30

GGT GGT CCC GGG CTC CCA CAT ACT CTC AGC

P2 FORWARD

+

30

GGT GGT CAT ATG CCT GAT ATG AGT GAA AAG

P2 REVERSE

-

30

GGT GGT CCC GGG AGT AAT ATC CCC TTC AAC

Primers
Designed

Not C.O. POTRA1
FKKY-SMWE
158-240

Yes

Not C.O. POTRA2
PDMS-GDIT
263-358
Not C.O. POTRA3
QYLD-LEQK
363-442
EYKR- VEGD

POTRA2

POTRA3

POTRA2 Small

280-356
SEKE-VEGD

POTRA2 Inter

P2-EKEK-FORW
P2-VEGD-REV

POTRA2 Large

263-358
FKKY-LKEL
158-439

Potra1-2-3 small

ITVL-LKEL

Potra1-2-3 Inter

148-439
DEPK-LKEL
132-439

P2-EYKE-FORW
P2-VEGD-REV

266-356
PDMS - GDIT

P3 FORWARD
+
32
GGT GGT CAT ATG CAG TAT TTG GAT AAA CTT GG
P3 REVERSE
27
GGT GGT CCC GGG TTT CTG CTC CAA CTC
*Codon optimized POTRA2

Potra1-2-3 Large

P2-PDMS-FORW

+
+
+

30

GGT GGT CAT ATG GAA TAC AAA CGT CGT ATC

27

GGT GGT CCC GGG GTC ACC TTC AAC AAC

31
27

GGT GGT CAT ATG TCT GAA AAA GAA AAA ATC G
GGT GGT CCC GGG GTC ACC TTC AAC AAC

25

GGT GGT CAT ATG CCG GAC ATG TCT G

P2-GDIT-REV
24
GGT GGT CCC GGG AGT GAT GTC ACC
*Codon optimized POTRA1-2-3
P1 FORWARD
+
34
GGT GGT CAT ATG TTT AAG AAA TAC AAA ATC TCA G
P3-LKEL-REV
25
GGT GGT CCC GGG CAA CTC TTT GAG C
P1-ITVL-FORW
P3-LKEL-REV
P1-DEPK-FORW
P3-LKEL-REV
T7 Universal
Intein reverse

+

28

GGT GGT CAT ATG ATC ACG GTT TTA CTG G

+
-

25
31
25

GGT GGT CCC GGG CAA CTC TTT GAG C
GGT GGT CAT ATG GAC GAA CCA AAA TCA GAA G
GGT GGT CCC GGG CAA CTC TTT GAG C

+
-

17
24

TAATACGACTCACTATA
GAGGTTGGTAATAAGGTCATGGGT

* For cloning of codon optimized POTRA1-2-3, the codon optimized Toc75-pET23 (a) template was used with the redesigned drimers.
Only the primers highlited in the bold resulted in the cloning of optimized target gene.

Table 1 List of primers generated for the design of POTRA domains of psToc75
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Yes

Yes

Yes

Yes

Yes

Yes

Yes
Yes

Amino acid sequence
and Residue
numbers

Protein name

Primer name

Strand

Length

LFFD – NADG

B1 IMS

B1 IMS F

+

30

GGT GGT CAT ATG CTT TTC TTC GAT AGG AAC

B1 IMS R

-

25

GGT GGT CCC GGG CCC GTC TGC ATT G

A1 CYT F

+

29

GGT GGT CAT ATG TGT CTT TTG CCT ACT TC

A1 CYT R

-

26

GGT GGT CCC GGG AGC ACA AGC ATA CC

A2 CYT F

+

25

GGT GGT CAT ATG GTT GTT GAA GGG G

A2 CYT R

-

28

GGT GGT CCC GGG AGC CAG GGA ATT TAT G

B2 CYT F

+

28

GGT GGT CAT ATG ACT ATT ACT TTT GAA C

B2 CYT R

-

25

GGT GGT CCC GGG CGC AAG ATC ATC C

B2 IMS F

+

29

GGT GGT CAT ATG CCC TAT TCT GTT AGG GG

B2 IMS R

-

26

GGT GGT CCC GGG ACC AGC ACC ATA AG

A1 IMS F

+

29

GGT GGT CAT ATG CGT ATA CCT ATT AAA GG

A1 IMS R

-

26

GGT GGT CCC GGG ACC AGC ACC ATA AG

B1 CYT F

+

31

GGT GGT CAT ATG ATT CAG TAT TTG GAT AAA C

B1 CYT R
T7 Universal

-

29

+

17

GGT GGT CCC GGG AAT GTT GGA AAA CAA AG
TAATACGACTCACTATA

Intein reverse

-

24

GAGGTTGGTAATAAGGTCATGGGT

167-226
CLLP – YACA

A1 CYT

291-335
VVEG – NSLA

A2 CYT

352-411
TITF – DDLA

B2 CYT

470-502
PYSV – YGAG

B2 IMS

711-780
RIPI – YGAG

A1 IMS

736-780
IQYL – FSNI
362-416

B1 CYT

Sequence 5’ -> 3’

Table 2 List of primers generated for the design of Toc Loop Domains of psToc75
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Primers
Designed

Yes
Yes
Yes
Yes
Yes
Yes
Yes

PCR set-up 100 µl PCR reaction
5X Green Go-taq buffer
psToc75-pET23(a) template
Primer forward (100 ng/µl)
Primer reverse (100 ng/µl)
10 mM dNTPs
ddH2O
Taq polymerase (Go taq)

PCR Cycle Parameters
20
2.5 µl
1.5- 3 µl
1.5 - 3 µl
2.5 µl
68- 72.5 µl
1 µl

94°
94°
55°
72°
repeat steps 2-4 35 times
72° final elongation
4°

Table 3 PCR set up
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2 min.
1 sec.
1 min.
1 min.
5 min.
hold

screening of the ligation products to confirm insertion of the gene into the pTYB2 vector was
accomplished by colony screening. The colonies were handpicked and dissolved in ddH2O for 10
min. Primers were also heated on warm plate to allow proper annealing. PCR amplification of
the ligation product using the T7 universal primer and the Intein reverse primer shown in Table
1 resulted in a 222 bp product if the insert wasn’t present and a x+171 bp product depending
on the expected size of the construct if the TLE or POTRA domains were inserted. The PCR
reaction set up is shown in Table 4. The PCR screen was performed in an Eppendorf thermal
cycler using the cycling conditions mentioned in Table 4.
The PCR products were visualized by running on a 6% Acrylamide, 1 X TAE (Tris, acetic
acid, EDTA) gel and staining with Ethidium Bromide. Colonies were selected for plasmid prep
and automated sequencing in both directions using the T7 universal primer and Intein reverse
sequencing primers listed in Table 1. DNA sequencing results were analyzed using SeqMan
software (DNASTAR, Madison, WI).

2.3 Protein Purification
Plasmid containing the sequence confirmed DNA was transformed into an ER2566 E. coli
expression line. Transformed colonies were selected and induction screens were performed.
For the purification of Toc loop domains, 1-2 L culture in Luria Broth media with 150 µg/ml
Ampicillin were shaken at 370C to an OD600 of 0.6. 1 mM IPTG was added to allow protein
production. Cells from the cultures were harvested after 12-hour incubation at 25°C. Cells were
harvested by centrifugation, resuspended in 25-30 ml lysis buffer per liter of cell culture being
prepared (20 mM Na-phosphate (pH 8), 0.5 M NaCl, 1mM EDTA, and 0.1% Triton X-100) with
protease inhibitors (100 µg/ml PMSF, 1 µM leupeptin, and 1 µM pepstatin) and lysed by probe
sonication set at medium power on ice for 3 min total sonication time, in 10-sec bursts.
Benzonase was added to the lysed cells to allow the digestion of bacterial DNA on ice for 15
min. The supernatant was collected by spinning it in the Oak Ridge tubes in an SS-34 rotor at
40,000 x g for 30 min. The supernatant was gravity flowed over 10 ml chitin bead slurry (5 ml
volume/ liter prepped, NEB, Beverly, MA) pre-equilibrated column containing the column buffer
(20 mM Na-phosphate (pH 8), 0.5 M NaCl, 1mM EDTA, 100 µg/ml PMSF, 1 µM leupeptin, and 1
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Colony Screen 25 µl PCR reaction
5 X GoTaq Buffer
5% Triton X-100
10 mM dNTP’s
T7 universal primer (100 ng/µl)
Intein reverse primer (100 ng/µl)
Taq polymerase
ddH2O*

PCR Colony Screen Parameters
5 µl
1 µl
0.25 - 0.7 µl
0.5 - 0.7 µl
0.5 - 0.7 µl
0.1 - 0.2 µl
16.7 -17.65 µl

94°
94°
55°
72°
repeat steps 2-4 35 times
72° final elongation
4°

4 min.
30 sec.
20 sec. - 1 min.
30 sec. - 3 min.
7 min.
hold

Table 4 Direct colony PCR screen
* E. coli colony is added directly to ddH2O in the PCR tube before adding remaining ingredients
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µM pepstatin). To remove non-specifically bound proteins, the column was thoroughly washed
with ice-cold high salt column/wash buffer for 10 column volumes. The chitin column with now
bound peptides was allowed to incubate in an elution/phosphate buffer (1 mM Na2HPO4, 0.17
mM KH2PO4, pH 7.5) containing 50 mM β-Me overnight at 4°C. After overnight incubation, six
fractions of 6 ml each were collected with elution buffer containing 50 mM β-Me. The elutions
were flash frozen and lyophilized overnight. The lyophilized fractions were brought up in 1 ml
ddH20 and centrifuged at max speed in the tabletop centrifuge to remove DnaK and other
chaperones. To determine the binding and cleavage efficiency, purification profile of flow thru
and washes was run on 15% SDS-PAGE acrylamide gel. Tris-tricine gel was run in order to
determine the sample purity followed by MALDI-TOF mass spectrometry to ensure the size and
cleavage efficiency. Protein concentration was calculated and the aliquots of 0.1 mg, 0.2 mg
and 0.5 mg were flash frozen and lyophilized. The lyophilized peptides were stored in -80°C and
some were sent to Agrisera Inc., (Vannas, Sweden) for antibody production.
The purification of POTRA1, POTRA2 and POTRA3 domains were performed as above
except a few variations: 0.5-1 mM IPTG was added to allow protein production. Cells from the
cultures were harvested after 8-hour incubation at 20°C. The clarified lysate was loaded over
pre-equilibrate column containing column buffer. The column was washed extensively with icecold wash buffer and incubated overnight at 4°C in the presence of β-Me in the column buffer
instead of low salt phosphate buffer. The elutions were collected as above; dialyzed with
appropriate dialysis buffer and concentrated with Amicon Centricon Concentrator MWCO 3000
(Millipore, Billerica, MA). Purified proteins were quantified using the BCA protein quantification
assay (Pierce, Rockford, IL). The aliquots containing 0.1 to 0.5 mg of protein were prepared and
lyophilized for antibody production. The remaining elutions were either directly used for
MALDI-TOF mass spectrometry and circular dichroism or stored at -80°C containing 20%
glycerol. Only partial purification of POTRA2 (unadapted), codon optimized POTRA2-small,
intermediate and large and codon optimized POTRA1-2-3-intermediate were achieved due to
low solubility of the protein.
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2.3.1 Gel Electrophoresis
For PCR Colony Screens
PCR products were visualized using 0.7-1% agarose gel (0.6 gram of agarose, 60 ml 1X
TAE, 3 µl). Agarose was allowed to fully dissolve in 1 X TAE (40 mM Tris pH 8.0, 20 mM Acetic
Acid, 2mM EDTA) by warming it up in microwave oven for 2 min. DNA was then visualized using
the UVP white/UV transilluminator BioImaging system. The PCR colony products were
visualized using a 5-6% acrylamide gel (0.833-1ml 40% acrylamide for DNA gels, 6 ml 1 X TAE, 50
µl 10% APS, 25 µl TEMED). The acrylamide was poured in 0.75 mm-spaced Bio-Rad MiniProtean
gel plates (BioRad Laboratories, Hercules, CA), without a stack. Gels were run at 100 V for
approximately 1 hr in the MiniProtean apparatus with 1 X TAE used as the gel running buffer.
The gels were incubated with 0.1% Ethidium Bromide (in ddH2O) for 15 mi and then quickly
rinsed in ddH2O for 3 min. DNA was then visualized using UVP white/UV transilluminator
BioImaging system and images were captured using LabWorks Bioimaging software.
SDS PAGE (15%), Tris-Tricine, Bis-Tris
All the samples were prepared by adding 4X sample solubilizing buffer (40mM Tris-HCl
pH 6.8, 40 mM DTT, 20% Glycerol, 4% SDS, Bromophenol blue) vortexed and boiled for 3 min.
To allow separation of large proteins, 15% acrylamide gels were utilized. The gels were run at
20-30 mA /gel in 1 X Tris/glycine running buffer (25 mM Tris, 275 mM glycine pH 8.3, 0.1% SDS)
until the Bromophenol blue of the sample buffer ran off the bottom of the gel. The proteins
were stained with Coomassie stain (10% acetic acid, 50% methanol, 0.25% Coomassie Brilliant
Blue R 250) for 30 min, followed by quick rinse with ddH2O and destained (10% acetic acid, 50%
methanol) for 30-40 min. Proteins were visualized using UVP white/UV transilluminator
BioImaging system and images were captured using LabWorks Bioimaging software.
For small Toc Loop domains and POTRA domains ranging from 3,000-9,000 Da,
Tris/tricine gel system was utilized for resolution of low molecular weight peptide. The recipes
for the separating and spacer gel solutions were adapted from (143). The gels were run at a
constant 100 V for 2-3 hours or until the dye front ran off the bottom and stained with
Coomasie stain for 1 hr and destain by warming in destain buffer in microwave oven and
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incubating for 30 min to reduce the background significantly. The gels were visualized as
above.

2.4 Circular Dichroism
Since lyophilized POTRA domains are unstructured polypeptide chains and do not adopt
2 structure in aqueous solution, POTRA1 was purified on the same day. Circular dichroism
spectroscopy was performed on an Aviv Series 202 circular dichroism spectrometer (Aviv
Biomedical, Lakewood, NJ). Circular dichroism spectra were collected at 25°C as 10 s averages
at 1 nm intervals from 185 to 240 nm (190 to 260 nm for POTRA1). Three spectra were
averaged, corrected for buffer, smoothed, and converted to molar ellipticity using the Aviv
software, version 2.71. Deconvolution was performed using the CDPro software with IBase1
and IBase3, reference set of 29 and 37 soluble proteins for POTRA1 and POTRA3. Theoretical CD
spectra were calculated using two difference secondary structure estimation tools (CDSSTR and
ContinLL). These secondary structure prediction algorithms are available as part of the CDPro
package. From these data, the secondary structural features of POTRA domains were
determined.

2.5 MALDI-TOF of Toc loop and POTRA Domains
MALDI-TOF (Matrix-Assisted Laser Desorption Ionization-Time of Flight) mass
spectrometry analysis was performed to confirm the purity and site specific cleavage of Toc
Loop and POTRA domains. MALDI-TOF MS was performed on a Bruker Daltonics MicroflexTM
mass spectrometer (Bruker Daltonics Inc., Billerica, MA) and the data was captured and
analyzed using Flex Control and Flex Analysis software, respectively. β-oxidized-insulin was used
as an internal standard for TLDs. The lyophilized standard protein and Toc loop domains were
resuspended in 50% ACN v/v with 0.1% TFA, v/v at 1, 10 and 100 pmol/ µl concentrations in 10
µl. The samples were mixed with 10 µl of CHCA ( -cyano-4-hydroxycinnamic acid, SigmaAldrich, St. Louis, MO) matrix suspended at 10mg/ml in 50% acetonitrile, 0.1% trifluoroacetic
acid v/v. For POTRA1, apomyoglobin and β-oxidized-insulin were used as internal standards and
samples were prepared as above. 1 µl was spotted on the plate and the drop was allowed to
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dry thoroughly in a vacuum dessicator. MALDI-TOF of POTRA3 was performed by a fellow
student, Mr. Richard Simmerman. Mass spectra were acquired and the resulting mass value
data

was

analyzed

using

the

FindPept

program

available

online

at

http://ca.expasy.org/tools/findpept.html (see ‘Supplementary data’).

2.6 Chloroplasts Isolation (Small prep for FACS, LSCM and
Agglutination Assays)
For chloroplasts isolation, approximately 400-ml dry pea seeds progress #9 (P. sativum)
were imbibed overnight with aeration and planted with A-3 horticultural vermiculite (Knoxville
Seed and Greenhouse). Hydrated peas were planted in a 12x24x5 inch metal flat supplying
ddH2O every 48 hours. The seedlings were grown in an EGC growth chamber with incandescent
and fluorescent illumination at 160 μE/m2/sec on a 14 hour light and 10 hour dark cycle. The
chloroplasts were isolated from 10-11-day old pea seedlings at the end of the dark cycle, and all
the steps were performed on ice in the dark or under dim light according to protocol described
according to (105). The pellet of final intact chloroplasts was resuspended in appropriate
volume of 1 X IB (Import buffer) to assess chlorophyll content as described later.

2.6.1 Chloroplasts Isolation (Large prep) (For import and binding assays)
Chloroplasts were isolated from approximately 10-12 day old pea seedlings. The leaves
were harvested at the end of the dark cycle and processed as described above. To the 1XGB
(Grinding buffer), 10 mg/ml ascorbate and glutathione were added. To homogenize leaf tissue,
a polytron was used in 2-3 sec bursts 3-4 times. The homogenate was filtered and centrifuges at
3500 rpm for 6 min in a Sorvall RC 26 Plus using GSA F14S – 6x250 rotor. The supernatant was
decanted and pellet was resuspended in 5-10 ml IB. The resuspended chloroplasts were gently
layered onto 50% Percoll continuous gradients which were previously prepared by mixing 2 X IB
and Percoll at equal volumes and centrifuging for 30 min at 17,800 rpm in Sorvall SS-34 rotor
with the brake off. Loaded gradients were then centrifuged at 6,000 rpm for 6 min in a Sorvall
HB-6 rotor. The dark-green band containing intact chloroplasts near the bottom of the tube was
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collected using a large-bore syringe needle, diluted with 3 times their volume of 1 X IB, and
centrifuged at 3500 g for 7-9 min to remove Percoll. The supernatant was discarded and pellet
of intact chloroplasts were again resuspended and reloaded on another set of 50% Percoll
gradients as described above. The resulting band of intact chloroplasts was harvested, diluted
with 1 X IB to remove Percoll and centrifuged as above. The resulting pellet of intact
chloroplasts was resuspended with appropriate volume of 1 X IB and the chlorophyll content
was assessed as described below.

2.6.2 Chlorophyll Measurement
Chlorophyll

concentration

was

determined

using

Shimadzu

UV-Visible

spectrophotometer (Shimadzu Scientific Instruments, Columbia, MD) in order to bring the
chloroplasts to the final concentration of 1 mg chlorophyll/ml. To determine the chlorophyll a
and b content, 50 µl of chloroplast suspension was added to 5 ml of 80% acetone and
centrifuged at 14,000 g for 1 min in a microcentrifuge to remove starch.

Absorbance

measurements were taken at 663 and 645 for chlorophyll a and chlorophyll b, respectively. The
absorbance measurements were used to calculate total chlorophyll content with the following
equation (144).

After chlorophyll concentration was determined, chloroplasts were diluted with appropriate
volume of 1 X IB to obtain 1 mg chlorophyll/ ml final concentration.

2.6.3 Envelope Preparation
In order to purify crude envelopes containing inner and outer chloroplasts membranes,
doubly purified intact chloroplasts were lysed by adding 12.5 mM MOPS-NaOH (pH 7.0), 2.5
mM magnesium acetate to yield a final chlorophyll concentration of 1.5 mg/ml. The
chloroplasts were allowed to lyse on ice in the dark for 10 min. The lysate was centrifuged at
1500 g for 5 min to remove thylakoids and form a lose pellet. The green supernatant fraction
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was stored on ice. The pellet was resuspended in half of the original volume of MOPS buffer.
The remaining material was centrifuged at 4000 g for 5 min. The resulting yellow supernatant
fraction was combined with the previously removed green fraction. The combined envelops
were pelleted at 48,000 g for 30 min In SLA 55 rotor in a Beckman Coulter Optima Max
Ultracentrifuge. The final pellet was resuspended in 50mM Hepes-KOH pH 8.0 buffer. The
remaining material was centrifuged at 4000 g for 5 min and the yellow supernatant fraction was
combined with the previously removed fraction. The combined envelopes were pelleted by
centrifugation at 48,000 g for 30 min (145).

2.7 Chloroplast Fixation and Labeling
The lyophilized TLDs and POTRA domains were used as antigens to raise mono-specific
antibodies in two rabbits per antigen. Three bleeds and pre-immunes were tested for crossreactivity. Antibodies isolated from the terminal bleeds were used for production of antibodies
against A1CYT, A2CYT, B2CYT, B2IMS, POTRA1 and POTRA3 domains. Two antibodies were
selected for POTRA1 – Sandra and Fugle - and POTRA3 – Tindra and Demo.
Chloroplasts were fixed and labeled according to general laboratory protocol. The
doubly purified intact chloroplasts were resuspended in ice-cold 1X IB and incubated with 25%
EM grade Glutaraldehyde and 16% Paraformaldehyde (Electron Microscopy Sciences, Hatfield,
PA) to a final solution of 0.05% and 0.25%, respectively. The reactions were carried out in the
dark on ice for 30 min. Following the incubation, one volume of ice cold 1 X IB containing 10mM
NH4Cl was added to quench the reaction. The chloroplast suspension was overlaid 40% Percoll
and centrifuged at 1600 g for 4 min. The supernatant was discarded and pellet was
resuspended in appropriate volume of 1 X IB containing 2% BSA and 20mM KCl. Chlorophyll
content was assessed as above and stock solution of 1 mg/ml was prepared. The resultant
suspension was aliquoted into appropriate volume to make final concentration of 0.125 mg/ml
chlorophyll for flow cytometry experiment.
For flow cytometry, the aliquots were incubated with α-POTRA and α-TLD immune and
pre-immune sera of five titers ranging from 1:200 to 1:1000 on ice in the dark for 20 min. For
positive controls, chloroplasts were incubated with α- Toc75, α-Toc34, and α-atToc159G at
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1:100. Chloroplasts without any antibody and pre-immune sera were set-up as negative
controls. Following the incubation, 4-5 volumes of cold 1 X IB was added and centrifuged at 800
g for 4 min. The pellets were again resuspended in appropriate volume of fresh 1 X IB
containing 2% BSA and 20mM KCl as blocking agents. Donkey-α-rabbit (DAR) DyLite488
(Thermo Scientific, Rockford, IL) secondary antibody was added to all experimental tubes
except for chloroplasts-only control tube at dilution of 1:100 (since it was found to work the
best). The suspension was allowed to incubate on ice in the dark for 20 min. The chloroplasts
were centrifuged as above. Final pellets were brought up in 500 µl 1 X IB for flow cytometry.
Flow cytometry was performed using BD FACSCalibur and analyzed using FlowJo 7.5. For Laser
Confocal Scanning Microscopy, chloroplasts were labeled and fixed as described above.
Chloroplasts were incubated with primary at 1:100 and DyLight 488 was used as secondary at
dilution of 1:250. The images were captured using Leica Laser Scanning Confocal Microscope
SP2.

2.8 Laser Scanning Confocal Microscopy (LSCM)
DyLight-488 labeled and unlabeled chloroplasts were prepped and labeled as described
earlier and analyzed using a Leica SP2 Laser Scanning Confocal Microscope (Leica Biosystems,
Richmond, IL). Chloroplasts were incubated with primary at 1:100 and secondary DyLight 488 at
1:250. The DyLight-488 fluorescence and the chlorophyll autofluorescence were visualized
sequentially using an air-cooled Argon-ion laser for excitation at 488 nm and detection at 500 550nm and 650 - 750nm for the DyLight488 (green) and the chlorophyll autofluorescence (red),
respectively. Samples were imaged with a HCX PLAN Apo 63.0x1.32 oil immersion objective and
a 2.95X image zoom giving a final image size of 80 µm X 80 µm. Images were collected at 1024 X
1024 pixel resolution giving a pixel size of 78.9nm X 78.9nm and visualized using Leica software
version 2.61.

2.9 Flow Cytometry
The fluorescently labeled chloroplasts were isolated, fixed and labeled as described in
Section 2.6-2.7. Primary antibodies were used at titers ranging from 1:200 to 1:1000 and
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secondary DyLite488 at 1:100. The positive controls (α-Toc34, α-Toc75, α-atToc159G) were
incubated with primary antibodies at 1:100. Flow cytometry analysis was performed using
Becton Dickinson FACSCalibur system (BD Biosciences, San Jose, Ca). This instrument is
equipped with two lasers (488 nm and 635 nm) and detectors for forward scatter, side scatter,
and four fluorescence PMTs (photomultiplier tube). It is a multicolor flow cytometer which
utilizes blue Argon-ion tuned for 488 (15 mW of the 488 line) output. Data were acquired using
Becton Dickinson CellQuest 5.1.1 software and analyzed with FlowJo 7.5. Forward scatter was
collected with the forward photodiode and the right angle light scatter and fluorescent signals
were collected by fluorescence collection lens and a 488/10 nm band pass filter.
Forward and right angle light scatter were measured for DyLight488 labeled and
unlabeled chloroplasts and fluorescence was resolved with the 530/30 nm band pass filter.
Unlabeled chloroplasts were used to manually set the value of 4-5% positively labeled
chloroplasts for each experiment. Chloroplasts were gated to include only intact and large
chloroplasts for both DyLight488 (FL1) and chlorophyll autofluorescence (FL2). The flow rate
was set to 12 µL/min allowing ~1200 chloroplasts/min. 30,000 intact chloroplasts were
analyzed per sample and acquired with gating. Sheath buffer was composed of 1 X PBS
(phosphate buffered saline). Dot plot analysis of forward and right angle light scatter was used
to determine the percent intact plastids (80 - 90% of total plastids).

2.10 Chloroplasts Agglutination Assay
Chloroplast agglutination assay was performed on doubly purified thermolysin treated
intact chloroplasts in the presence of POTRA and TLD antibodies. 11-d old pea plants were
harvested for the small chloroplast prep as described earlier. The isolated chloroplasts were
blocked with 1 X IB + 1% BSA + 20 mM KCl + 1% donkey serum containing 1 mM CaCl 2 and 3
mM MgCl2 and kept on ice in the dark to prevent lysis. For thermolysin treatment, stock
solution of 1mg/ml thermolysin in 1X IB+ 1 mM CaCl2 + 3 mM MgCl2 was used at final
concentration of 250 µg/ml. The tubes were allowed to incubate on ice in the dark for 30-40
min while gently flicking every 3-4 min to prevent chloroplasts from pelleting at the bottom. To
this, 10 mM EDTA was added to inactivate thermolysin. The suspension now was added on the
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top of 40% percoll gradient to remove excess thermolysin from the suspension and centrifuged
at 800 x g for 4 min in Sorvall tabletop centrifuge. The pellets were resuspended in enough 1X
IB % BSA + 20 mM KCl + 1% donkey serum to make 50 µl aliquots in 96-well plate. Chlorophyll
measurement was performed and 50 µl aliquots of 100 µg/ml chlorophyll concentration was
added per well. Hemocytometer was used to calculate the particles per well which was found
to be 1,285,000,000 particles per well. To this now-thermolysin treated chloroplasts, primary
antibodies against TLEs and POTRAs were added at titers of 1:25 and 1:250 for immune and
pre-immune sera. The reactions were incubated for 30 min on ice in the dark while gently
rocking to keep chloroplasts suspended. No primary antibody was added in the control sample.
The positive (immune) and negative (pre-immune) controls contain the same titer of primary
antibodies. After 30 min incubation, the samples were viewed using Leica DM 6000 B
(Hamamatsu ORCA ER C4742-80 Digital Camera) Bright Field microscope and images were
captured with the Simple PCI 6 software provided with the microscope.

2.11 Thermolysin Treatment on Chloroplasts (for western blotting)
The doubly purified dark adapted chloroplasts were resuspended in ice cold 1 X IB +1%
BSA + 20 mM KCl containing 1 mM CaCl2 and 3 mM MgCl2 to make the stock concentration of 1
mg/ml. The control samples did not include any antibody incubation and thermolysin
treatment. Thus a control sample of intact chloroplast was removed. For the experimental
samples, α-POTRA1 antibody was added at titers described below. First, 600 µl reactions were
prepared by aliquoting various volumes of 1 X IB +1% BSA + 20 mM KCl containing 1 mM CaCl 2
and 3 mM MgCl2 into different tubes. To this, α-POTRA1 was added to the final concentration of
1:600, 1:300, 1:150, 1:60, 1:30 and 1:20. Lastly, 75 µl of the stock chloroplast solution (1mg/ml)
was added to bring the final reaction volume to 600 µl at final chlorophyll concentration of 125
µg/ml. The chloroplasts were incubated with the primary antibody at room temperature for 15
min in the dark. After the incubation with α-POTRA1 antibody, tubes containing various titer
treatments were used for thermolysin treatment. 10mg/ml stock thermolysin was added to the
final concentration of 250 µg/ml. The incubation was carried out on ice in the dark for 30 min.
To see the effect of higher concentration of thermolysin, tubes containing 1:60 titer of primary
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antibodies were treated without any thermolysin and with 250 µg/ml and 500 µg/ml
thermolysin. All the reactions were inactivated by addition of 10 mM EDTA. 100 µl aliquots
were removed from each sample and labeled as ‘Sup’ before reisolating over 40% percoll
gradient to remove free thermolysin. To these samples, 50 µl of 2X SSB was added. The samples
were boiled and stored in -20°C. The remaining samples were washed by overlaying the top of
the Percoll gradient and centrifuged at 2400 x g for 8 min in tabletop centrifuge. The
supernatant was discarded and the final pellets were resuspended in 2X SSB and labeled as
‘Pellet’. These samples were boiled for 5 min and stored as above. The samples were run on 412% pre-cast Bis-Tris NuPAGE Novex pre-cast gels (Invitrogen, Carlsbad, CA) at 200 V for 35 min
and stained and visualized as discussed earlier. The same samples were transferred and blocked
(1hr) for analysis by western blot. The bands identified by a demo version of TotalLab quant
program available online. The similar experiment was performed for experimental control
samples treated with α-A1C and α-POTRA3 antibodies at 1:60 and followed by thermolysin
treatment and collection of ‘sup’ and ‘pellet’ samples.

2.12 Western Blot
For Western blot analysis, the blots were marked with a number 2 pencil and soaked in
100% methanol for 3 min, quickly rinsed with ddH2O and then soaked in transfer buffer for 5
min or until ready to use. the gels with EZ-run prestained markers were transferred to
Immobilon PVDF membrane (Millipore, Billerica, MA) with a Genie transfer apparatus (Idea
Scientific) at 24 V for 2 hr or 12 V for 4 hr in a cold room (4 C) in the presence of ice cold high
molecular weight transfer buffer (48 mM Tris, 390 mM glycine, 20% methanol). After the
transfer, the blots were removed and blocked with Tris Buffered Saline with Tween-20 (TBST 25
mM Tris-HCl pH 8.0, 137 mM NaCl, 3 mM KCl, 0.1% Tween 20) containing 3% non fat milk
(NFM) for 1 hr at room temperature with rocking or overnight at 4 C. After the blocking, the
blots are incubated with primary antibodies (α-TLEs and α-POTRAs at 1:20,000 or depending on
the experiment) in TBST + NFM for 1 hr at room temperature with constant rocking. The blots
were then washed 3 times with TBST for 10 min each followed by incubation with secondary
antibodies for 1 hr at 1:20,000 (may vary depending on the experiment titer in TBST + NFM).
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The secondary antibodies were DAR-HRP conjugated (Thermo Scientific, Rockford, IL) and goatanti-guinea pig (GAG) for atToc159G protein. The blots were again washed 2 times with TBST
alone and lastly with TBS (without Tween-20) for 10 min each. The blots were exposed by
mixing 1:1 volume of HRP substrate and Luminol (Millipore) (1 ml total per blot) for 5 min. The
blots were analysed using a Chemidoc Biorad imager for 600 seconds and 6 images were
captured at each 100 sec interval. The blots were analyzed with Quantity One software 4.4
(BioRad) and bands were quantitated by photon counting. To probe the same blot with
different primary antibody, the immobilon was stripped by incubation in stripping buffer (25
mM glycine-HCl pH 2.0, 1% (w/v) SDS) for 30 min with agitated rocking at room temperature.
The blots were then washed for twice with TBST for 10 min, and then the western blot protocol
continued with blocking of the membrane.

2.13 In vitro Chloroplast Protein Import Competition Assay
The chloroplast protein import competition assay was performed as per protocol
described in (105). In vivo radiolabeling of prSSU and purification of prSSU and mSSU were
performed as described in (105) by P. Chotewutmontri. Briefly, intact chloroplasts were
isolated from 10-d old pea plants and used at 0.125 mg/ml chlorophyll final concentration. The
competition assay kept 35S radiolabeled prSSU at 100 nM while increasing the concentration of
cold competitors. Three concentrations were tested for each control competitor protein: 0.1
µM, 1 µM, and 6 µM. Three concentrations of POTRA3 were tested: 0.1 µM, 1 µM, and 6 µM.
The reactions were initiated by adding chloroplasts, previously stored on ice, to the import
mixture. The reactions were incubated at room temperature for 15 min with gentle tapping
every 2-3 min. to keep chloroplasts suspended. The reactions were terminated by the addition
of 700 µl of ice-cold 1 X IB. Lysed chloroplasts and unimported free proteins were separated by
centrifugation through a small 40% Percoll gradient in a 1.5 ml Eppendorf tube. The pellet
containing intact chloroplasts was resuspended in ice-cold 1 ml 1 X IB, and 50 µl sample was
removed for quantification by the BCA assay. The remainder sample (950 µl) was centrifuged
and final pellet was resuspended in 50 µl of 2 X SSB (sample solubilizing buffer) and boiled for 5
min. Samples were brought to equal protein concentration by adding 2 X SSB, which was
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determined by the BCA results. Finally, samples were run on a large slab 10-20% SDS-PAGE gels
at 6-8 mA overnight. The gels were dried on a gel-dryer (BioRad Laboratories, Hercules, CA) and
placed on storage phosphor screens for 3-24 hours. The Storm Phosphorimager (Molecular
Dynamics, CA) was used for visualization by scanning the screens and quantification of band
intensity was performed using ImageQuant analysis software (Molecular Dynamics, CA). Data
analysis was performed with non-linear regression using GraphPad Prism 4.0c (GraphPad
Software Inc., CA) and expressed as percent of

35

S-labeled prSSU imported/chloroplast/min.

The data can be presented as straight lines or one-phase exponential decay for competing
proteins and linear regression for non-competing proteins.

2.14 In vitro Chloroplast Protein Binding Competition Assay
The chloroplast protein binding assay was performed as per protocol described in (105).
Intact chloroplasts were harvested from 10-12-d old pea at the end of their dark cycle to
minimize the internal ATP; the purified chloroplasts were brought to 0.250 mg/ml chlorophyll
content. The competition assay kept

35

S radiolabeled prSSU at 100 nM while increasing the

concentration of cold competitors by serial dilution. To the reaction mix containing intact
chloroplasts, radiolabeled prSSU and cold competitors (range from 0.1 µM to 72 µM) were
added in rapid succession. The reactions were incubated at room temperature for 30 min with
gentle tapping every 3 min to keep the chloroplasts suspended. The intact chloroplasts are
isolated and processed as described for import and in (105). The samples were bleached by
adding 90 μl of 50% H2O2 to the 50 μl of the samples and incubating at 80°C for 1-2 hr. The
bleached samples are transferred to scintillation vials containing 2-4 ml Scintillation fluid and
measured by Beckman Coulter LS 6500 Multi Purpose Scintillation Counter (Beckman Coulter,
Inc., Brea, CA). To ensure that the assay did not result in import of preproteins, binding
competitors prSSU and control
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S radiolabeled prSSU samples are run (30 µl) on a 15% SDS-

PAGE acrylamide gel. The data obtained from the scintillation counter were corrected for the
background and normalized using nonlinear regression One-site Fit Ki using GraphPad Prism
4.0c (GraphPad Software, Inc.). The data obtained for POTRA1, POTRA3 and prSSU were results
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of two independent experiments. The data obtained for mSSU were results of four independent
experiments performed by P. Chotewutmontri.
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CHAPTER 3 Results and Discussion
3.1 Part I - Analysis of the psToc75 Topology Models
3.1.1 Introduction
Toc75 is a β-barrel pore-forming chloroplast outer membrane channel protein. It
belongs to the OMP85 superfamily of proteins, whose members share conserved domain
architecture of an N-terminal soluble portion containing one or more POTRA domains and a Cterminal transmembrane region consisting of β-strands. Although much is now known about
the β-barrel proteins in the outer membrane of Gram-negative bacteria and mitochondria, the
mechanism by which β-barrel proteins in chloroplasts transport proteins across the chloroplast
membranes is still not known. In the case of α-proteobacter and mitochondrial proteins, the Nterminal POTRA domains are postulated to exist in the intermembrane space with lipoprotein
located in the periplasmic side of the bacterial outer membrane (103, 132, 137). In contrast, the
topology of the chloroplastic Toc75 is less defined. In order to understand protein transport
across the chloroplast outer membrane, it is crucial to explore the structure and function of the
components of the TOC complex. The aim of this research is to investigate the i) orientation
(cytosolic versus intermembrane space) and ii) function of the POTRA domains associated with
β-barrel protein Toc75.
Toc75 contains three repeats of the POTRA domains. Although no clear function has yet
been determined, a conserved chaperone-like function of the POTRA domains of Toc75 has
been postulated (102, 146) (74). We hypothesize that POTRA domains of Toc75 facilitate import
by directly interacting with transit peptide or preproteins and could possibly act as scaffolding
for the TOC/TIC components.
The crystal structure of the POTRA domains of other OMP85 family members, FhaC in B.
pertussis and BamA in E. coli, provided a new understanding of the orientation and role(s)
psToc75 POTRA might play in the protein import (123-124). In order to gain an insight into the
topology of the psToc75 β-barrel protein prior to the crystal structures of POTRA domains of
FhaC and BamA, two previously proposed topology models of the Toc75 were utilized (110,
114). The first model of Toc75 was generated by the secondary structure prediction and
hydropathy plot indicating that Toc75 contains 16 β-strands and is clustered into three domains
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with a stretch of 229 amino acids composed of shorter hydrophobic β-strands exposed to the
cytosol as shown in Fig 3-1, Model A (110). Sveshnikova et al. proposed another model with the
same number of transmembrane β-strands, but this model proposed its N-terminus (putative
POTRA domains) in the membrane-anchored regions based on secondary structure prediction
and proteolytic fragmentation patterns of proteins reconstituted into liposomes. This model
proposed an Nin-Cin orientation of Toc75 and large loop regions facing intermembrane space at
both the N- and C-terminus as shown in Fig 3-1, Model B (114). Since the two models predicted
differential localization of the Toc75 large loops in the outer membrane, identifying the inter-βstrand loops facing the cytosol and/or intermembrane space can be useful in determining
Toc75 orientation. This analysis would be made possible by raising the mono-specific
antibodies, which can be used to decorate the intact chloroplasts thus confirming the topology
of these candidate loop fragments of Toc75 in the chloroplast outer membrane. Seven
predicted Toc75 inter-β-strand loops were selected, subcloned into the pTYB2 expression
vector and purified as presented in Part I of Chapter 3. Part II of Chapter 3 focuses on the postcrystal structure identification, cloning and purification of psToc75 POTRA domains for antibody
production. Part III of Chapter 3 focuses on the topology determination of the Toc Loops and
POTRA domains. Preproteins may also have an affinity for the POTRA domains: one hypothesis
is that these domains may interact with the translocating preproteins; to this end, chloroplast
protein import and binding assays were designed as presented in Chapter 4. GTP hydrolysis
experiments carried out in the presence of the loop fragments to determine their effects on the
GTPase cycle are presented in Chapter 4. Finally, utilizing the data obtained from hydrolysis,
import experiments and antibody decorated chloroplasts, the topological organization of these
Toc75 loop fragments and POTRA domains were proposed to face the cytosolic side of the
chloroplast outer membrane.

3.1.2 Results and Discussion
3.1.2.1 Identification and Selection of the Toc75 Loop Domains
Since the purification of the full-length Toc75 is difficult due to solubility issues inherent
with intermembrane proteins, and in order to confer the topology of Toc75, the two previously

72

Figure 3- 1 Proposed topology models of Toc75 orientation within the outer membrane
(A) The putative secondary structure of Toc75 was derived using a program based on the
hydrophobicity (110). The stretch of 229 amino acids is localized on the cytosolic side at the Cterminus. (B) Panel B shows the topological model of Toc75 derived using rules for β-barrel
proteins and treatment using proteases such as endoproteinase Glu-C, trypsin, chymotrypsin
and thermolysin (114). Large domains are facing the intermembrane space at both the N- and
C- termini. The individual Toc Loop Domains (TLDs) facing either cytosol or intermembrane
space are highlighted in different colors. The models are adapted and reconstructed from
(114).
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published models of the Toc75 topology were analyzed for the selection of the candidate loop
domains. Seven different loops were selected and resulting peptides were named, Toc75 Loop
Domains, TLDs. These seven loops ranged between 40-100 amino acid residues in length and
included “large” loops both at N- and C-terminal of Model B as proposed by Sveshnikova et al
(114). Three loops were selected from Model A, which contained two loops facing the cytosol
and one loop in the intermembrane space (Fig 3-1, Model A) (110). Four loops were selected
from Model B, which included two loops facing the cytosol and two facing the intermembrane
space (Fig 3-1, Model B) (114).
The candidate loops were named from the model which it originated, followed by the
loop number given during the selection process and the location within the membrane. For
example, Loop 1 in Model A facing the cytosolic side was named ‘A1CYT’ and loop 2 from Model
B facing the intermembrane space was named ‘B2IMS’ and so on. Various loops are highlighted
in different colors in Fig 3-1. The amino acid numbers in the published models refer to the
residue numbers of the mature Toc75 sequence without the transit peptide sequence. Toc75
has 131 residues in its transit peptide sequence. Therefore, during the selection of Toc loop
domains, the addition of 131 residues of the transit peptide sequence led to the identified of
loop elements as A1CYT (291-335), A2CYT (352-411), A1IMS (736-780) of model A. Model B
residues were identified as B1IMS (167-226), B1CYT (362-416), B2CYT 470-502, and B2IMS (711780). All the residues correspond to the psToc75 preprotein sequence, i.e. with its transit
peptide. Table 5 lists all the loops selected for topological analysis with their amino acid
sequence and expected molecular mass highlighted in different colors.
3.1.2.2 Sequence Conservation of the Toc75 Loop Domains
In order to gain information about the conservation of the psToc75 loop domains, the
full-length sequence of Toc75 was used to search the database for non-redundant protein
sequences for sequences closely related to psToc75. Multiple sequence alignments were
performed using the T-Coffee program. Pea Toc75 homologues are clearly conserved among
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Amino acid
sequence
and Residue
numbers

Protein name

MW
(Da)

Amino acid sequence

LFFD – NADG
167-226
CLLP – YACA
291-335
VVEG – NSLA
352-411
TITF – DDLA
470-502
PYSV – YGAG
711-780
RIPI – YGAG
736-780
IQYL – FSNI
362-416

B1 IMS

6991.01

A1 CYT

5516.33

A2 CYT

6824.98

B2 CYT

3946.36

B2 IMS

7741.76

A1 IMS

5051.69

B1 CYT

6344.3

MLFFDRNKKSK VETQDSFLDM VSLKPGGVYT KAQLQKELES
LATCGMFEKV DMEGKTNADGPG
MCLLPTSVHEE IKDMLAEQGR VSARLLQKIR
DRVQSWYHEE GYACAPG
MVVEGDITKLS IQYLDKLGNV VEGNTEGPVV QRELPKQLLP
GHTFNIEAGK QALRNINSLAPG
MTITFEHRNLQ GLNRSLTGSV
TTSNFLNPQD DLAPG
MPYSVRGYNMG EIGAARNILE LAAEIRIPIK GTHVYAAEHG
TDLGSSKDVK GNPTVVYRRM GQGSSYGAGPG
MRIPIKGTHVY AFAEHGTDLG SSKDVKGNPT
VVYRRMGQGS SYGAGPG
MIQYLDKLGNV VEGNTEGPVV QRELPKQLLP
GHTFNIEAGK QALRNINSLA LFSNIPG

Subcloned Expressed
into
pTYB2

Purified

Antibodies

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

No

Yes

Yes

Yes

No

Table 5 Sequence information and summary of results of the Toc75 Loop Domains
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different plant species of both monocots and dicots which included Arabidopsis, maize, legume,
cotton, grape vine, and rice. The proteins with the highest sequence similarity were part of the
rice and algal group presented by the proteins found in species of Arabidopsis lyrata,
Ostreococcus lucimarinus, atToc75-I, atToc75-III, Physcomitrella patens subsp. Patens,
Chlamydomonas reinhardtii and Volvox carteri f. nagariensis with Blast score of 300 to 545 and
E value = 6e-152 of Micromonas pusilla to 8e-77 of Selaginella moellendorffii. The algal group
was followed by several OMPs from different Gram-negative bacteria, mainly cyanobacteria,
with Blast scores ranging from 172 with an E value of 1e-40, an OMP of Microcoleus
chthonoplastes to the Blast score of 112 with an E-value of 1e-23 of atOEP80. This included the
range of OMP85 proteins including Sam50, an OMP85 homolog, of Ricinus communis. The
closest cyanobacterial Toc75 homolog was found in Synechocystis sp. PCC 6803 with Blast score
of 130 with an E score = 6e-28. Other OMP85 homologues included Synechococcus elongatus,
Thermosynchococcus elongatus, and alr2269. The sequence search also included the D15related surface antigen proteins similar to Toc75. The complete list of all the sequences with
the lowest score of 1e-23 is included in Fig 3-2 and proteins belonging to each group are
highlighted according to different groups. From the analysis of the multiple alignment of Toc75,
it is clear that Toc75 shares significant sequence similarity with the homologues present in
species of monocots and dicots, and have homologues present in D-15 related surface antigens,
mitochondria, and cyanobacteria, which is consistent with their origin from the cyanobacteriallike endosymbiont. The BLAST sequence analysis of psToc75 also resulted in the phylogenic
analysis of proteins related to the Toc75 as shown in Fig 3-3. The analysis of the tree revealed
that only Toc75 subunit has a clear cyanobacterial set of orthologs. However the protein
conducting channel members unique to plants and algae are distinct. Furthermore, atOEP80
does not belong to the same group of Toc75 proteins (See Fig 3-2 and Fig 3-3). In fact, it is more
closely related to the cyanobacterial Toc75 homologues supporting the hypothesis that both
Toc75 and atOEP80 must have diverged early in the evolution process. All the proteins of the
OMP family represent the proteins of highest similarity to one another, confirming that they
form a distinct protein family. Furthermore, it is clear that the C-terminus is quite conserved in
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Figure 3- 2 Multiple alignment of the psToc75 and conservation of the TLDs and POTRA
domains
The representative multiple alignments of psToc75 with other proteins similar to the psToc75
as identified by the blastP search. The alignment was produced with blastP and T-Coffee by
searching for sequences closely related to psTOC75. The blastP search identified sequences
closely related to psToc75 in the species of monocots and dicots as shown by the ‘Rice group’
highlighted in light pink. This group included Oryza sativa indica, Oryza sativa japonica, Populus
trichocarpa, Sorghum bicolor, Vitis vinifera, Zea mays, Medicago truncatula and Arabidopsis
thaliana homologs atToc75-III, atToc75-IV and atOEP80. The second group with the closest
sequence similarity was identified as an ‘Algal group’ as shown in light green. This group
included sequences from Physcomitrella patens, Chlamydomonas reinhardtii, Nodularia
spumigena, Microcystis aeruginosa, Nodularia spumigena, Microcystis aeruginosa,
Ostreococcus lucimarinus, Selaginella moellendorffi, Micromonas pusilla, Ostreococcus tauri,
Volvox carteri f. nagariensis, and Trichodesmium erythraeum. The other groups included the
similar proteins found in mitochondrial Sam50 of Ricinus communis as well as Gram-negative
bacteria as identified D15-surface antigens (light orange) and cyanobacterial Omp85
homologues (light aqua). The D15 surface antigens include Cyanothece, Oscillatoria,
Acaryochloris marina, Crocosphaera watsonii, Anabena variabilis, and Trichodesmium
erythraeum. The cyanobacterial OMP85 group included Microcoleus chthonoplastes,
Synechococcus, Nostoc punctiforme, Gloeobacter violaceus, Synechococcus elongatus PCC 7942,
Thermosynechococcus elongates, and Anabena sp PCC7120. The multiple alignments here do
not include the conservation of the transit peptide.
(A) Conservation of POTRA1 (black dotted line) and B1IMS (purple solid line) domains of
psToc75 with other sequences, (B) Conservation of POTRA2 (gray dotted line) and A1CYT (pink
solid line) domains of psToc75, (C) Conservation of POTRA3 (light gray dotted line), A2CYT
(green solid line), and B1CYT (red solid line) of psToc75, (D) Conservation of B2CYT (blue solid
line) of psToc75, (E) Conservation of A1IMS (orange solid line) and B2IMS (black solid line) of
psToc75 with other similar sequences
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Figure 3- 2 Continued.
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Figure 3- 2 Continued.
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Figure 3- 3 Phylogenic analysis of the Toc75
The phylogenic tree of Toc75 with its related homologues. The tree shows the close relationship
between the psToc75 and homologues found in the rice, algal Arabidopsis thaliana family are
distinct and form part of the protein conducting channel. Toc75 has a clear set of
cyanobacterial orthologs (green shade). atOEP80 did not belong to the same group as Toc75
and more closely related to the cyanobacterial proteins (orange shade).
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all the proteins homologous to the Toc75 (Fig 3-2 D-E). This observation is consistent for all the
members belonging to the OMP85 superfamily (74). The analysis of multiple alignment and
phylogenic tree further confirms the evolutionary relationship of Toc75 and cyanobacterial
proteins. The conservation of individual TLDs is highlighted as shown in Fig 3-2 (A-E). The
sequence identity of psToc75 with the members of the rice, algal and cyanobacterial group is
also presented as percent sequence identity for individual loop domains as shown in Fig 3-4.
A1IMS and B2IMS fragments share between 40-50% sequence identity with Synechococcus and
Prochlorococcus as expected since these regions are part of the C-terminus which is highly
conserved region of the OMP85 superfamily. All of Toc loop domains share up to 85% sequence
identity with the A. thaliana and rice homologues except atOEP80 which shares <40% identity
with psToc75 and shows higher identity to the cyanobacterial homologues than to psToc75 or
atToc75-III. The multiple alignments, sequence identity, and the phylogenic tree indicate that
the C-terminus of the psToc75 is highly conserved at the C-terminus and atOEP80 represents
the earliest form of Toc75. Furthermore, all the Toc75 loop domains share significant sequence
similarity with the algal and rice groups and members of the OMP85 superfamily.
3.1.2.3 Generation and Purification of Toc Loop Domains
Subcloning of the TLDs into the pTYB2 vector
The TLDs were subcloned into the pTYB2 vector of the IMPACT system (NEB, Ipswich,
MA). This system allows the purification of the target protein without any addition of tags or
proteases that might interfere with the biochemical analysis of the purified proteins; however,
the fusion proteins have to be soluble to bind to the affinity matrix in the IMPACT system. This
system takes an advantage of the self-cleavage of intein in the presence of reducing agents
such as DTT or β-Mercaptoethanol (β-Me) and releasing the target peptides from the column
bound intein- chitin-binding domain (CBD) tag. The only disadvantage of this system is that the
yield of the target protein is often as low as 1 mg per 4-L culture. The loops were generated
from the DNA amplification of the full-length Toc75 from P. sativum (psToc75-pET23(a)) as
described in the ‘Methods and Materials’. The PCR product and the pTYB2 vectors were
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Figure 3- 4 Conservation of psToc75 Toc loop Domains
The conservation of psToc75 Toc Loop Domains as percent sequence identity found in homologues of psToc75. These domains
shared significant (>75%) sequence identity with homologues found in arabidopsis (atToc75-III), grape and legume (red, dark green,
and dark purple bars), while they shared between 65-75% identity with rice homologues (light blue and orange bars). B2CYT, B2IMS
and A1CYT (which localize on the C-terminal) shared 40-50% sequence identity with the algal and cyanobacterial proteins, which is
consistent with the observation that C-terminal is highly conserved in the OMP85 family of proteins. A1CYT and A2CYT, which
localize at the N-terminus, did not share sequence identity with these species.
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restriction digested with NdeI and XmaI (an isoschizomer of SmaI) resulting in the products with
sticky ends. A cleavable Intein tag and a CBD were introduced onto the C-terminus of the target
peptide, which allowed one-step affinity purification using a chitin column. As a result of the
cloning strategy, Methionine was restored at the N-terminus and two residues, Proline and
Glycine, were introduced at the C-terminus of the target sequence. The expected molecular
mass of all the loops with M- and –PG are shown in Table 5. In order to evaluate the success of
cloning of target TLDs into the vector, the colonies were selected for PCR colony screen and the
positive constructs were selected for plasmid prep and sequence confirmation. Figure 3-5 A
shows a 6% acrylamide gel of the success of the direct colony PCR screen for TLD constructs.
Cloning of these peptides resulted in the addition of ~171 base pair modification from the
pTYB2. The colonies that resulted as re-ligation or without insertion, resulted in only 222
basepair bands when run on an acrylamide gel. Colonies that produced a larger PCR product (X
+ 171) were selected and sequenced using an automated sequencer. To ensure that all the
positive constructs were correctly cloned with their fusion Intein-CBD tags, the positive
construct DNA was also doubly digested with restriction sites present at the N-terminal of the
construct (NdeI) and immediately following the CBD tag at the C-terminus (PstI). The resulting
digests would produce two bands i) length of DNA insert + 1562 bp product and ii) cut vector
(~5912 bp +/- (length of the insert + 1562 bp)) product (data not shown). Finally, all seven interβ-strand loop constructs were sequence confirmed, midi prepped and transformed into
competent E. coli ER2566 for protein production.
Expression and Purification of TLDs
The protein expression was induced with 0.7-1 mM IPTG at 250 C overnight to increase
the solubility of the large fusion protein. The colonies producing the most protein were used to
inoculate the large cultures for protein production. After the overnight induction, the cells were
harvested and lysed using sonication followed by benzonase treatment to digest DNA. The
purification profile of a representative TLD, B2CYT, is shown in Fig 3-5 B. After overnight
induction, the total cell lysate contained the expressed protein as a major band present at
about 60 kDa (Lane 2 ‘Total Lysate’, Fig 3-5 B). This corresponds to the theoretical molecular
weight of the TLD (3949.36 Da) plus the intein and CBD of 56 kDa. Following sonication, the
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Figure 3- 5 PCR colony screen and purification of the Toc Loop Domains
(A) The success of the PCR colony screen of seven TLDs was determined by 6% acrylamide gel as
shown in the color coded arrows. The negative products ran at about 222 base pair. (B) 15%
acrylamide gel shown the purification profile of representative B2CYT domain prior to collecting
protein elutions. (C) Six TLDs were purified with IMPACT system and ran on Tris-Tricine gel
system as shown here. The purity was determined by the MALDI-TOF mass spectrometry.
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samples of ‘pellet’ and ‘supernatant’ were run on lanes 3 and 4, respectively, as shown in Fig 35 B. Since the protein of interest was present in both pellet and supernatant, this indicated that
either that the cells were incompletely lysed or that some of the fusion protein was present as
inclusion bodies. Nevertheless, most of the fusion protein was present in the supernatant
fraction, most of which was bound to the chitin column, as the bands corresponding to the
protein is less than the original when loaded onto the column indicating that the protein must
have bound and very less flow-thru (lane 5 ‘FT’, Fig 3-5 B). To remove non-specifically bound
proteins, the columns were washed extensively with the wash buffer. Since there were no
bands detected at 60 kDa in both the washes (lane 6 ‘W1’ and lane 7 ‘W2’, Fig 3-5 B), it
indicated the CBD tag was bound to the chitin affinity matrix of the column. The target protein
was eluted from its fusion tag in the presence of 50 mM β-Me overnight at 4°C. This incubation
induced the intein self-cleavage reaction and released the protein from the column bound
intein-CBD. In order to determine the success of the cleavage, an aliquot of the chitin matrix
was removed, solubilized and run on the gel (lane 8 ‘Chitin’, Fig 3-5 B). There were two bands
present in the chitin sample: i) band corresponding to the intein-CBD tag at about 56 kDa
indicating the success of the cleavage of the protein from its tag and ii) a band at about 60 kDa
corresponding to the protein attached to its fusion intein-CBD. This indicated that some protein
was still bound to the column. After an overnight incubation with β-Me, the target protein was
eluted in elution buffer with β-Me added to it. The final elutions were lyophilized to
concentrate the proteins and to remove β-Me. The lyophilized elutions were solubilized in
water and centrifuged at the max speed to precipitate DnaK and other various chaperones that
often co-purifies. These elutions were run on a Tris/Tricine gel system for peptides and
Coomassie staining was used to stain and visualize the purified peptides. Fig 3-5 C shows the
purification of six of Toc loop domains. The purification of one of the loops, A1IMS, was not
successful since this region contains many rare codons which are hard to express in the E. coli
system. Thus, only six peptides were purified. Expression and purification profiles were run on
15% SDS-PAGE gels. The purity and integrity of these domains were evaluated using both the
Tris/Tricine gels and Matrix Assisted Laser Desorption Ionization-Time Of Flight Mass
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Spectrometry (MALDI-TOF MS). The expected molecular mass of individual domain is shown in
Table 5.
3.1.2.4 MALDI-TOF of the Toc75 Loop Domains
In order to evaluate the Toc75 loop domains for purity and size, MALDI-TOF MS was
performed with β-oxidized-insulin used as an internal standard on a Bruker-Daltonics
MicroflexTM mass spectrometer. The mass spectra of the TLDs, A1CYT, A2CYT, B2CYT, B1IMS,
B2IMS, are shown in Fig 3-6 A-E, respectively. Although the purification of B1CYT was
successful, the yield was extremely low. Therefore, MALDI-TOF analysis was not performed on
B1CYT. The FindPept tool was used to identify the peptides that correspond to the main peaks
(See ‘Supplementary data’ Fig S-1 to S-5). The largest peak was found at 5534.11 m/z
corresponding to the full-length A1CYT, which is very similar to its expected molecular weight.
The minor peaks between 5052.309 and 5380.198 m/z represents either an alternative
translation initiation at Met 15, modification at the C-terminal by the presence of β-Me or a
degradation product generated during expression and purification of the protein (Fig 3-6 A).
The spectra for A2CYT peptide is shown in the Fig 3-6 B. The species at 6857.034 corresponds to
the full-length A2CYT. The other two species at 6480.918 and 6678.641 can be due to the
modifications from the Methionine and C-terminal β-modification between residues 1-58 and
1-60, respectively. The spectra corresponding to the B2CYT is shown in Fig 3-6 C. The major
peak at 3992.190 m/z corresponds to the full-length B2CYT. The peak at 3856.289 m/z was
potentially due to an unknown contaminant and did not correspond to any cleavage or
modification by FindPept. Shown in Fig 3-6 D is the spectrum of B1IMS. The expected molecular
weight of the peptide is 6991.01 and the major peak corresponding to the +1 charged species
can be found at 7064.964. The difference of approximately 74 Da in the molecular mass
between the expected and observed molecular mass can be explained by the modification of βMe at the C-terminus. The +2 charged species is found at 3533.206 m/z. The spectrum of B2IMS
is shown in Fig 3-6 E. The expected molecular weight of B2IMS is 7741.77 Da which is shown by
a wide peak in this region; however, the spectra suggested that this peptide largely exists in +2
charged state at 3754.848 m/z. Other species found around this peak can be due to alternative
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Figure 3- 6 MALDI-TOF of the Toc loop domains
A to E show the MALDI-TOF analyses of A1CYT, A2CYT, B2CYT, B1IMS and B2IMS, respectively.
Analyses of each loop peptide via MALDI reveals molecular weights to be slightly different from
theoretical molecular weights due to distinct site-specific cleavage for each peptide. The
IMPACT has specific cleavage sites, but these have been shown to vary by several amino acid
residues. The expected masses corresponding to the main peaks are labeled in each panel.
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translation initiation at Met 59 or degradation products. MALDI-TOF analysis confirmed the
purity and site-specific cleavage for Toc75 loop domains. The lyophilized and MALDI-confirmed
peptides were used for the production of antibodies and were also used for GTP hydrolysis
experiments (to be discussed in Chapter 4).
3.1.2.5 Cloning of Codon Optimized POTRA Domains of psToc75
In order to improve the heterologous protein expression of full-length psToc75 in E. coli,
a region with the most codon bias in E. coli was optimized to match the codon usage frequency
in E. coli, without modifying its amino acids. Fig 3-7 A shows the chart of the inverse frequency
of codon usage of psToc75 in E coli. The codons that are the rarest in the sequence of psToc75
are shown with the largest peaks between residues 222 to 410 as shown by the presence of
dense tall peaks within that region. This region also corresponds to the two of the three POTRA
domains of psToc75 (to be discussed in Part II). Therefore, residues 248 to 420 (INVG-EVNP) of
the mature Toc75 sequence were codon optimized. Depicted in Fig 3-7 B and C is relative
adaptiveness of the codon usage of Toc75 residues 248-420 in E. coli before and after codon
optimization, respectively. The relative adaptiveness of 0 corresponds to the absence of those
codons in the E. coli t-RNAs. The target sequence was selected and modified using E. coli codon
usage table using the Synthetic Gene Designer and JCat. The programs allowed codon
manipulation showing a graphical presentation of the relative adaptiveness (wij) of the codons
in psToc75-POTRA gene based on the codon usage of E. coli. The full-length sequence of the
psToc75 before and after codon optimization is provided in the Supplementary data Fig S-6
and S-7. The codon optimized synthetic gene was sent for synthesis. It was flanked by the NsiI,
SacII restriction sites, which are also present in the Toc75-pET23(a) template (unadapted)
sequence, which was to be used as ‘vector’ for the insertion of the codon optimized gene. The
synthesized codon optimized gene was cloned into SmaI digested pBluescript II SK derivative
lacking its multiple cloning site. This DNA was sequence confirmed and both synthetic codon
optimized gene and psToc75-pET23(a) were digested (NsiI, SacII), ligated and screened for the
presence of the insert. However, since the cloning did not result in a different size of product
from the original, EcoR1 restriction enzyme was used to screen for the positive inserts. The
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Figure 3- 7 Codon frequency of psToc75 in E. coli
(A) The chart of the inverse frequency of codon usage in E. coli versus residues of psToc75. The
codons which are the rarest in E. coli are shown with the clusters of tall peaks at about 900.
Since E. coli lacks tRNA for these codons, these are usually harder to express in E. coli
expression system. (B-C) The charts of the relative adaptiveness against codons from residues
248 to 420 of psToc75 sequence before and after codon optimization, respectively. Relative
adaptiveness of each codon is a ratio of the usage of each codon, to that of the most abundant
codon for the same amino acid. Relative adaptiveness of zero refers to the absence o that
codon in t-RNA (Panel B). The codons were optimized (relative adaptiveness of 1) to match the
t-RNAs present in bacterial system.
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unadapted psToc75-pET23(a) contained one EcoR1 restriction site, while the codon optimized
gene contained two EcoR1 site. Digestion of the final ligated DNA with EcoR1 resulted in the
presence of three bands (at 445, 449 and 1773 bp) for the codon optimized and two bands (at
about 500 and 2200 bp) for unadapted Toc75-pET23(a) DNA, respectively (data not shown). The
positive constructs were selected and prepped for the automated sequencing. The sequences
were confirmed for the presence of now-codon optimized gene into the full-length template
Toc75-pET23(a). The final construct resulted in codon optimized POTRA2 and part of POTRA3
(aa # 248 – 420, the residues corresponding to the preprotein, i.e. 131 residues in transit
peptide) into the Toc75-pET23(a) template (discussed later in this chapter). The purification of
TLDs and POTRA 1 and 3 discussed in this thesis was performed before cloning of codon
optimized gene. The proteins cloned and expressed post-codon optimization will be referred as
‘codon optimized (C.O.)’ proteins.

3.1.3 Summary
Table 5 summarizes the outcome of the analysis and selection of seven of inter-β-strand
loop domains of psToc75 using two predicted topology models. Seven Toc Loop Domains were
identified and cloned into pTYB2 expression vector. Six peptides, A1CYT, A2CYT, B2CYT, B2IMS,
B1CYT AND B1IMS were purified via IMPACT system and confirmed for purity and site-specific
cleavage by MALDI-TOF (except B1CYT). However, the expression and purification of A1IMS
could not be achieved. The analysis of the codon usage of psToc75 in E. coli revealed that
psToc75 gene contains many codons that are rare to the codon usage by E. coli. This included
the region corresponding to one of the potential POTRA domains. The target Toc75 template
DNA was codon optimized and cloned into the pTYB2 expression vector.
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3.2 Part II - Identification and Initial Characterization of psToc75
POTRA Domains
3.2.1 Introduction
Toc75, a member of an OMP85 superfamily, contains three POTRA domains, which are
predicted to contain three β-strands with the later two separated by two α- helices (74). The
members of this family of proteins are involved in protein translocation into and across the
outer membrane of Gram negative bacteria (Omp85/BamA), chloroplast (Toc75) and
mitochondria (Sam50/Tob55) (73). Although there is no crystal structure available of the
Omp85 homologues in mitochondria and chloroplasts, biochemical studies of the N-terminus of
psToc75 truncations have suggested that the N-terminus of psToc75 is involved in the substrate
recognition by serving as binding sites to the transit peptides of preproteins to be targeted to
or across the chloroplast outer membrane (102). The same study showed that a structural role
of N-terminal region of Toc75 in mediating the contact between Toc75 and Toc34.
Furthermore, a chaperone-like function has also been proposed which would explain how the
TOC complex can function without the presence of chaperones (74-75). It is clear that Toc75 is
involved in protein translocation and thus the domains might function in protein recognition,
translocation and gating the pore or might be involved in the complex formation with other
TOC subunits as discussed above depending on the orientation of these domains within the
membrane, which is currently unknown (102).
Fig 3-8 depicts a model of possible of interactions of POTRA domains depending on its
orientation within the outer membrane of the chloroplasts. Although many possible of
interactions exist in the cytosolic face, a few possibilities include interaction with the transit
peptide of incoming preproteins, hetero-oligomerization with the other component of the TOC
apparatus such as Toc159 and/or Toc34, or in the dimerization with other POTRA domains as
shown in Fig 3-8 A-D, respectively. If the orientation of these domains is in the intermembrane
space, they may interact with the translocating transit peptide of the preproteins, the
components of the TIC apparatus, or intermembrane space chaperones as shown in Fig 3-8 E-F.
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Figure 3- 8 Proposed interactions of POTRA domains of psToc75
Shown in panels A to D are the proposed interactions of POTRA domains, if they localize in the
cytosolic side. They can interact with (A) incoming transit peptide/preprotein (B) with cytosolic
Toc159, (C) Toc34, (D) or dimerize with POTRA domains of other active TOC translocon. If they
localize in the intermembrane space, they can interact with (E) translocating transit
peptide/preprotein or (F) TIC components of the inner membrane.
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3.2.2 Results and Discussion
3.2.2.1 Homology Modeling of psToc75
This section focuses on the initial identification and characterization of the N-terminal
POTRA domains of Toc75 from P. sativum. Using HMMer to perform Hidden Markov Profile
searches and the HMM profiles of POTRA2 and the related Bacterial Surface Antigen (both
downloaded from the pFam database, Sanger Institute), the POTRA domains of psToc75 were
identified as POTRA1, residues 161-237, POTRA2, residues 266-355, and POTRA3 residues 366439, POTRA3 being closest to the pore (all residue numbers correspond to the preprotein i.e.
131 residues in transit peptide) (105). The domains were named from P1 to P3 from the Nterminus. The residues 440-809 represent the entire postulated pore-forming region at the Cterminus which is a highly conserved region within members of the OMP85 superfamily sharing
>75% similarity to a known outer membrane protein, FhaC of B. pertussis (102, 105). However,
the sequence similarity between the N-terminal regions is fairly low (also shown in Fig 1-5,
Chapter 1). By superimposing the crystal structures of the four of the BamA (E. coli) and two of
FhaC (identified and discussed in Chapter 1) as well as three POTRA domains of the AnaOmp85
and TeOmp85 each, the secondary folds within the POTRA domains was determined as shown
in Fig 3-9 A. The superimposition of different POTRA domains revealed that the folds in each
domains are very similar, comprising a three-stranded β-sheets and two α-helices despite low
sequence similarity (11-14%). This new structural insight provided the confidence to generate
the molecular modeling to identify the structural elements found within psToc75 from P.
sativum. The overlay of these structures reflect their conserved secondary structures and
therefore some of the features of recently crystallized POTRA domains (discussed in Chapter 1)
can be applied to the psToc75 POTRA domains. Initially, the crystal structure of FhaC along with
the identification of the POTRA domains by HMMer provided adequate information to give a
reasonable homology model including POTRA 2 and 3 as well as the β-barrel as shown in Fig 3-9
B. The alignment of psToc75 homology model based on the FhaC is depicted by superimposing
(r.m.s.d. of 2.71, identity 11.2%) the template and psToc75 in Fig 3-9 C.
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Figure 3- 9 Homology models of psToc75-POTRA domains
(A) Panels A shows the superimposition of the crystal structures of the two POTRA domains of
FhaC, four POTRA domains of BamA, and three POTRA domains of AnaOmp85 and TeOmp85
each. High degree of structural similarity was seen when these domains were superimposed
using STAMP alignment program. The β-strands are labeled in yellow and the helices are
labeled in purple; the loops are shown in light blue. (B) Panel B shows the homology model of
the psToc75 using the crystal structure of FhaC as a template. POTRA1 was not included in the
homology model as the template only contains two POTRA domains. (C) Panel C shows the
superimposition of the crystal structure of FhaC with the homology model of psToc75 (in
orange). Both models superimposed with an r.m.s.d. of 2.71. (D) Panel D shows the homology
model of three POTRA domains of psToc75 without the barrel based on the crystal structure of
the TeOmp85 POTRA domains (r.m.s.d. = 1.1). (E) Panel E shows the homology model of three
POTRA domains of psToc75 without the barrel based on the crystal structure of the AnaOmp85
POTRA domains (r.m.s.d. = 0.58). The features observed in the crystal structure of to the
AnaOmp85 (such as β-augmentations) POTRA domains are also shown with arrows. (F) Panel F
shows high degree of structural similarity by the superimposition of homology models of
psToc75 based on TeOmp85 and AnaOmp85, in orange and green, respectively with both
templates. (G) Panel G shows the cut view of homology model of psToc75 based on FhaC. The
“loop” that folds inside the pore is labeled.
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However, since the template - FhaC - only contained two POTRA domains, the resulting
homology model of psToc75 only included POTRA2 and POTRA3. This homology model did not
include the most N-terminal POTRA domain, POTRA1. The recent crystal structures of
AnaOmp85 and TeOmp85, which contain three POTRA domains, provided insight into
reinvestigating and building a homology model of all three of POTRA domains. For the
alignment of Toc75 with the AnaOmp85 and TeOmp85 POTRA domains, SwissModel Alignment
Mode was used along with the alignments generated by ClustulW. Shown in Fig 3-9 D and E are
the homology models of the three POTRA domains of psToc75 based on the crystal structures
of TeOmp85 and AnaOmp85, respectively. The POTRAs of TeOmp85 and Toc75 superimposed
with an r.m.s.d. of 1.10 (18% identity) and with an r.m.s.d. of 0.58 with the AnaOmp85 (17%
identity) (data not shown). Both homology models of psToc75 POTRA domains superimposed
with an r.m.s.d. of 3.25 and the overlay of both models along with their templates are depicted
in Fig 3-9 F. The superimposition of these homology models can provide insight into the
mechanism and assembly of the psToc75 POTRA domains in protein import. All three homology
models, two from AnaOmp85 and TeOmp85 and one from FhaC, provided a reasonable
orientation of the POTRA domains with β-barrel and all agreed on the region between POTRA 3
and the β-barrel containing 16 β-strands. Finally a loop corresponding to the residues LVLH
(687) – SVRG (716) of the β-barrel was also identified folded inside the barrel in the homology
model of the psToc75 based on FhaC as shown in Fig 3-9 G. This loop was also identified in FhaC
and AnaOmp85. It corresponds to the loop “L6” (motif 3) of FhaC, which has been shown to
play an important role in polypeptide translocation across the outer membrane of B. pertussis.
Whether this loop plays a role in the protein import into chloroplasts has yet to be determined;
however, it is clear that some of the features unique to each of the crystal structure such as L6
loop of FhaC, β-augmenting strands of TeOmp85, AnaOmp85 and BamA are conserved and can
also be observed with the homology modeling of psToc75 as well.
3.2.2.2 Selection of POTRA Domains and Intra-POTRA Linkers
The identified POTRA domains of psToc75 were named as each of the three psToc75
POTRA domains individually (P1; P2; P3), in adjacent pairs (P1-2; P2-3), and as all three POTRA
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domains combined together (P1-2-3). In order to clone the full-length of identified POTRA
domains, three residues at the N- and C- termini of each POTRA domains were included in the
cloning strategy. The amino acids 158-240, 263-258 and 363-442 now corresponded to the
individual POTRA domains. These identified POTRA domains have already been aligned for
sequence conservation along with the multiple alignment of TLDs as shown in Fig 3-2. Depicted
in Fig 3-10 is the schematic representation of the identified POTRA domains of psToc75 with its
sequence information. The linker region between POTRA1 and POTRA2 of psToc75 is
approximately 25 residues, while the linkers between POTRA1 and POTRA2 in other identified
outer membrane proteins of algal group, surface antigens such as FhaC, BamA, Omp85, and
cyanobacterial homologues are no more than five residues. Because the initial modeling was
only based on the crystal structure of the FhaC, an attempt was made to identify the most
conserved “linker” regions between each POTRA domain and between the most C-terminal and
β-barrel domain. In order to identify the most conserved intra-POTRA linker regions, different
secondary structure prediction programs, alignment of intra-POTRA linker regions, along with
the results from the homology modeling and HMMer were used.
Shown in Fig 3-11 is the multiple alignment of intra-POTRA linker domains of psToc75
with POTRA domains found in other family of outer membrane proteins. The proteins
containing POTRA repeats were identified and included in the analysis. Shown in Fig 3-11 A is
the alignment of intra-POTRA1-POTRA2 linker regions identified in most closely related ‘rice
group’ followed by the proteins in the ‘algal, cyanobacterial and OMP85 group. The linker
regions for each group are highlighted in black boxes. Fig 3-11 B and C show the alignment of
intra-POTRA2-POTRA3 and POTRA3-barrel linker regions, respectively. As expected, the highest
conservation was observed in the POTRA3-barrel region. The conservation observed here
identified a amino acid residue number 440 corresponding to Glutamic acid immediately
following predicted most C-terminal LKEL residues of POTRA3. Furthermore, the alignment was
analyzed for the presence of Proline and Glycine residues in the linker regions, since prolineinduced kinks can facilitate helical packing motifs and may provide ligand binding site for the
proteins (147).
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Figure 3- 10 Identification of the psToc75 POTRA domains with sequence information
The full-length sequence of the psToc75 is shown along with the representation of the domain
architecture of the psToc75 N-terminal POTRA domains (green) and β-barrel (blue). Three
POTRA domains are highlighted in green and residues included to ensure the efficient cloning of
full-length POTRA domains at both N- and C-terminal are underlined. The transit peptide is
highlighted in black; intra-POTRA linker regions are highlighted in light blue; sequence
corresponding to the barrel is highlighted in blue.
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Figure 3- 11 Alignment of the intra-POTRA linker region of psToc75
The alignment of the intra-POTRA linker regions found in different proteins of OMP85
superfamily. The sequences are separated by the group they belong to such as, Rice, Algae,
Cyanobacteria and Omp85 proteobacteria. POTRA domains of FhaC, BamA, AnaOmp85,
TeOmp85, Omp85 were also included in the analysis. (A) Panel A shows the alignment of linker
region between POTRA1 and POTRA2 of psToc75 with other proteins. Individual linkers are
highlighted in boxes. The residues most conserved in all groups were used for primer design. (B)
Panel B shows the alignment of intra POTRA2-POTRA3 linker regions. Residues GDI and KLSI
were most conserved throughout all the groups. (C) Panel C shows the alignment of linker
between POTRA3 and barrel region. This alignment also included POTRA4 and 5 of BamA,
Omp85 and POTRA2-barrel of FhaC since these are closest to the pore. The alignment shows
high conservation at the N-terminus residues KELE and SAEV. The conserved C-terminal domain
of all the members of OMP85 superfamily is reflected in this panel as high degree of
conservation.
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The secondary structure prediction analysis also provided the information of the folds
found in POTRA domains. Seven different secondary structure prediction programs were
analyzed to observe the β-α-α-β-β fold found in each POTRA domains (See Supplementary data
Fig S-8 to S-12, Table S-1). The domains corresponding with these patterns were identified.
Lastly the homology model and HMMer results were utilized. The analyses from these resulted
in the designing of the primers for the residues conserved in primary sequence, secondary
structure and agreed with the prediction from homology modeling. The complete list of primers
that resulted in the protein production is shown in Table 6. The list of all the other primers that
were not utilized and therefore not part of this thesis is listed in Table 7. The combination of
different forward and reverse primers would result in amplification of various POTRA regions.
All the primers that were designed from the codon-optimized template are highlighted in the
bold in Tables 6 and 7.
Prior to this analysis, POTRA1 and POTRA3 domains were already successfully purified.
Thus only different regions of C.O. POTRA2 and C.O. POTRA1-2-3 were amplified by the
combining different forward and reverse primers. POTRA1, POTRA3 and three different regions
corresponding to POTRA2 (Small, intermediate and large) and POTRA1-2-3 (full-length) were
cloned into an expression vector. The cloning of POTRA1-2 and POTRA2-3 was attempted but
colony screens did not result in the sequence confirmation. The rest of the thesis utilized
POTRA1 (158-240), POTRA3 (363 to 442) and C.O. POTRA2 (280-356, 266-356, 263-358) and
C.O. POTRA1-2-3 (158-439, 148-439, 132-439). Residues at 356-359 and 439 were the most
conserved and agreed well with the HMMer analysis therefore various C.O. POTRA2 and C.O.
POTRA1-2-3 domains were cloned by using different 5’- primers. The identified POTRA regions
as well as codon optimized POTRA2 (S, I and L) and PORA1-2-3 (S, I and L) are shown in the
schematic in Fig 3-12.
3.2.2.3 Subcloning of the POTRA Domains into the pTYB2 vector
The cloning of POTRA1, POTRA2 (unadapted), POTRA3 and codon optimized POTRA2
Small-Intermediate-large and codon optimized POTRA1-2-3 Small-Intermediate-large was
performed as discussed previously for the TLDs using the IMPACT system. For the cloning of
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Amino acid
sequence and
residue numbers

Not C.O. POTRA1
FKKY-SMWE
158-240
Not C.O. POTRA2
PDMS-GDIT

Protein name

MW
(Da)

Purified

Antibodies
made

POTRA1

9667.13

MFKKYKISDILFFDRNKKSKVETQDSFLDMVSLKPGG
VYTKAQLQKELESLATCGMFEKVDMEGKTNADGSLGL
TISFAESMWEPG

Yes

Yes

Yes

Yes

11585.2

MPDMSEKEKIEFFRRQEREYKRRISSARPCLLPTSVHEEIKDM
LAEQGRVSARLLQKIRDRVQSWYHEEGYACAQVVNF
GNLNTREVVCEVVEGDITPG

Yes

Yes

With
impurities

No

MQYLDKLGNVVEGNTEGPVVQRELPKQLLPGHTFNIEAGK
QALRNINSLALFSNIEVNPRPDEMNEGSIIVEIKLKELEQKPG

Yes

Yes

Yes

Yes

Yes

Yes

With
impurities

No

6395.34

ME YKRRISSARP CLLPTSVHEE IKDMLAEQGR VSARLLQKIR
DRVQSWYHEEPG

Yes

Yes

With
impurities

No

8259.44

MSEKEK IEFFRRQER E YKRRISSARP CLLPTSVHEE
IKDMLAEQGR VSARLLQKIR DRVQSWYHEEPG

Yes

Yes

With
impurities

No

Yes

No

No

No

POTRA2

263-358
Not C.O. POTRA3
QYLD-LEQK
POTRA3
363-442
*Codon optimized POTRA2
EYKR- VEGD

POTRA2 Small

280-356
SEKE-VEGD

POTRA2 Inter

266-356
PDMS - GDIT

9251.58

POTRA2 Large

263-358
*Codom optimized POTRA1-2-3
FKKY-LKEL
Potra1-2-3 small
158-439
ITVL-LKEL

Potra1-2-3 Inter

148-439
DEPK-LKEL
132-439

Potra1-2-3 Large

11585.17

Amino acid sequence

MPDMSEKEKIEFFRRQEREYKRRISSARPCLLPTSVHEEIKDM
LAEQGRVSARLLQKIRDRVQSWYHEEGYACAQVVNF
GNLNTREVVCEVVEGDITPG

32458.21

Subcloned Expressed
into
pTYB2

FKKYK........................................ IVEIKLKEL
33468.45

ITVL........................................ IVEIKLKEL

Yes

Yes

With
impurities

No

35320.31

DEPK........................................ IVEIKLKEL

Yes

No

No

No

* For cloning of codon optimized POTRA1-2-3, the codon optimized Toc75-pET23 (a) template was used with the redesigned drimers.
Only the primers highlited in the bold resulted in the cloning of optimized target gene.

Table 6 Identification of the psToc75 codon optimized POTRA domains
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POTRA domains

Amino acid
sequence

Primer name

Strand Length

Sequence 5’ -> 3’

Primers Subcloned Expressed Purified Antibodies
Designed
into
pTYB2

Not C.O. POTRA1 -2

FKKY-GDIT
158-359

P1 FORWARD
P2 REVERSE

+
-

34
30

GGT GGT CAT ATG TTT AAG AAA TAC AAA ATC TCA G
GGT GGT CCCGGG AGT AAT ATC CCC TTC AAC

Yes

No

No

No

No

Not C.O. POTRA2-3

PDMS-LEQK
263-443

P2 FORWARD
P3 REVERSE

+
-

30
27

GGT GGT CATATG CCT GAT ATG AGT GAA AAG
GGT GGT CCC GGG TTT CTG CTC CAA CTC

Yes

No

No

No

No

Not C.O. POTRA 1-2-3

FKKY-LEQK
158-443

P1 FORWARD
P3 REVERSE

+
-

34
27

GGT GGT CAT ATG TTT AAG AAA TAC AAA ATC TCA G
GGT GGT CCC GGG TTT CTG CTC CAA CTC

Yes

No

No

No

No

Not C.O. POTRA 1

FKKY-SFAE

No

No

Yes

No

No

No

No

ITVL-NVGL

GGT GGT CATATG TTT AAG AAA TAC AAA ATC TCA G
GGT GGT CCCGGG CTC AGC AAA CGA AAT CG
GGT GGT CATATG GAC GAA CCA AAA TCA GAA G
GGT GGT CCCGGG TTC AAC CGG TTT AGA C
GGT GGT CATATG ATC ACG GTT TTA CTG G
GGT GGT CCCGGG CAG GCC AAC GTT G

No

C.O. POTRA 1

34
29
31
28
28
25

No

DEPK-KPVE

+
+
+
-

Yes

C.O. POTRA 1

P1-FKKY-FORW
P1-SFAE-REV
P1-DEPK-FORW
P1-KPVE-REV
P1-ITVL-FORW
P1-NVGL-REV

Yes

No

No

No

No

P2-KIEF-FORW
P2-VNFG-REV

+
-

29
27

GGT GGT CATATG AAA ATC GAA TTC TTC CG
GGT GGT CCCGGG GCC GAA GTT AAC AAC

Yes

No

No

No

No

Yes

No

No

No

No

Yes

No

No

No

No

Yes

No

No

No

No

Yes

No

No

No

No

C.O. POTRA2
C.O. POTRA2

KIEF-VNFG

C.O. POTRA3
C.O. POTRA3
C.O. POTRA3
C.O. POTRA3
C.O. POTRA3

DKLG-LKEL

P3-DKLG-FORW
+
28 GGT GGT CATATG GAC AAA CTG GGT AAC G
P3-LKEL-REV
25 GGT GGT CCCGGG CAA CTC TTT GAG C
LSIQ - LKEL
P3-LSIQ-FORW
+
28 GGT GGT CATATG CTG TCC ATC CAG TAC C
P3-LKEL-REV
25 GGT GGT CCCGGG CAA CTC TTT GAG C
EVVCE - EVNP P3-VVCE-FORW
+
28 GGT GGT CATATG GAA GTT GTT TGC GAA G
P3-EVNP-REV
24 GGT GGT CCCGGG CGG GTT AAC TTC
VVQR - PGRGG P3-VVQR-FORW
+
30 GGT GGT CATATG GTT GTT CAG CGT GAA CTG
P3-GRGG-REV
25 GGT GGT CCCGGG TCC TCC TCG CCC G
* Only the primers highlighted in bold here will result in the codon optimized product

Table 7 Primer design of all the Toc75 POTRA domains
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Figure 3- 12 Schematic representation of various lengths of POTRA domains
The representation of the psToc75 domain organization with the residue numbers and
sequence corresponding to each POTRA domain. Various sizes of POTRA2 and POTRA1-2-3
domains are color coded and shown with two sided arrows.
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C.O. POTRA2 and C.O. POTRA1-2-3, primers were designed with the same parameters as
described in the ‘Materials and Methods, except the use of codon optimized psToc75-pET23(a)
template instead of the wild type. For cloning of POTRA1, POTRA2 (unadapted), and POTRA3,
wild type psToc75-pET23(a) template was used. The PCR product and the pTYB2 vectors were
restriction digested with NdeI and XmaI resulting in the products with sticky ends. The success
of the cloning was evaluated by the PCR colony screens and the positive constructs were
selected for plasmid prep and sequence confirmed (data not shown). The cloning of POTRA1-2
and POTRA2-3 did not result in the positive sequence confirmation, and therefore only POTRA1,
POTRA2 (unadapted), POTRA3, codon optimized POTRA2 (S, I, L), and codon optimized POTRA12-3 (S, I, L) were transformed into the competent E. coli strain ER2566 for protein production.
3.2.2.4 POTRA Protein Expression and Purification
The protein expression was induced with 0.5-1 mM IPTG for overnight to increase the
solubility of the large fusion protein. The expression study of POTRA1, POTRA2 (unadapted) and
POTRA3 and C.O. POTRA2 and C.O. POTRA1-2-3 is shown in Fig 3-13 A and B. The colonies
producing the most protein were used to inoculate the large cultures for protein production.
POTRA1, POTRA2, POTRA3 and C.O. POTRA2 S-I-L and POTRA1-2-3-I resulted in protein over
expression as shown by large bands at 66 kDa, 66 kDa, 69 kDa and 90 kDa; however, the
expression of POTRA1-2-3-small and large domains could not be achieved. The expected
molecular mass plus intein-CBD is shown in the Fig 3-13. After an overnight incubation with βMe, the target proteins were eluted in the elution buffer with β-Me added to it and dialyzed
with appropriate dialysis buffer and concentrated with Amicon Centricon Concentrator for the
analysis by CD and MALDI-TOF. The lyophilized and dialyzed elutions were run on a Tris/Tricine
gel system for proteins. The purification of POTRA1 at 9.7 kDa and POTRA3 9.3 kDa resulted in
proteins without any contamination; However, unadapted POTRA2, POTRA2-L and POTRA1-2-3I were purified with other contaminants as shown in Fig 3-13 C (data not shown for POTRA2-L).
Since POTRA1-2-3 is the full-length POTRA domain, its expected molecular mass is
approximately 33.5 kDa. However, with the SDS-PAGE used here, it runs higher than expected.
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Figure 3- 13 Expression and purification of the psToc75 POTRA domains
(A) Panel A shows the expression study of POTRA1, POTRA3 and POTRA2 (unadapted) domains.
The induced protein expression is shown in lanes labeled as ‘Ind’. (B) Panel B shows the
expression of codon optimized POTRA2 small, intermediate and large and POTRA1-2-3intermediate domains. The expected weight of POTRAs with intein-CBD ranges from 66 -69 kDa
for POTRA1, POTRA2 and POTRA3. While for POTRA1-2-3 (S, I, L) ranges from 89-92 kDa. (C)
Panel C shows purified POTRA1 and POTRA3 domains via IMPACT purification system (red
arrow). The purified proteins were free from any contaminants. The center panel shows
purified codon optimized POTRA2-Large domain. The presence of two high molecular weight
contaminants is probably due to the intein-CBD co-eluting with the POTRA2. The purification of
POTRA1-2-3-intermediate is shown in the far right panel at mw of approximately 33 kDa;
however, it contained other unknown higher molecular weight contaminants.
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The contamination in these elutions can be due to the presence of intein-CBD co-eluting with
the proteins and protein unable to cleave off the column. To remedy this, the columns were
treated with different detergent conditions and incubated at different temperatures. The
samples were also run thru the HPLC; however none of these methods resulted in the proteins
without contaminants. Thus they were not utilized for the characterization and other assays.
However, a recent attempt by a fellow student, Richard Simmerman, to purify POTRA1-2-3Small resulted in pure, folded protein (unpublished data). With purified POTRA1 and POTRA3,
aliquots containing 0.1 to 0.5 mg of proteins lyophilized to remove β-Me and for antibody
production, and the rest was used to evaluate the purity and integrity of POTRA1 and POTRA3
by MALDI-TOF.
3.2.2.5 CD and MALDI-TOF of POTRA Domains
MALDI-TOF MS of POTRA1 was performed with apomyoglobin and β-oxidized-insulin
used as internal standards. The spectrum of the POTRA1 is shown in Fig 3-14 A. The +1 and +2
charged POTRA1 species are found at 9727.08 and 4872.15 m/z, respectively. The largest peak
at 9727.08 m/z corresponds to the full-length POTRA1 and is well in agreement with the
expected mass of POTRA1. MALDI of POTRA3 was performed by R. Simmerman and resulted in
the main peak at 9.2 m/z (data not shown). The MALDI-TOF spectrum confirmed the purity and
size-specific cleavage of both POTRA domains. To determine if the purified proteins were folded
correctly and to determine their secondary structure content, circular dichroism was
performed. The spectra of purified POTRA1 and POTRA3 from 185 to 240 nm (190 to 260 nm
for POTRA1) were obtained. The data was averaged and subtracted for the buffer. The
corrected spectra of POTRA1 and POTRA3 are shown in Fig 3-14 B and C, respectively. In
addition, two different computation tools (CDSSTR & ContinLL) were used to compute
theoretical CD spectra of the proteins based on its recognized secondary structural elements as
shown by the overlay in Fig 3-14 B-C for POTRA1 and POTRA3, respectively. Finally, using
CDSSTR to deconvolute the experimental spectra, secondary structure of the folded proteins
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Figure 3- 14 CD and MALDI-TOF of POTRA domains
(A) Panel A shows the MALDI-TOF spectra of purified POTRA1 domain. +1 charged species
corresponding to the full-length POTRA1 is shown at 9727.08 Da, and +2 charged species was
seen at 4972.15 Da. The MALDI-TOF confirmed the size and purity of purified POTRA1 domain.
(B) The secondary fold of POTRA1 (green) domain was analyzed by circular-dichroism. Two
different computation tools (CDSSTR & ContinLL) were used to compute theoretical CD spectra
of the proteins based on its recognized secondary structural elements as by blue line. (C) Panel
C shows the overlay of POTRA3 (red) deconvoluted spectra with calculated spectra using
CDSSTR and ContinLL. (D) Deconvolution of CD spectra provided an estimation of the secondary
structure of observed spectra which compares with the % residues of the calculated
composition of the average of the four E. coli BamA and the two B. pertussis FhaC POTRA
domains. The comparison of the percent composition of the secondary structural elements
found in experimental POTRA1 (green) and POTRA3 (red) with the POTRA domains from FhaC
and BamA (blue). The comparison shows that secondary structures are similar to the expected
POTRA domains.
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was determined as shown in Fig 3-14 D. The deconvolution of CD spectra provided an
estimation of the secondary structure. It allowed the comparison of the % residues composition
of the observed spectra as well as the calculated composition of the average of the four E. coli
BamA POTRA domains and the two B. pertussis FhaC POTRA domains Fig 3-14 D. Table 8
provides comparison of the secondary structural elements of all the POTRA domains in percent
composition. Interestingly, although there are reasonable amount of the each of the secondary
structural elements, psToc75 POTRA 1 and 3 have significantly more unstructured regions with
a concomitant decrease in the α-helical content. This can be explained by the unstructured
intra-POTRA linker regions since cloning of these domains was performed prior to the re-design
of POTRA primers. Furthermore, the increase in the random coil compared to those for the
crystal structures can be explained by the proteins being in the solution. Furthermore, this was
an initial attempt to analyze the secondary structure folds (POTRA1). Circular dichroism with
various buffer conditions resulted in better secondary structure folds as observed by R.
Simmerman. CD of POTRA3 was performed by R. Simmerman.

3.2.3 Summary
Three POTRA domains of the psToc75 were identified by the HMMer profile searches
and a homology model was generated based on the crystal structures of FhaC, TeOmp85 and
AnaOmp85. POTRA1 and POTRA3 were cloned, expressed, purified via IMPACT system. Their
purity and folds were determined by MALDI-TOF and CD, respectively. These two domains were
lyophilized for the production of antibodies. Codon optimized Toc75 template was used to
generate three sizes (small, intermediate and large) of POTRA2 and POTRA1-2-3 domains.
Codon optimized POTRA2-L and POTRA1-2-3-I were purified with contaminants. The design of
different POTRA domains was based on the analysis of the secondary structure prediction
programs, multiple alignments of the intra-POTRA linkers and HMMer profiles. Table 6 lists all
the domains cloned into pTYB2 expression vector for the purpose of purification. The primers
designed for the generation of various lengths of POTRA domains using the codon optimized
gene (highlighted in bold) is listed in Table 7.
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Table 8 Comparison of percent composition of secondary structural folds of psToc75
Table 8 shows the comparison of composition found in BamA and FhaC POTRA domains with
observed composition of POTRA1 and POTRA3 domains
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3.3 Part III - Topological Analysis of TLDs and POTRA Domains
3.3.1 Introduction
In order to understand the role(s) POTRAs play in protein import and translocation
across the chloroplast outer membrane, it is crucial to investigate their orientation in respect of
the chloroplast outer membrane. To this end, the lyophilized TLDs and POTRA1 and POTRA3
domains were used to raise antibodies. Fig 3-15 shows overlapping regions of identified TLDs
and POTRA domains in the full-length sequence of the Toc75. Residue 132 corresponds to the
first amino acid of the mature domain. Individual TLDs are highlighted in different colors within
the mature protein. Three POTRA domains of the Toc75, as identified by HMMer, are also
highlighted in individual colors within the psToc75 sequence. The overlapping proteins are
labeled below the full-length sequence. Since B1IMS and B1CYT are part of the identified
POTRA1 and POTRA3 domains, respectively, they were not sent for the antibody production.
A1CYT forms the part of POTRA2 domain. In the absence of purified POTRA2, A1CYT was used
to map the topology of POTRA2 domain. A2CYT was also included since it contains C-terminus
of POTRA2 domain and N-terminus of POTRA3 domains.

3.3.2 Results and Discussion
3.3.2.1 Antibody Production
Seven different antigens were sent to Agrisera Inc. (Vannas, Sweden) for antibody
production. Two of these proteins formed part of the β-barrel, B2IMS and B2CYT, while the rest
were part of the N-terminus of psToc75 POTRA domains. The pre-immune sera of 24 rabbits
were screened for cross reactivity, and the ones with the least cross reactivity against
chloroplasts were selected for antisera. The immune-sera with the highest cross reactivity
against chloroplasts from peas and spinach were used for antibody production. The westerns
were carried out by conventional western blotting protocol with primary antibody incubation at
1:25000 and secondary Goat anti-rabbit horse radish peroxidase (GAR-HRP) conjugated
antibody at 1:10000 (data not shown). All the purified peptides against which the antibodies
were raised were run on Tris-tricine gel system and subjected to probe with each antibody.
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Figure 3- 15 Overlapping TLDs and POTRA domains highlighted in the psToc75 sequence
The full-length sequence of psToc75. The identified POTRA domains are underlined and Toc
loop domains are highlighted and color coded.
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Shown in Fig 3-16 A is the specific cross reactivity of TLD and POTRA antibodies against
individual purified TLDs and POTRA1 and POTRA3. Partially purified C.O. POTRA1-2-3 was used
as a control to evaluate the efficiency of B2CYT and B2IMs antibodies. Since these domains
form part of the β-barrel, the α-B2CYT and α-B2IMS should not cross react against C.O.POTRA12-3 as shown in Fig 3-16 B. The cross reactivity was observed when purified B2CYT and B2IMS
were probed with the same antibodies further confirming the efficiency of these antibodies (as
expected). The final bleeds of antibodies were used to probe purified intact chloroplasts (580
ng) and crude envelopes (10 µg) at two titers, 1:2000 and 1:5000 as shown in Fig 3-16 C. The
isolation of intact chloroplasts and preparation of crude envelopes are described in ‘Methods
and Materials.’ The efficiency of the antibodies to recognize the Toc75 protein was shown by
presence of single band above 72 kDa in both intact chloroplasts and envelope samples at both
titers. Since rabbits were used to raise antisera, they might have some reactivity against the
chloroplastic proteins. In order to rule out the non-specific cross-reactivity, the pre-immune
sera were also used against individual TLDs and POTRA domains. As shown in Fig 3-16 D the
pre-immune sera did not cross react with any antigens, except POTRA1. This can be explained
by exposure to high titer or non-specific interaction due to insufficient stripping procedure from
previous blot with antisera (when probed same antigens with α-POTRA1 antibody – data not
shown). The final bleeds of antibodies were used to immuno-decorate the intact chloroplasts.
Experiments such as flow cytometry, chloroplasts agglutination assay and Laser Scanning
Confocal Microscopy (LSCM) were performed to map the topology of the TLDs and POTRA
domains by decorating the intact chloroplasts with mono-specific antibodies.
If the antigenic domains of these polypeptides are exposed to the surface of the
chloroplasts and therefore accessible by these antibodies, the isolated intact chloroplasts
would agglutinate and fluoresce when incubated in the presence of these antibodies. The
epitopes not facing the cytosolic face of the chloroplast outer membrane would not be able to
be recognized by these antibodies and therefore no agglutination or fluorescence should be
observed. Furthermore, thermolysin can be used to probe the surfaces of organelles and
isolated membranes (148).
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Figure 3- 16 Antibody testing with TLEs and POTRA domains
(A) Panel A shows the chemiluminescent images of the cross-reactivity of the antibodies
against purified antigens. Since A2CYT is part of POTRA3, it cross reacted when probed with
POTRA3 antibody. (B) Since B2CYT and B2IMS are not part of the POTRA domains, when
purified POTRA1-2-3 was used as an antigen, no cross reactivity was seen confirming the
efficiency of these antibodies. (C) Panel C shows the chemiluminescent images of the crossreactivity of the antibodies against purified intact chloroplasts and crude envelopes. The band
at >72 kDa corresponds to the Toc75 of Pisum sativum. (D) Chemiluminescent image of the
cross-reactivity of the pre-immune sera against other purified antigens and POTRA1-2-3
domains serving as negative control. No bands were seen when blots were probed with preimmune sera indicating that they did not contributed to non-specific interaction. The bands
seen with the blot probed with POTRA1 pre-immune sera were due to inefficient stripping of
blot from the previous experiment.
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3.3.2.2 Determination of Working Thermolysin Concentration
Thermolysin was chosen to probe the chloroplast surface because it is a type of nonspecific metalloprotease, when added exogenously, digests the proteins exposed on the outer
surface of the chloroplasts but does not have access to proteins on the other side of the outer
membrane (148). Therefore, protease treatment can be useful in determining the orientation
of the polypeptides which might be bound to the surface of the chloroplasts. The thermolysin
was activated by addition of Ca2+ and inhibited by EDTA. (149). In order to determine the
working concentration of the thermolysin, isolated intact chloroplasts were treated with
various concentrations of thermolysin. Chloroplasts were treated with 100, 200, 400, and 750
µg/ml (Fig 3-17 A-F, Lanes 2 to 5) thermolysin and probed with α-Toc34, α-PC, and α-POTRA3-T,
α-A1CYT, α-A2CYT and α-B2CYT antibodies at 1:25,000 and secondary at 1:25,000 with GARHRP-conjugated antibody. The resulting blots are shown in Fig 3-17 A-F. Plastocyanin (as well as
ferredoxin) is peripheral electron transport component which is located within the chloroplast
stroma in the thylakoid membranes (150). Therefore, various concentration of thermolysin
treatment on chloroplasts should not have any effect when probed with these antibodies. On
the other hand, Toc34 is exposed to the cytosolic face of the chloroplast, and treatment of
thermolysin should result in the degradation of this protein as concentration of thermolysin
increases (Fig 3-17 A, compare Lane 1 with Lanes 2 to 5). It was clear from the blots that when
chloroplasts were treated with as low as 100 µg/ml thermolysin, resulted in complete
degradation of Toc34 protein as the bands disappeared. The presence of other bands could be
due to the non-specific cross-linking with other chloroplastic proteins. When the samples were
probed with α-PC, the bands did not disappear at concentrations as high as 750 µg/ml Fig 3-17
B (compare Lane 1 with lanes 2 to 5), respectively. The disappearance of the band at 400 µg/ml
thermolysin could be due to the sample loading error since the band was still intact at 750
µg/ml thermolysin (Fig 3-17, lane 4). This finding also confirms that the chloroplasts were not
disrupted by the thermolysin treatment and were still intact at such high thermolysin
concentrations. The chloroplasts probed with various α-POTRA3 and α-A1CYT/POTRA
antibodies resulted in minor degradation of Toc75 to bands between 40-55 kDa (Fig 3-17 C-F,
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Figure 3- 17 Thermolysin concentration determination using various antibodies
Intact chloroplasts were treated with various concentrations of thermolysin as shown in the far
right, from lanes 2 to 5. Lane 1 has intact chloroplasts without any treatment. The proteins
usually run at higher molecular weight probably because of the use of molecular markers
incompatible with the Bis-Tris electrophoretic system. (A) Sample probed with α-Toc34 resulted
in the degradation of Toc34 as concentration of thermolysin increased, shown by red arrow.
The other bands can be due to non-specific crosslinking with other chloroplastic proteins. (B)
Probing with α-PC did not result in degradation of the protein since plastocyanin is thylakoid
membrane protein. The disappearance of band at in lane 4 can be due to the sample loading
error. (C) Probing with α-POTRA3 resulted in the digestion of Toc75 to 55 kDa bands as shown
by increase in band intensity, lanes 2-5 (D) Probing with α-A1CYT/POTRA2 resulted in the
digestion of Toc75 to 55 kDa bands as shown by increase in band intensity, lanes 2-5 (E) Probing
with α-A2CYT/POTRA3 resulted in the digestion of Toc75 to 55 kDa bands only at 400- 750
µg/ml thermolysin, lanes 4-5 (F) Probing with α-B2CYT resulted in the digestion of Toc75 to 55
kDa bands only at 400- 750 µg/ml thermolysin, lanes 4-5.
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lanes 2 and 3). When concentration was increased up to 400 µg/ml, the intensity of bands at 55
kDa increased (Fig 3-17 C-F, lanes 4 and 5). When probed with α-A2CYT/POTRA, and α-B2CYT
antibody, it did not result in any degradation of Toc75 until the concentration of thermolysin
was higher than 400 µg/ml Fig 3-17 E and F (lanes 4-5), respectively. This is consistent with the
previous finding that Toc75 is resistant to thermolysin treatment. Therefore, it can be assumed
that the antibodies specific to these proteins might not have access, and these domains might
be localized in the interior of the outer chloroplast membrane. Alternatively, since B2CYT forms
part of the β-barrel region, it might be protected by a thermolysin-resistant domain. A2CYT
might be protected from other domains since it is embedded in POTRA3 region until treatment
with high thermolysin resulting in bands at 55 kDa. Utilizing other assays can provide further
evidence to support this observation. From this experiment, it was concluded that the
thermolysin can be used at the concentration between 200 – 400 µg/ml. For chloroplasts
agglutination assay and thermolysin treatment with various TLDs/POTRA antibodies assays,
thermolysin was used at concentration of 250 µg/ml. The flow cytometry and LSCM did not
involve the treatment of isolated chloroplasts with thermolysin.
3.3.2.3 Laser Scanning Confocal Microscopy of Labeled Chloroplasts
In order to gain visual information regarding the localization of TLDs and POTRA with
respect to the chloroplasts outer membrane, LSCM was performed on isolated labeled
chloroplasts. Intact chloroplasts were harvested from pea plants, fixed and labeled as described
in ‘Methods and Materials’. The isolated chloroplasts were incubated with primary TLDs and
POTRA antibodies at 1:100 and secondary DAR-DyLight488 at 1:250. For negative controls, two
samples were prepared: i) the chloroplasts without any antibodies, and ii) the chloroplasts
incubated with secondary antibody alone. For the positive controls, chloroplasts were labeled
with α-Toc75 and α-Toc34 antibodies. For experimental samples, intact chloroplasts were
labeled with α-A1CYT (POTRA2), α-A2CYT (POTRA3), α-POTRA1, α-POTRA3, α-B2CYT, and αB2IMS antibodies. Fig 3-18 A top two rows show the staining of the control chloroplasts. The
top right panel shows a superimposition image of the two panels on the left, the chlorophyll
autofluorescence and the FITC channel.
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Figure 3- 18 Visualization of localization of TLDs and POTRA to the cytosol using Laser
scanning confocal microscopy (LSCM) of intact chloroplast
Samples were imaged with a HCX PLAN Apo 63.0x1.32 oil immersion objective and a 2.95X
image zoom giving a final image size of 80 µm X 80 µm. Images were collected at 1024 X 1024
pixel resolution giving a pixel size of 78.9nm X 78.9nm. (A) Left column shows the chlorophyll
autofluorescence of chloroplast in red; center column shows the fluorescence from labeling
with anti-TLD and anti-POTRA antibodies and secondary DyLight488 in green; right column
shows the merged labeling due to DyLight488. The labeling at the outer surface of chloroplasts
suggested that these domains are cytosolically exposed. (B) Control samples: left column shows
the chlorophyll autofluorescence in red, center panel shows fluorescence due to DyLight488;
right column shows the merged fluorescence. Only chloroplasts labeled with α-Toc34 and αToc75 were labeled as exposed to the cytosol (bottom two rows). The labeling due to the nonspecific secondary interaction was ruled out when no labeling was seen in the center column,
top two rows.
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The top row shows the chlorophyll autofluorescence (in red) when no antibody was
added, while the second row also shows the chlorophyll autofluorescence ruling out the nonspecific antibody-antigen reaction of the secondary antibody to the chloroplast surface. The
bottom two rows show the staining of the positive control chloroplasts when chloroplasts were
incubated with α-Toc34 and α-Toc75 antibodies labeled with DyLight488. The bright green
patches at the periphery of the chloroplasts indicate the regions of antibodies binding to the
chloroplast surface. In Fig 3-18 B, all eight rows show the immunofluorescence staining of αA1CYT (POTRA2), α-A2CYT (POTRA3), α-POTRA1, α-POTRA3, α-B2CYT, and α-B2IMS antibodies
from top to bottom, respectively. POTRA1 and POTRA3 antibodies were raised in two rabbits
each and thus additional rows for each antibody. Comparison of the eight rows of Fig 3-18 B
with the bottom two rows of Fig 3-18 A indicates that the staining pattern of the chloroplasts
labeled with TLDs and POTRA antibodies are similar to that for the α-Toc34 and α-Toc75
antibodies, while no staining was observed in the negative control samples. As noted, not all
the chloroplasts were stained to the same extent. In fact, the staining of chloroplasts labeled
with α-B2CYT was less than that with other antibodies but similar punctate pattern is usually
observed in chloroplasts labeled with outer membrane antibodies. Although not entirely clear,
one of the explanations for the heterogeneity observed between these labeling could be
explained by the specificity for each antibody for antigen. Another explanation is that the
concentration of the chlorophyll was not measured to be at the final concentration of 100-125
µg/ml unlike in the other assays (as high as 1 mg/ml). Therefore, there might not be sufficient
pool of antibodies to stain the chloroplasts completely. The age of the pea plants can also
contribute to heterogeneity observed here. Although the chloroplasts were isolated from 11-d
old pea plants, the leaves might be at a developmental stage which may not contain highly
active chloroplast protein import (151).
From this analysis, it was clear that these antibodies were able to recognize the epitopes
resulting in the fluorescence at the outer surface of the chloroplasts. Therefore, our evidence
suggested that these peptides were accessible to the antibodies and likely localized on the
outer surface of the chloroplast outer membrane. Although more evidence will be necessary
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with control antibodies against inner membrane proteins (Tic110), with outer membrane
protein (atToc159-G), and pre-immune sera, this observation provided initial observation for
the presence of these domains to the cytosolic surface of the chloroplasts.
3.3.2.4 Flow Cytometric Analysis of TLDs and POTRA Domains
In order to facilitate a more accurate means of quantifying the amount of the labeling
observed with the bound antibodies, flow cytometry was performed. This assay allows the
measurement of each chloroplast individually instead of measuring an average of signal that
results from a population of organelles. Flow cytometry relies on the principles of light
scattering, light excitation and emission of fluorochromes to generate multi-parameter data
from the particles. In flow cytometry of DyLight488 fluorescently labeled chloroplasts, a single
particle passes through a laser beam. As the laser beam hits each particle, the light is scattered
and fluorescent dye associated with that particle is excited. The scattered and fluorescent light
are picked up the by the detectors (Photomultiplier tubes – PMT) and converted to data
according to the size (forward scatter), shape and complexity (side scatter) of the particle. The
data is plotted on a graphical scale as a two-parameter dot plot (Fig 3-19 A) or as oneparameter histogram (Fig 3-19 B). In the plot, each cell is recorded as a single dot according to
forward and side scattering properties of intact and lysed chloroplasts, as shown in Fig 3-19 A.
The chloroplasts can be gated to include only intact and excludes lysed and debris as shown in
Fig 3-19 A. Histograms can be used to represent the fluorescence intensity distribution of
individually measured chloroplasts as shown in Fig 3-19 B. In this assay, approximately 30,000
individual particles were analyzed for the each sample including controls.
The intact chloroplasts were purified and resuspended in the final volume of 125 µg/ml
chlorophyll content per sample. The stocks of 1:10 dilution of antisera and pre-immunes were
prepared and serial dilutions of 1:300, 1:500 and 1:1000 were made for each antibody in
question. For the positive controls, α-Toc34, α-Toc75 and α-atToc159-G antibodies were used
for labeling (in aqua) and α-Tic110, α-PC as well as chloroplasts with DyLight488 only and no
antibodies were set-up for negative controls (in blue).
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Figure 3- 19 Typical graphical representation of flow cytometry analysis
(A) Dot plot representation of flow cytometry analysis. Broken chloroplasts, which are usually
smaller and scattered, were not included in the analysis. The intact chloroplasts were gated as
shown in the enclosed region. Only chloroplasts that were stained positive with DyLight488 in
the enclosed region were used in the later analysis. The broken and intact can be seen by the
forward and side light scatters. (B) Control sample used in the analysis is shown fluorescence
intensity using the histogram. The values are plotted against number of chloroplasts. (C) The
positive fluorescent intensity was seen in the chloroplasts labeled with POTRA3 antibody
(87.92% positive). The percent positive labeling was also seen when labeled chloroplasts
samples were overlaid the control samples (intact and secondary alone, black and blue lines).
The clear shift in the spectra indicated positive labeling as seen by green, orange and gray
spectra.
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The antibodies in the control samples were used at 1:100 titer, while secondary was
kept at 1:100 constant for all the samples. The control samples were treated with 1:100,
because a previous experiment of various titer treatments using these antibodies resulted in
the most positive staining observed at 1:100 for these controls. The samples were also treated
with pre-immune sera at the above titers to see the % positive labeling due to non-specific
interaction. With the negative controls such as unlabeled chloroplasts, the signal intensity can
be adjusted to identify the positively labeled chloroplasts. Lysed chloroplasts can be identified
based on their light-scattering pattern using forward and side scatter as they are smaller and
more scattered in the distribution. In contrast, the large chloroplasts are usually towards the far
end near 800-1000 on the forward scatter. Chloroplasts were gated to include only intact and
large chloroplasts for both DyLight488 and chlorophyll autofluorescence and used for the
analysis as seen in Fig 3-19 A. Chloroplasts that were not treated with any antibodies and those
treated with DyLight-488 only should have relatively weak autofluorescence as shown in Fig 319 B and D, which also verified that secondary does not bind nonspecifically to the chloroplast
surface. Unlabeled chloroplasts were used to manually set the value of 4-5% positively labeled
chloroplasts for each experiment (Fig 3-19 B). When the chloroplasts were labeled with the
POTRA3 (1:300) and secondary DyLight88, there was a substantial shift in the fluorescence
intensity as shown in Fig 3-19 C. When the gating was applied to the sample, it resulted in the
percent positive fluorescently labeled chloroplasts. The incubation of chloroplasts with antiTLDs and anti-POTRA antibodies resulted in the clear shift of the signal from the negative
fluorescence as shown by the overlay of spectra in Fig 3-19 D (spectra not shown for all the
samples). Finally, incubation of chloroplasts with α-Tic110, α-PC followed by staining with
DyLight488 were also negative (<20% stained).
The percent positively stained chloroplasts were identified for all anti-sera and preimmune sera by applying the gating to all the samples as shown in Fig 3-20 A-F for α-A1CYT, αA2CYT, α-POTRA1, α-POTRA3, α-B2CYT and α-B2IMS, respectively. As titers goes down, the
percent positively labeled chloroplasts also decreases for all pre-immune sera as expected. For
chloroplasts labeled with α-A1CYT, the percent positive labeled chloroplasts did not decrease as
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Figure 3- 20 Percent positive FACS labeling using anti-TLD and anti-POTRA antibodies
Bar graphs showing the comparison of percent positive labeling observed using different
antibodies. Shown in blue columns are the negative controls of intact chloroplasts or with
antibodies which are specific to the inner or thylakoid membrane protein. The positive controls
were labeled with α-Toc34, α-atToc159G and α—Toc75 antibodies as these regions are
localized in the cytosol. The labeling seen with different immune sera are shown light colors,
while pre-immune sera are shown in dark colors at titers from 1:300 to 1:1000. The chloroplasts
were labeled with (A) α-A1C – green, (B) α-A2C – yellow, (C) α-POTRA1 – gray, (D) α-POTRA3 –
orange , (E) α-B2CYT – red , and (F) α-B2IMS – purple antibodies.
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Figure 3- 20 Continued.
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Figure 3- 20 Continued.
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the titer decreased but were well within the range of the positive controls (46-98%) (Fig 3-20
A). The labeling of α-A2CYT (POTRA2) was also within the range of the positive controls and
decreased at the titer of 1:100. (Fig 3-20 B). This along with the labeling with POTRA1 and
A2CYT/POTRA3 resulted in similar positive labeling (Fig 3-20 C and D), respectively. The
comparison of B2CYT and B2IMS with other antibodies revealed that % positive labeling was
less than 60% and 70% for B2CYT and B2IMS, respectively (Fig 3-20 E and F). Overall, from Fig 320 A-F, it is clear that the incubation of chloroplasts with anti-TLEs and anti-POTRA antibodies
result in the positive labeling as shown in the form of percent positive chloroplasts and are well
within the range of positive controls such as those treated with α-Toc34, α-Toc75 and αat159G. The labeling with POTRA1 and POTRA3 resulted in 80-90% positive FACS labeling
confirming that these antibodies are able to recognize and stain the epitopes which are
exposed to the outer surface of the chloroplasts outer membrane. Although percent positive
labeling of B2CYT and B2IMS was lower than POTRA1 and POTRA3, they were well within the
range of the positive controls. A loop of this protein can be present in the cytosol resulting in
the observed fluorescence and positive staining. Alternative explanation for less labeling can be
explained by the localization of B2CYT within the membrane. These regions might not be
exposed to the antibody as much as the others due to the protection by the cytosolic POTRA
domains. The percent positive labeling observed with these antibodies due to non-specific cross
reactivity as observed in the pre-immune sera was corrected by subtracting percent positive
labeling of immune sera minus pre-immune sera at all three titers as well as an average of the
difference as shown in Table 9. The data suggested that all the positive labeling corrected for
the non-specific cross-reactivity for α-A1CYT (POTRA2), α-A2CYT (POTRA3), α-POTRA1 and αPOTRA3 were well within the range of the positive controls. The labeling wit α-B2CYT and αB2IMS were fairly low. These, along with other observations suggest that these domains reside
in the cytosol. Although not performed here, similar flow cytometric experiment can be
repeated with the treatment with thermolysin protease to analyze the effect of thermolysin on
positively labeled chloroplasts, the current experiment provided evidence to support previous
observation that the candidate loop domains and POTRA domains are exposed to the cytosol of
the chloroplast.
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Table 9 Percent positive labeled chloroplasts corrected for non-specific labeling
Highlighted in the bold are the positively labeled chloroplasts stained with the α-POTRA and αToc loop domain antibodies.
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3.3.2.5 Topological Analysis by the Chloroplasts Agglutination Assay
Chloroplasts agglutination assays were performed to map the topology of the TLDs and
POTRA domains by decorating the intact chloroplasts. If the antigenic domains of these
polypeptides are exposed to the surface of the chloroplasts and therefore accessible to these
antibodies, the isolated intact chloroplasts would agglutinate. The epitopes not facing the
cytosolic face of the chloroplast outer membrane would not be able to be recognized by these
antibodies and therefore no agglutination should be seen. Furthermore, treating the
chloroplasts with thermolysin prior to the antibody treatment will degrade the thermolysinsensitive proteins. These potential cytosolic domains would not be available for antibody
recognition and no agglutination would be seen.
α-Toc75 and two other antibodies, α-Toc34 and α-atToc159-G (raised in Guinea pig),
which localize on the cytosolic side of the outer membrane of the chloroplasts, were used as
positive controls, while pre-immunes of TLDs and POTRA domains, α-Tic110, α-Ferredoxin (Fd),
α-plastocyanin (PC), and unlabeled chloroplasts served as negative controls. Fd and PC are
thylakoid outer membrane proteins, while Tic110 is chloroplast inner membrane protein. The
intact chloroplasts were isolated and brought to the final concentration of 100 µg/ml and
blocked prior to the thermolysin treatment (at 250 µg/ml). Two identical sets of tubes were
labeled and treated in the presence and absence of thermolysin prior to the addition of antisera
and pre-immunes. All the samples were treated with 1:25 and 1:250 titers of primary
antibodies. Six different titers 1:25, 1:250, 1:500, 1:750, 1:1000, and 1:2000 were tested prior
to this set-up to determine the range at which agglutination worked the best (data not shown).
The chloroplasts did not agglutinate at titers of 1:500 and below, therefore the experiment was
carried out with primaries incubated at titers of 1:25 and 1:250. Leica DM 6000 B Bright Field
microscope was used to view the agglutination at 20X as shown in Fig 3-21. As shown in Fig 321 A the chloroplasts agglutinated strongly in the presence of the primary antibodies at 1:250
and 1:25 in the samples treated without the protease thermolysin (two right columns). No
agglutination was observed in the samples treated with pre-immune sera (far left column). The
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Figure 3- 21 Chloroplasts agglutination assay in presence of anti-TLD and anti-POTRA
antibodies prior to thermolysin treatment
(A) Experimental samples: Chloroplasts agglutination assays in the presence of immune sera at
1:250 and 1:25, right two columns at 20X zoom. Control samples treated with pre-immune
(1:250) sera are shown in left panel. No agglutination was seen in these samples. (B) Control
samples: Top three rows shows positive controls when chloroplasts were incubated with αToc34, α-Toc75 and α-atToc159 antibodies resulting in agglutination, while no agglutination
was seen in negative control samples treated with α-Tic110, α-Fd and α-PC antibodies. (C)
Intact chloroplasts without any antibodies did not result in the agglutination serving as negative
control
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chloroplasts treated with positive controls α-Toc34 and α-Toc159G resulted in strong
agglutination as seen in Fig 3-21 B in top three rows, while no agglutination was observed in the
samples treated with α-Tic110, α-Fd, and α-PC bottom three rows. This agreed well with the
negative control when no antibody was added to the sample (Fig 3-21 C). In the samples
treated with antisera, strong agglutination was seen in the samples at 1:25 while the
agglutination of chloroplasts slightly decreased at 1:250 as expected. The aggregation of the
chloroplasts in the presence of the antibodies indicated that some (if not all) of the regions of
the TLDs and POTRA domains must contain antigenic domains exposed to the outer face of the
chloroplast outer membrane. The overall agglutination of chloroplasts treated with α-POTRA1
and α-POTRA3 was less than α-A1CYT and α-A2CYT probably because antibodies from two
different bleeds were combined for both POTRA1 and POTRA3. Furthermore, thermolysin was
used to confirm these findings. If the agglutination observed in the chloroplasts treated with
the antibodies was indeed the result of the antibody-antigen interaction of surface exposed
epitopes, the treatment with thermolysin should degrade those exposed proteins and therefore
agglutination will not be seen in these samples. Indeed as expected, when intact chloroplasts
were treated with thermolysin following the incubation with antibodies, they did not
agglutinate or less agglutinated in some cases as shown in Fig 3-22 A, right two columns. The
thermolysin treatment on the chloroplasts treated with α-Toc75, α-Toc34 and α-atToc159G
positive controls also resulted in absence of agglutination supporting the observation with
antibodies in question Fig 3-22 B, while there was no difference in the agglutination of the
negative controls treated with α-Tic110, α-Fd and α-PC (compare Fig 3-21 and Fig 3-22 B).
Shown in Fig 3-22 C is the thermolysin treated chloroplasts without any antibodies, which did
not differ from the pre-thermolysin treated samples. Although the agglutination assay is not a
quantitative measurement of the antibody-antigen interaction, it is an excellent visual tool in
mapping the topology of these domains using various antibodies. The results of chloroplast
agglutination assays are summarized in Table 10. The intact chloroplasts can be differentiated
from the broken by the appearance of halo bright light (not shown here). To further support
these results, the samples were prepared and treated in the presence and absence of
thermolysin and western blot with various antibodies was carried out to support these findings.
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Figure 3- 22 Chloroplasts agglutination assay in presence of anti-TLD and anti-POTRA
antibodies after thermolysin treatment
(A) Experimental samples: Chloroplasts agglutination assays in the presence of immune sera at
1:250 and 1:25, right two columns at 20X zoom. Intact chloroplasts were thermolysin (250
µg/ml) treated prior to incubation with antibodies. Control samples treated with pre-immune
(1:250) sera are shown in left panel. No agglutination was seen in the controls and only minor
agglutination was observed in some experimental samples. (B) Control samples: Top three rows
shows the control samples when chloroplasts were thermolysin treated prior to incubation with
α-Toc34, α-Toc75 and α-atToc159 antibodies. Thermolysin treated chloroplasts resulted in the
disruption of agglutination. As expected, no was seen in negative control samples treated with
α-Tic110, α-Fd and α-PC antibodies. (C) Thermolysin treated chloroplasts without any
antibodies did not result in the agglutination as expected.
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Table 10 Summary of results of chloroplast agglutination assay
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3.3.2.6 Thermolysin Treatment on Chloroplasts Incubated at Various Antisera Titers
In order to investigate the role of thermolysin in probing the outer surface proteins
effectively, the isolated intact pea chloroplasts were incubated with POTRA antibodies at
different titers followed by thermolysin treatment. The aim behind such experimental design
was that if the POTRA domains are folded inside the β-barrel – like the H1 helix of FhaC and
TeOmp85 - and work as “in plugs” and interact with the translocating preproteins, the addition
of antibodies would result in exposing these domains out of the barrel. These presumably nowexposed antibody-antigen interactions can be disrupted by treating the chloroplasts with the
thermolysin. Such treatment should result in degradation of now-exposed domains of the
Toc75 protein.
The intact chloroplasts were isolated from pea plants at 1 mg/ml and two aliquots of
intact chloroplast were stored on ice. One aliquot was used as a control for untreated sample,
while the experimental samples were treated with α-POTRA1 antibody at titers of 1:600, 1:300,
1:150, 1:60, 1:30 and 1:20. Following the antibody incubation, the experimental samples were
treated with 250 µg/ml thermolysin. The thermolysin was inactivated by an addition of EDTA
and washed over the Percoll gradient. Prior to removing the thermolysin, an aliquot was
removed and stored with 2X SSB on ice. These samples were labeled as “Sup.” If thermolysin
worked efficiently at cleaving outer membrane proteins, presumably outer exposed POTRA may
now be “free” in solution and might be washing off with thermolysin. To rule out this
possibility, only the samples at the titer of 1:60 were run on the gel for the presence of any
lower molecular species. After removing the ‘Sup’ samples, the thermolysin treated samples
were re-isolated over the Percoll gradient and named “Pellet.” These samples were collected
for all six titers described above. Moreover, to analyze the effect of higher thermolysin
treatment on antibody-incubated chloroplasts, the chloroplasts at 1:60 antibody titer were also
treated with 500 µg/ml thermolysin. The titer of 1:60 was used because it was placed in the
mid-range of the selected titers. All the samples were run on the gels, transferred and probed
with α-A1CYT (POTRA2) and α-POTRA3 antibodies at 1:20,000 and secondary at 1:20,000.
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Shown in Fig 3-23 A and B are the blots probed with two different antibody, α-A1CYT
and α-POTRA3, respectively. Both blots include the experimental samples treated with various
POTRA1 antibody titers. These blots include the chloroplasts treated with α-POTRA1 antibody
at six various titers followed by thermolysin at 250 µg/ml and the samples treated at the titer
of 1:60 followed by 500 µg/ml thermolysin. The ‘Sup’ and ‘Pellet’ samples are labeled in the
figures. Shown in Fig 3-23 C is the blot including the same experimental samples as in Fig 3-23 A
and B but probed with secondary antibody only. Shown in Fig 3-23 D is the blot of the
experimental ‘Pellet’ and ‘Sup’ samples treated with α-A1C antibody at 1:60 followed by 500
µg/ml thermolysin treatment and probed with the α-A1C antibody. Fig 3-23 E is the blot of the
experimental ‘Pellet’ and ‘Sup’ samples treated with α-POTRA3 antibody at 1:60 followed by
500 µg/ml thermolysin treatment and probed with the α-POTRA3 antibody.
Fig 3-23 A-B (Lane 1) shows the chloroplasts without any treatment resulted in the band
at nearly 80 kDa marker, which corresponds to the full-length Toc75. The incubation of the
chloroplasts with thermolysin without any antibody incubation resulted in the slight
degradation of Toc75 to lower molecular weight species appearing at approximately 51 kDa as
shown in Fig 3-23 A-B (Lane 2). The bands were identified by the TotalLab blot quantification
program and molecular mass corresponding to each bands were assigned (in red). Increased
antibody titers should result in more degradation of Toc75 resulting in increased bands
intensity at ~51 kDa. For the samples that were treated with various increasing concentrations
of antibodies followed by the thermolysin treatment, the intensity of the bands at 51 kDa
increased as the intensity of Toc75 went slightly down Fig 3-23 A, lanes 4-8 and Fig 3-23 B,
lanes 4-9. Although the percent intensity of the two main bands, full-length Toc75 (at 80 kDa)
and its degradation product (at 51 kDa), respectively, were difficult to quantify due to the
presence of irrelevant band appearing at 57 kDa, the intensity of the degradation product of
Toc75 (at 51 kDa) appeared to increase and full-length Toc75 (at 80 kDa) decreased as the
antibody titer increased. Moreover, as the concentrations of antibodies were increased, the
presence of dark, high intensity bands appeared above the 57 kDa. The samples treated with
1:60 antibody titer without any thermolysin treatment also resulted in this broad band (Fig 3-23
A-B, lanes 3). The probing of the same samples in the absence of any primary antibody but
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Figure 3- 23 Thermolysin treatment on chloroplasts treated with various antibody titers
(A) Chemiluminescent image of chloroplasts samples treated with various POTRA1 antibody
titers followed by thermolysin treatment, lanes 2 to 11. Molecular marker is loaded in Lane 12.
Intact chloroplast alone is loaded in lane 1. The identified lower molecular weight bands are
highlighted in red with arrows. The treatments are provided in the table next to the blot with
the percent intensity of bands appearing at 51 kDa. The blot was probed with α-A1CYT
antibody. (B) POTRA1 antibody treated samples were probed α-POTRA3 antibodies. Intact
chloroplast sample is loaded in lane 1, while different treatments on chloroplasts are loaded
from lanes 2 to 13. The treatments and percent band intensity are also provided in the table
next to the blot. (C) POTRA1 incubated samples were probed with secondary only to rule out
the non-specific interactions. The bands seen at 57 kDa are due to the non-specific interaction
with secondary antibody. (D) Chemiluminescent image of samples were treated with αA1CYT/POTRA2 antibody at 1:60 and treated with 500 µg/ml thermolysin before (left panel)
and after (right panel) reisolating over the Percoll gradient. The blots were probed with αA1CYT/POTRA2 antibody. Bands identified by TotalLab are shown in red arrow. The treatments
are shown below each blot. (E) Chemiluminescent image of samples were treated with αPOTRA3 antibody at 1:60 and treated with 500 µg/ml thermolysin before (left panel) and after
(right panel) reisolating over the Percoll gradient. The blots were probed with α-A1CYT/POTRA2
antibody. Bands identified by TotalLab are shown in red arrow. The treatments are shown
below each blot.
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Figure 3- 23 Continued.
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secondary only resulted in the identification of those bands as non-specific interaction between
the antibodies already present in the samples and secondary antibody as shown in Fig 3-23 C.
Therefore, the bands appearing above 57 kDa were not included in the analysis. The ‘Sup’
samples prior to reisolating over the Percoll are shown in Fig 3-23 A lanes 9 and 11, Fig 3-23 B,
lanes 10 and 12. Interestingly, only in these samples, the lower molecular weight bands were
observed. These bands corresponded to the approximate molecular weights of 28-34 kDa and
30-40 kDa as predicted by the quantification program. Furthermore, in the samples incubated
with α-A1CYT and treated and probed with α-A1CYT, another band also showed up > 17 kDa in
the samples treated with 500 µg/ml thermolysin as shown in Fig 3-23, D right panel. The same
lower molecular band also showed up in the α-POTRA3 samples probed with α-POTRA3 at
thermolysin 500 µg/ml Fig 3-23 E, right panel. A similar independent experiment also resulted
in the appearance of lower molecular weight bands at approximately 17 kDa, 29 kDa, 36 kDa
and 46 kDa when treated and probed with α-POTRA1 antibody (data not shown). Interestingly,
these bands were not presence in any of the other samples indicating that thermolysin
sensitive polypeptides which were exposed to the cytosolic face were being washed off in the
Percoll gradient and being recognized by the antibody against A1CYT/POTRA2 and POTRA3
domains.
Analysis of thermolysin treatment
Analysis of all the samples under the same treatment resulted in presence of this lower
molecular weight species along with the 51 kDa bands. This was the first time any lower
molecular weight species was observed for Toc75 samples as previous proteolytic degradation
studies on Toc75 resulted in identification of bands between 40-56 kDa (19, 114). These studies
suggested that further potential cleavage sites have to be either present in the intermembrane
space and other cytosolically exposed regions must be protected by interaction with other TOC
components or deeply embedded in the membrane (114). According to the Model B by
Sveshnikova et al., thermolysin digestion identified three bands at 49 kDa, 43 kDa and 40 kDa
(114). The N-terminal sequencing identified these bands at cleavage occurring at the sequence
DEPK, xAxFS and KQL, respectively (114). DEPK corresponds to first the four residues of the
mature Toc75 protein (132-136), while xAxFS and KQL are part of POTRA3 domains. According
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to the current study, the bands appearing at 51 kDa, and 39-41 kDa post-thermolysin are
comparable to the cleavage pattern identified in the prior experiments. The appearance of
bands at 17, 22, 29-34 could correspond to different combination of POTRA domains. The
individual molecular weights of POTRA1, POTRA2, and POTRA3 domains are 9.6 kDa, 9.2kDa
and 11.5 kDa, respectively. If there are potential thermolysin-cleavage sites present within
POTRA domains or between POTRA3 and β-barrel, the bands observed in these assays around
29-34 kDa can correspond to all three cleaved POTRA domains, while 17 kDa ad 29 kDa can
correspond to the individual POTRA domain 1, 2 and 3 or in adjacent pairs as POTRA1-2,
POTRA2-3 or POTRA dimers (22 kDa). Whether the POTRA domains work as “in plugs” or not
cannot be confirmed entirely, it is clear from the titer experiment that increased concentration
of antibodies were able to recognize and result in increased degradation of Toc75 to 51 kDa
bands. Furthermore, the chloroplasts treatment with 250 µg/ml and 500 µg/ml thermolysin
resulted in previously unidentified bands appearing at 17 kDa, 22-29 kDa (Fig 3-23 A, B, D and E
in the ‘Sup’ samples). This suggested that Toc75 contains domains that are thermolysinsensitive. When treated with thermolysin, these regions were cleaved and being washed away
in the Percoll gradient. The probing of the blots with the POTRA-specific antibodies identified
these bands as POTRA domains. Since Toc75 was not completely degraded, it suggested that
other thermolysin sensitive sites must be present in the intermembrane space.
To investigate the thermolysin cleavage sites within the psToc75, an online version of
ExPASy software was used to identify thermolysin sensitive regions. Although amino-terminal
sequencing and MALDI-TOF would provide a more sensitive and accurate means of predicting
the cleavage sites corresponding to observed molecular weight species, the use of ExPASy tool
can provide initial evidence to identify these potential thermolysin sensitive psToc75 sites
resulting in observed band patterns. The molecular masses of observed bands are listed in
Table 11 A. Finally, Table 11 B lists all the potentially identified thermolysin sites which
corresponded to the identified bands with POTRA antibodies along with the residue numbers.
As seen in Table 11 B, a cleavage site was identified between POTRA1-POTRA2 and also
between POTRA3-barrel regions. This would result in the cleavage of individual POTRA domain
or in adjacent pair. Another site was identified multiple times resulting in the identification of
141

Table 11 Identified thermolysin cleavage sites within the Toc75 sequence
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cleavage sites at 430-437. This region corresponds to the region between POTRA3 and barrel,
cleaving all three POTRA domains together (at >33 kDa). The analysis also showed the potential
cleavage site within the B2IMS region, however, no thermolysin sensitive cleavage site was
present in the B2CYT region (data not shown). Such experimental design with the protease
which penetrates the outer membrane, such as trypsin, can be repeated to rule out the
possibility of localization of these domains to the intermembrane space. According to Model B,
trypsin treatment of Toc75 resulted in the digestion of Toc75 to four bands at R787, R405,
R483, R566 (114). According to the homology model of Toc75, all except R405 forms the part of
the β-barrel, while R405 is part of POTRA3 domain. Interestingly, the same study also identified
residues 409-413, which correspond to xAxFS sequence, as cytosolically exposed region.
Whether B2CYT faces the intermembrane space cannot be entirely confirmed, N-terminal
sequencing along with MALDI-TOF would be useful in conferring the current findings. The
current study provided encouraging and promising evidence for the localization of POTRA
domains in the cytosolic side of the chloroplast outer membrane.

3.3.3 Conclusions and Future Directions
The crystal structures of the POTRA domains of members of the OMP85 superfamily
provided valuable insights into understanding the topology of the POTRA domains of psToc75.
However, prior to any crystal structures and domain architecture of proteins of the OMP85
superfamily, two topology models psToc75 were proposed. In order to confer the topology of
the psToc75, these two models were analyzed and seven inter-β-strand loop domains of
psToc75 were identified as Toc Loop Domains (TLDs). These domains were cloned into an
expression vector for protein purification. Six of these domains, A1CYT, A2CYT, B2CYT, B2IMS,
B1CYT AND B1IMS, were expressed and purified. All except B1CYT and B1IMS were used the
antibody production. All these peptides were also used in the GTPase hydrolysis assay to be
discussed in Chapter 4.
Post-crystal structure of the POTRA domains provided a valuable insight into building a
very promising homology model of psToc75. Three POTRA domains of the psToc75 were
identified, cloned and expressed into the IMPACT system. POTRA1 and POTRA3 were purified
143

and used for antibody production. In order to improve the expression of recombinant protein,
codon optimized psToc75 gene was used to clone three sizes of POTRA2 and POTRA1-2-3
domains. The cloning of all codon optimized POTRA domains was successful; only C.O. POTRA2L and C.O. POTRA-1-2-3-I were purified with contaminants. Secondary structural folds were
determined on POTRA1 and POTRA3 by CD, and these potentially folded proteins were used for
the chloroplast competitive import and binding assay to be discussed in Chapter 4. The
antibodies raised against the TLDs and POTRA domains were used to confer the topology of
these domains of psToc75. The antibodies were used to immune-decorate the intact
chloroplasts utilizing laser scanning confocal microscopy, flow cytometric analysis, chloroplasts
agglutination assay and thermolysin treatment with various concentrations of antibodies.
The data obtained from these experiments suggested that POTRA domains are exposed to the
cytosolic side of the chloroplast outer membrane. LSCM confirmed the presence of these
domains to the cytosol by labeling observed at the periphery of the outer surface. Similar
experiment can be repeated with more negative controls and treating the chloroplasts with
thermolysin prior to the labeling. Thermolysin should cleave the cytosolically exposed domains,
and no labeling would be seen. Chloroplasts agglutination assays resulted in the chloroplasts
agglutination in the presence of the TLD and POTRA antibodies. Thermolysin treatment resulted
in digestion of these domains and no agglutination was seen. Flow cytometric analysis
confirmed these observations. When isolated chloroplasts were incubated with various
antibody titers, the percent positive fluorescence increased as antibody concentration
increased and were well within the range of positive controls. Cytometric analysis with the
thermolysin treated chloroplasts still remains to be determined. Finally, thermolysin treatment
on intact chloroplasts treated with increasing titers of POTRA1 antibody resulted in
identification of several lower molecular bands appearing due to partial digestion of the Toc75.
These bands were recognized when probed with POTRA-specific antibodies. Furthermore,
analysis of thermolysin-sensitive sites of psToc75 identified several sites within POTRA domains,
confirming that psToc75 POTRA domains are sensitive to thermolysin degradation and
therefore surface-exposed. Taken together, these data suggested that A1CYT, A2CYT/POTRA2,
POTRA1, and POTRA3 localize on the cytosolic side of the chloroplast outer membrane.
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The A1CYT and A2CYT were predicted as cytosolic loops domains according to Model A by
Hinnah et al (101). The data shown here agrees well with the predicted topology of these two
domains as shown in Table 12. Previously, B2IMS was identified as an intermembrane space
loop domain. According to data presented here, it forms part of the C-terminal β-barrel domain
and a loop might be exposed to the cytosolic face. POTRA1, POTRA3 and POTRA2 as shown by
α-A2CYT antibody suggest that the N-terminal POTRA domains of the psToc75 localizes in the
cytosolic surface of the chloroplasts, which supports the postulated hypothesis. Furthermore,
the B1IMS domain that was shown to face the intermembrane space according to the Model B,
faces the cytosol since it is the part of the POTRA1 which faces the cytosol. B1CYT is part of the
POTRA3, which is also presumed to localize in the cytosolic face, supporting the localization of
this loop in the cytosol according to the Model B. Finally, the homology model of psToc75 was
used to map the identified TLDs and POTRA domains, and a model was proposed with the
topology of psToc75 POTRA domains in the outer membrane of chloroplasts as shown in Fig 324. The POTRA domains and the embedded TLDs are highlighted in different colors. The
topology of B2CYT cannot be confirmed entirely, however, a short loop region might be
exposed to the cytosol resulting in observed agglutination and fluorescence. According to the
model presented here, a part of B2CYT forms a β-strand and majority of it is localized in the
intermembrane space. According to the model B, three residues were identified as
intermembrane space domain by the proteolytic digestion of Toc75 by trypsin: R483, R566 and
R787 (114). According to the homology model presented here, R483 is part of the B2CYT region
facing the cytosol. The other two residues, R566 and R787 stand in the agreement with the
major loops facing the intermembrane space, as shown in the current homology model of
psToc75. Finally, the fragments observed here with the thermolysin treatment are required to
N-terminal amino acid sequencing and MALDI mass spectrometry. Another treatment with
protease trypsin would also be useful in confirming the current findings.
Concluding Remarks
The homology model of Toc75 identified a “loop” folded within the barrel. In FhaC,
similar loop folds inside the pore and has been shown to play a key role in the secretion
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Table 12 Comparison of the topology models with the current prediction of psToc75 topology

146

Figure 3- 24 Proposed topology model of POTRA and Toc Loop Domains of psToc75
The topology model of psToc75 POTRA and Toc loop domains from the membrane plane.
POTRA domains and TLDs are highlighted in different colors. POTRA domains are exposed to the
cytosolic side resulting in observed band patterns. B2CYT (blue), B2IMS (gray), and A1IMS
(orange) form part of the β-barrel and some loop regions are exposed to the cytosol. Majority
of B2CYT is proposed to be located in the intermembrane space. POTRA1 (white) and B1IMS
(purple), POTRA2 (white) and A1CYT (pink), POTRA 3 (white) and B1CYT (red) are localized in
the cytosolic side.
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mechanism. Whether the loop of Toc75 plays any role in the protein import into the chloroplast
is yet to be determined. Furthermore, crystal structure of AnaOmp85 identified an involvement
of POTRA3 domain in the regulation of the protein transport through its L1-loop. Similar loop is
also seen in the homology model of Toc75 POTRA domain as shown Fig 3-24, in red. It was also
suggested that the N-terminal POTRA domains, POTRA1 and POTRA2, might be involved in
substrate recognition and hetero-oligomerization through protein-protein interactions by βaugmentation. Whether psToc75 POTRA domains function by similar β-augmentation or not is
yet unknown, but the localization of POTRA domains into the cytosol and previous study that Nterminal of psToc75 hetero-oligomerization with Toc34 is consistent with their observation.
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CHAPTER 4 Initial Characterization of the POTRA Domains
4.1

Introduction
In order to investigate the role of the N-terminal POTRA domains in protein import, in

vitro competition import experiments were designed in presence of prSSU (small subunit to the
precursor of RuBiSCo). It has been shown that Toc75 remained in close physical proximity to the
transit sequence of preproteins during protein import across the membrane (46). Furthermore,
the N-terminal region of psToc75 was shown to act as a specific receptor for proteins
containing N-terminal transit sequences; this was in agreement with postulated transit peptide
binding sites within the protein (102, 110). In our lab, pull-down assays with POTRA domains
and transit peptide confirmed that the transit peptide co-eluted in the fractions containing
POTRA1 and POTRA3 domains (Unpublished data, by R. Simmerman). Furthermore,
sedimentation velocity analysis (AUC) also showed a shift in the sediment coefficient of POTRA3
in presence of higher concentration of transit peptide (SStpNT) indicating possible interaction.
Furthermore, recent cross-linking experiments of POTRA1 with increasing transit peptide
concentrations resulted in the shift of POTRA1 from the dimeric to the oligomeric state
(Unpublished data, by R. Simmerman). Observations from previous and current work provided
reasonable information to presume the role of POTRA(s) in recognizing the transit peptides of
translocating precursor proteins. Therefore, the role of the individual as well as full-length
POTRA domains in protein import was investigated by in vitro import and binding inhibition
experiments.
In vitro import and binding experiments allow the quantitative measurement of
chloroplast protein import. This assay utilizes the effect of the test subjects, such as prSSU,
mSSU and POTRA domains, to the import/binding of the radiolabeled prSSU. The process of
translocation can be divided into a binding step and a translocation step, with different energy
requirements at each step (105). The binding of transit peptide to the chloroplast surface is the
step which requires very low concentrations of ATP (≤100 µM). However, for the complete
import of the precursor proteins across both membranes of chloroplasts, high levels of ATP are
required (> 1 mM). Import is inhibited in the binding experiments in the presence of very low
ATP concentrations.
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4.2

Results and Discussion

4.2.1 Effects of the POTRA Domain on Import of Precursor Protein into Isolated Chloroplasts
The import competence of the POTRA domains was evaluated by chloroplast import
competition assays testing the ability of these domains to inhibit import of

35

S-prSSU into

isolated chloroplasts. The purified POTRA domains as well as prSSU and mSSU were used as
competitors of 35S-prSSU for in vitro import assays. The concentration of the 35S-prSSU was kept
constant at 100 nM, while the concentrations of the non-labeled competitor proteins, such as
POTRA3, mSSU and prSSU were increased from 0.1 µM, 1 µM, and 10 µM. Import of the labeled
prSSU can be traced as accumulation of radioactive mSSU because processing and cleavage of
the transit peptide occurs after the preprotein is imported into the chloroplasts. Ability of the
competitor to compete for import results in a decrease of processed radioactive mSSU as more
concentration of competitor is added to the import reaction.
Fig 4-1 shows the effect of the cold competitors such as POTRA3 on the in vitro import
competition assays. The tube containing POTRA1 protein was accidently switched with the tube
containing ATP, and therefore data was not obtained for POTRA1 protein. SDS-PAGE separates
the bound precursor proteins from the imported precursor proteins (processed as mSSU)
labeled as P and M in Fig 4-1 A. Quantification of the imported 35S-prSSU is acquired by drying
SDS-PAGE gel and subjecting it to analysis by Phosphoimager. The data can be interpreted as
the number of molecules/chloroplast bound or imported after 15 min as shown in Fig 4-1 B-D.
This data can be fitted with linear regression (for non-competing protein, mSSU) and one phase
exponential decay (for competing protein, prSSU) (Fig 4-1 E). Using exponential decay fit, the
normalized for number of molecules/chloroplast/min imported proteins were plotted against
respective concentrations of the cold competitors at 15 min (Fig 4-1 E). mSSU was used as a
negative control, because it does not have the transit peptide region and does not does not
compete with the 35S-prSSU for import into chloroplasts as shown in Fig 4-1 B (105). Increasing
concentration of mSSU did not result in the change of the linear regression. prSSU was used as
positive control, because it is one of the best-studied precursor proteins. It acts as positive
control because it competes with 35S-prSSU for import into the chloroplast.
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Figure 4- 1 In vitro chloroplast import competition assay of POTRA3 domain of psToc75
(A) Phosphor Images of SDS-PAGE gels of import competitions between 100 nM 35S-prSSU and
prSSU (positive) and mSSU (negative). Lane 1 is 35S-prSSU loading control. Competitor
concentrations in lanes 2-4 at 0.1 µM at 5, 10 and 15 min, lanes 5-7 at 1 µM at 5, 10 and 15
min, and lanes 8-10 at 6 µM at 5, 10 and 15 min for cold competitors; labeled prSSU was held
constant at 100 nM throughout. P indicates bound precursor and M denotes mature protein.
(B-D) Quantification of the bands of mature protein was performed and import was expressed
with linear-regression for imported 35S-labeled mSSU molecules per chloroplasts per min for (B)
mSSU, (C) prSSU, and (D) POTRA3 cold competitors. Three concentrations are represented as
green solid circles, blue solid squares and navy blue solid upside down triangles for 0.1 µM, 1.0
µM and 6 µM of prSSU and mSSU and 0.1 µM, 1.0 µM and 10 µM for POTRA3. (E) One phase
exponential decay fit of the imported number 35S-mSSU/chloroplast/min expressed as percent
of 35S-prSSU imported. mSSU is represented with upside down red solid triangles, prSSU with
green solid triangles, and POTRA3 with blue solid squares.
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This was shown by shown by declined slope as increase in concentration in Fig 4-1 C. When
POTRA3 was exogenously added to the reaction mix containing 35S-prSSU, it mimicked behavior
similar to that of cold prSSU. As concentration of exogenously added POTRA3 increased (at 10
µM), the amount of the 35S-prSSU molecules being imported into the chloroplasts reduced after
15 min as seen in Fig 4-1 D, dark triangles with blue line. This indicated that POTRA3 might be
competing with the 35S-prSSU for import into the chloroplasts. Using exponential decay fit, the
normalized for number of molecules/chloroplast/min imported protein were plotted against
respectives concentrations of the cold competitors (Fig 4-1 E). In this figure, all the cold
competitors are added on the same graph which has been normalized to the molecules of

35

S-

prSSU being converted to mSSU per concentration at 15 min. Interestingly, POTRA3 exhibited a
nonlinear inhibition curve like prSSU; however, non-labeled prSSU significantly reduced the
import of the radiolabeled prSSU at increasing concentrations. As expected, mSSU did not have
an effect on the import of precursor protein. It did not act as competitive inhibitor of the

35

S-

prSSU, shown by the constant linear line, Fig 4-1 E, red up-side down closed triangles. The
observation that POTRA3 has an effect on the import of radiolabeled prSSU indicates its role in
the protein import, Fig 4-1 E, blue closed squares. This finding is in agreement with the previous
study that the region closest to the pore (POTRA3) acts in the regulation of protein transport.
The effect of POTRA1 in preprotein import still remains to be investigated. A whole precursor
non labeled prSSU is a more efficient inhibitor of import of radiolabeled precursor proteins than
the POTRA domains resulting in higher inhibition of import than POTRA3, Fig 4-1 E, green closed
triangles. The import data obtained here provided clear evidence that POTRA3 can inhibit the
import of the precursor protein into chloroplasts. The ability of POTRA1 to inhibit the import of
precursor proteins into the chloroplasts has yet to be investigated. The import experiments can
be repeated with purified POTRA1 and codon optimized POTRA1-2-3 domain to investigate the
effects of full-length versus individual POTRA domains.
4.2.2 Effects of the POTRA Domain on Binding of Precursor Protein to Isolated Chloroplasts

152

The binding competition assay kept

35

S radiolabeled prSSU at 100 nM while increasing

the concentrations of cold competitors by 12 serial dilutions. To ensure that the assay did not
result in import of preproteins, competitors prSSU and control 35S radiolabeled prSSU samples
were run on acrylamide gel. Import is prevented in the binding assay (due to very low ATP) and
no bands of imported 35S-prSSU were detected on the SDS-PAGE in Fig 4-2 A. The samples were
analyzed with liquid scintillation counter. The CPM obtained from scintillation counting were
corrected for background and normalized to % CPM using nonlinear regression One-site Fit Ki as
shown in Fig 4-2 B.
prSSU was used as a positive control, since it competes with the radiolabeled prSSU for binding
resulting in the inhibition of 35S-prSSU as the concentration of cold prSSU increased (Fig 4-2 B,
purple line). mSSU lacks a transit peptide and does not compete with

35

S-prSSU for binding,

serving as negative control (Fig 4-2 B, black line). The data for POTRA1 and POTRA3 were
obtained from two independent experiments. Interestingly, POTRA1 showed significant
inhibition of binding of the radiolabeled precursor protein (Fig 4-2 B, orange line). The resulting
non-linear curve is very close to the curve obtained for cold competitor, prSSU. As expected,
the binding of the non-radiolabeled prSSU was more efficient than that of non-radiolabeled
POTRA1 domain (Fig 4-2 B, purple line). In contrast to its effects on import of precursor protein,
POTRA3 domain did not exhibit significant inhibition on the binding of the radiolabeled
precursor protein (Fig 4-2 B, pink line). The effect of the full-length POTRA domain of psToc75,
C.O. POTRA1-2-3, on binding of 35S-prSSU was also investigated. Since this protein was purified
fused with its intein-CBD tag of the IMPACT system, intein-CBD protein was also used a negative
control. Intein-CBD did not have any effect on binding of 35S-prSSU ruling out the possibility of
inhibition due to non-specific interaction (Fig 4-2 B, green line). The full-length POTRA should
be required for maximal inhibition of precursor binding; however, C.O. POTRA1-2-3-intein-CBD
did not result in inhibition of binding of

35

S-prSSU under these binding conditions (Fig 4-2 B,

blue line).
The results obtained here provide direct evidence that POTRA1 domain can inhibit
binding of precursor protein to isolated chloroplasts. Therefore it can be presumed that it might
inhibit the import as well since binding is an early stage of import, and inhibition of binding
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Figure 4- 2 In vitro chloroplast binding assay of POTRA domains of psToc75
(A) Phosphor Images of SDS-PAGE gel of binding competitions between 35S-prSSU and prSSU.
POTRA1, POTRA3 and prSSU were derived from two independent scintillation counts; while
POTRA1-2-3-Intein-CBD and Intein-CBD were result of single experiment. Lanes 2-11 have
increasing concentrations of cold prSSU. Lane 12 is35S-prSSU loading control (B) Panel B shows
the graphical analysis of binding competition data generated from scintillation counting.
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should influence the import. In contrast to the import competition assays, POTRA3 did not have
any effect on the binding. As one might expect, the entire structure of POTRA domains should
be required for maximal inhibition of precursor protein. However, full-length POTRA1-2-3 did
not have any effect on the binding. The data obtained for POTRA1-2-3 was result on single
experiment, while POTRA1, POTRA3 and prSSU were obtained from two independent
experiments. Furthermore, purified POTRA1-2-3 alone (without intein-CBD) might be more
efficient inhibitor of radiolabeled prSSU than fused with tag. More detailed experiments will be
necessary to reproduce the observed results.
4.2.3 Effects of Toc75 Peptides on the Rate of Hydrolysis of Toc34
Previous studies have shown that GTP is involved in the early steps of translocation by
promoting the formation of early import intermediates (48-49). It has been proposed that TOC
GTPases, such as Toc34 and Toc159, are regulated by the association of a GTPase activating
protein (GAP) and/or a GTPase exchange factor (GEF). The transit peptides alone as well as
preproteins have been shown to be involved in the regulation of the activity of TOC GTPases by
stimulating GTP hydrolysis (92, 152). Recently, data obtained from our lab suggested that
transit peptides acts as a GAP for psToc34 (82). It stimulates the GTP to GDP hydrolysis resulting
in the lower affinity of GDP-loaded Toc34 for the transit peptide. The transit peptide is thus
released onto the β-barrel Toc75 (Dissertation, Dr. L. Evan Reddick). A previous study on Nterminal of psToc75 demonstrated that N-terminal is involved in the hetero-oligomeric complex
formation with Toc34. In order to characterize Toc75’s role in protein import, as a GTPase
regulator via GTPase Activating Protein (GAP) or Guanine Exchange Factor (GEF) activity, the
purified Toc loop domains of Toc75 were tested. The activated charcoal phosphate release
assays were performed by Dr. L. Evan Reddick as previously described in (82, 105) to investigate
the effect of these domains to stimulate Toc34 GTPase activity.
Briefly, six Toc75 purified domains, A1CYT, A2CYT, A1IMS, B1IMS, B2CYT and B2IMS,
were incubated in GBS (20 mM Tricine-KOH, pH 7.65, 1 mM MgCl2, 50 mM NaCl, 1 mM β-Me)
buffer, 10 nM g32P[GTP], and 25 µM 'cold' GTP. An aliquot of psToc34 was added to bring the
final concentration of peptide and psToc34 to 100 µM and 3 µM, respectively. At various time
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points, aliquots of the reaction were removed, treated with 10% w/v activated charcoal slurry,
and filtered. Aliquots of the filtrate were scintillation counted in a Perkin-Elmer 96-well plate
scintillation counter with cross talk filters applied. The resultant CPM was converted to
hydrolytic rate expressed as nmol GTP hydrolyzed per minute per µmol Toc as per (105).
GTPase measurements of basel hydrolytic rate of psToc34 alone and in the presence of TLDs
were performed as shown in Fig 4-3. With the assay conditions, the incubation of the TLDs in
the presence of the radiolabeled GTP and Toc34 did not have any effect on the rate of the GTP
hydrolysis by Toc34. None of the N-terminal peptides, A1CYT, A2CYT, B1CYT, and B1IMS or Cterminal B2CYT, and B2IMs affected the GTPase activity of psToc34. This does not, however rule
out the possibility of their interaction. Since these peptides are fairly small in size and their
folds have not yet been determined by CD, further testing will be needed to determine their
effect on the GTP hydrolysis. Moreover, potentially folded POTRA domains can now be utilized
to test their ability to stimulate the GTP hydrolysis by Toc34.

4.3

Conclusions
It is clear from the import assays that the import of the radiolabeled precursor was

reduced by exogenous POTRA3 domain. Although POTRA3 did not have any effect on the
binding of prSSU to the chloroplast, POTRA1 domain competed with the radiolabeled prSSU for
binding suggesting that POTRA1 is involved at the early stage of the protein import; while
POTRA3, being closest to the pore, might be involved in the import of the protein translocation.
Interestingly, POTRA1-2-3 domain did not have any effect on the binding of precursor proteins.
This however, does not rule out the possibility its role in protein import. Taken together, the
data obtained here along with the proposed orientation of these domains in the cytosolic face,
support the current findings of role of POTRAs in the import and binding of precursor proteins,
as individual POTRAs facilitate the import of precursor proteins from cytosol into the
chloroplast stroma. When Toc loop domains were tested for their ability to stimulate GTPase
activity of Toc34, they neither suppressed nor stimulated the rate of hydrolysis. Even though
B1IMS, A1CYT, and A2CYT utilized in this assays are embedded in the POTRA domains, the
effect of POTRA1, POTRA2 and POTRA3, respectively, cannot be determined from current assay.
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Figure 4- 3 Effects of Toc75 Peptides on the Rate of Hydrolysis of Toc34
GTP hydrolytic rate of psToc34 was measured alone, and in the presence of six Toc loop
domains, A1CYT, A2CYT, A1IMS, B1IMS, B2CYT and B2IMS.
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CHAPTER 5 Future Directions
In order to investigate the role(s) POTRA play in protein import, several experiments can
be envisaged. Using newly designed primers to include the intra-POTRA linker regions of POTRA
domains, various sizes of POTRA domains can be generated to optimize the expression and
folding of POTRA domains. For example, linker between POTRA1 and POTRA2 contains
approximately 22 residues. The POTRA domains of FhaC, TeOmp85, AnaOmp85, and BamA only
contain 2-3 residues between these two domains. Thus different sizes of POTRA1 can be
generated along with the design that would also include the region immediately following the
transit peptide of Toc75. With the purified POTRA domains, several experiments can be
performed to characterize the role(s) POTRA play in protein import. In the current study, it was
shown that POTRA3 inhibits the import of the radiolabeled prSSU into the chloroplasts, while
POTRA1 inhibits the binding of radiolabeled prSSU to the chloroplasts. It is clear that POTRA
domains interact with translocating precursor proteins; however, the roles of POTRA2 and
POTRA1-2-3 were not determined by these assays. With purified and folded domains, their
involvement in preprotein interaction can be determined. The data obtained from the in vitro
interaction of purified and folded POTRA1-2-3 domain might mimic the in vivo behavior due to
the presence of all three domains. Furthermore, antisera can be used to affinity purify these
antibodies. In fact, the affinity purification of POTRA1 and POTRA3 antibodies resulted in pure
antibodies which cross-reacted with the purified antigens as well as purified pea chloroplasts
and envelopes (data not shown). To avoid artifacts imposed by the agglutination of divalent
IgGs on intact chloroplasts, affinity purified antibodies can be used in in vitro chloroplast import
and binding experiments can be performed to investigate their ability to inhibit the preprotein
binding and import. The similar experiments can be repeated with the affinity purified TLD
antibodies as well. Furthermore, affinity purified antibodies can be used to test the
agglutination of chloroplasts. This will rule out the agglutination caused by any non-specific IgGs
usually present in whole sera. LSCM analysis can also be repeated with purified antibodies with
proper negative and positive controls. To determine the interactions of individual and in
tandem POTRA domains with the Toc GTPases (Toc34, Toc159) in vitro, GTP hydrolysis
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experiments can be performed. Furthermore, with the purified POTRA domains, Surface
Plasmon Resonance can be performed to test the interaction of the POTRA domains as well as
TLDs with other Toc GTPases and/or transit peptides.
The possible structural function of the POTRA domains in the assembly of the TOC
translocon can be investigated by Blue-Native PAGE. Purified POTRA domains can be utilized to
investigate their ability to disrupt the TOC translocon organization in isolated enveloped.
Although a former student, Mr. William Crenshaw, showed that POTRA1 did not have structural
function in altering the oligomeric state of TOC components; however, it does not rule out the
structural function of other domains in the TOC assembly. Furthermore, the interaction of
POTRA domains with the transit peptide and/or other components of the TOC complex can be
investigated by Analytical Ultracentrifugation, cross-linking with gluteraldehyde, pull-down
assays and surface Plasmon resonance (SPR). Finally, the role of the POTRA domains can be
investigated in vivo by utilizing the cDNA of atToc75-III, the psToc75 homolog in Arabidopsis
thaliana. cDNA from atToc75-III as well as heterozygote atToc75-III mutants (homozygous are
embryo lethal) can be used to generate various mutants lacking individual POTRA domains as
well as the ‘loop’ folded inside the barrel. The ability of these mutants to complement the
atToc75-III deletions can provide evidence for their importance in in vivo chloroplast import.
To investigate the role of full-length Toc75 in interaction with GTPases and/or preprotein, full-length Toc75 can be purified. However, psToc75 is a hydrophobic, transmembrane
protein. Because of its insolubility, inclusion bodies are often formed when full length protein is
expressed. With the codon optimized region already cloned into the template psToc75-pET23
sequence, purification of full-length Toc75 can be attempted with Ni-NTA column. In fact,
codon optimized full-length psToc75 has been shown to produce protein expression studies
(data not shown). With the 6X-His, full-length psToc75 can be purified via Ni-NTA column, and
mentioned above can be performed. Finally, with the potentially folded POTRA domains, high
throughput crystallization can be attempted (the Hauptman-Woodward Institute - Buffalo, NY).
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SUPPLEMENTARY DATA

Figure S- 1 FindPept analysis of Toc Loop Peptide – A1C
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Figure S- 2 FindPept analysis of Toc Loop Peptide – A2C
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Figure S- 2 Continued.
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Figure S- 3 FindPept analysis of Toc Loop Peptide – B2C
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Figure S- 3 Continued.
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Figure S- 4 FindPept analysis of Toc Loop Peptide – B1IMS
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Figure S- 4 Continued.
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Figure S- 5 FindPept analysis of Toc Loop Peptide - B2IMS
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Figure S- 5 Continued.
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Figure S- 5 Continued.
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FULL LENGTH SEQUENCE OF PSTOC75 BEFORE CODON OPTIMIZATION:
TRANSIT PEPTIDE:
ATGCGTACTTCCGTTATTCCCAATCGCTTAACTCCAACCCTAACAACCCATCCCTCTCGTCGCCGCAACGACCATATCAC
CACTCGTACTTCTTCCTTGAAATGTCACCTTTCTCCTTCTTCCGGCGACAACAACGATTCCTTCAATTCCTCCCTTCTTA
AAACCATATCCACCACCGTCGCTGTTTCCTCCGCCGCCGCTTCCGCTTTCTTCCTCACCGGCTCCCTCCACTCCCCCTTC
CCTAATTTTTCTGGACTCAATGCCGCCGCTGGAGGCGGTGCTGGTGGAGGAGGCGGAGGTTCATCTTCCTCCGGAGGCGG
TGGAGGTGGCTGGTTTAACGGTGACGAAGGATCGTTCTGGTCGAGAATTCTATCCCCAGCCAGAGCCATCGCC
MATURE DOMAIN:
GACGAACCAAAATCAGAAGATTGGGATTCGCATGAATTACCGGCGGACATCACGGTTTTACTGGGGAGGCTTAGCGGGTT
TAAGAAATACAAAATCTCAGATATCCTTTTCTTCGATAGGAACAAGAAGTCGAAAGTTGAAACGCAAGATTCGTTCTTGG
ATATGGTATCTCTTAAACCTGGAGGAGTATACACCAAAGCTCAGCTTCAGAAGGAGCTAGAAAGCTTAGCTACCTGTGGA
ATGTTCGAGAAGGTTGACATGGAAGGGAAAACCAATGCAGACGGGTCGTTAGGGTTGACGATTTCGTTTGCTGAGAGTAT
GTGGGAGAGAGCAGACCGGTTTAG
ATGCATC AATGTTGGTTTGATGGGTCAATCCAAACCGGTTGAGATGGACCCTGATA
TGAGTGAAAAGGAGAAGATTGAATTTTTTAGGAGACAAGAGAGGGAATATAAGAGGAGAATTAGTTCTGCCAGGCCTTGT
CTTTTGCCTACTTCGGTACATGAGGAGATTAAGGATATGTTGGCTGAACAAGGTAGGGTTAGTGCTAGGTTGTTGCAGAA
GATAAGGGACCGTGTTCAGAGTTGGTATCATGAGGAAGGTTATGCTTGTGCTCAGGTTGTTAATTTTGGTAACCTTAATA
CACGCGAGGTTGTGTGTGAGGTTGTTGAAGGGGATATTACTAAGTTGTCTATTCAGTATTTGGATAAACTTGGTAATGTT
GTTGAAGGTAACACGGAAGGTCCTGTTGTTCAAAGAGAACTTCCAAAACAGCTTCTACCGGGTCATACTTTTAACATTGA
AGCTGGGAAACAAGCTTTGAGGAACATAAATTCCCTGGCTTTGTTTTCCAACATTGAGGTGAAT CCGCGG
CCTGATGAGATGAATGAGGGAAGCATAATAGTTGAAATTAAGCTCAAAGAGTTGGAGCAGAAATCAGCTGAAGTTAGTAC
AGAGTGGAGTATTGTTCCCGGGCGAGGAGGACGTCCGACTTTGGCTTCGCTGCAGCCGGGAGGGACTATTACTTTTGAAC
ATCGGAATCTGCAAGGATTGAATAGGTCACTTACTGGTTCAGTGACAACTAGCAACTTCTTGAATCCTCAGGATGATCTT
GCGTTTAAAATGGAGTATGCACATCCATATTTGGATGGTGTAGATAATCCACGGAACCGAACTCTCCGTGTAAGCTGCTT
CAATAGCCGAAAGCTGAGTCCAGTATTCACTGGAGGGCCGGGGGTGGATGAAGTGCCTTCAATATGGGTTGACCGTGCTG
GTGTAAAAGCTAATATCACTGAGAATTTTTCTCGTCAGAGTAAATTCACTTATGGATTGGTAATGGAAGAGATAATAACA
CGTGATGAAAGCAATCATATCTGTTCCAACGGTCAAAGAGTATTACCTAATGGAGCAATTAGTGCAGATGGACCTCCAAC
CACCCTTAGTGGTACTGGTATCGATAGGATGGCGTTTTTGCAGGCTAATATTACGCGGGATAACACAAGGTTTGTGAATG
GAACTATAGTTGGAAGCAGGAATATGTTCCAGGTAGATCAAGGCCTTGGCGTTGGCAGCAATTTCCCATTCTTTAACCGT
CACCAATTAACTGTGACAAAGTTTCTCCAATTGATGTCTGTGGAGGAAGGTGCCGGTAAATCACCACCTCCAGTGCTTGT
CCTCCATGGCCACTATGGCGGCTGTGTAGGTGACCTTCCAAGTTATGATGCTTTTACTCTCGGGGGTCCCTATTCTGTTA
GGGGTTACAACATGGGTGAGATTGGAGCAGCCAGAAACATCCTCGAGCTGGCAGCTGAGATACGTATACCTATTAAAGGT
ACGCACGTGTATGCCTTTGCAGAACATGGCACTGATCTAGGAAGTTCGAAAGATGTCAAGGGAAATCCGACTGTAGTCTA
TAGGCGAATGGGTCAGGGGTCCTCTTATGGTGCTGGTATGAAGCTTGGTTTAGTAAGAGCAGAATATGCCGTTGATCATA
ATTCAGGAACGGGTGCAGTATTTTTCCGTTT

Figure S- 6 Full-length sequence of the psToc75 before codon optimization
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FULL LENGTH SEQUENCE OF PSTOC75 AFTER CODON OPTIMIZATION:
TRANSIT PEPTIDE:
ATGCGTACTTCCGTTATTCCCAATCGCTTAACTCCAACCCTAACAACCCATCCCTCTCGTCGCCGCAACGACCATATCAC
CACTCGTACTTCTTCCTTGAAATGTCACCTTTCTCCTTCTTCCGGCGACAACAACGATTCCTTCAATTCCTCCCTTCTTA
AAACCATATCCACCACCGTCGCTGTTTCCTCCGCCGCCGCTTCCGCTTTCTTCCTCACCGGCTCCCTCCACTCCCCCTTC
CCTAATTTTTCTGGACTCAATGCCGCCGCTGGAGGCGGTGCTGGTGGAGGAGGCGGAGGTTCATCTTCCTCCGGAGGCGG
TGGAGGTGGCTGGTTTAACGGTGACGAAGGATCGTTCTGGTCGAGAATTCTATCCCCAGCCAGAGCCATCGCC
MATURE DOMAIN:
GACGAACCAAAATCAGAAGATTGGGATTCGCATGAATTACCGGCGGACATCACGGTTTTACTGGGGAGGCTTAGCGGGTTT
AAGAAATACAAAATCTCAGATATCCTTTTCTTCGATAGGAACAAGAAGTCGAAAGTTGAAACGCAAGATTCGTTCTTGGAT
ATGGTATCTCTTAAACCTGGAGGAGTATACACCAAAGCTCAGCTTCAGAAGGAGCTAGAAAGCTTAGCTACCTGTGGAATG
TTCGAGAAGGTTGACATGGAAGGGAAAACCAATGCAGACGGGTCGTTAGGGTTGACGATTTCGTTTGCTGAGAGTATGTGG
GAGAGAGCAGACCGGTTTAG ATGCATCAACGTTGGCCTGATGGGCCAGTCTAAACCGGTTGAAATGGACCCGGACATGTCTGAAAAAGAAAAAATCG
AATTCTTCCGTCGTCAGGAACGTGAATACAAACGTCGTATCTCTTCTGCTCGTCCGTGCCTGCTGCCGACCTCCGTTCAC
GAAGAAATCAAAGACATGCTGGCTGAACAGGGTCGTGTTTCTGCTCGTCTGCTGCAGAAAATCCGTGACCGTGTTCAGTC
CTGGTACCACGAAGAAGGCTACGCTTGCGCTCAGGTTGTTAACTTCGGCAACCTGAACACCCGTGAAGTTGTTTGCGAAG
TTGTTGAAGGTGACATCACTAAACTGTCCATCCAGTACCTGGACAAACTGGGTAACGTTGTTGAAGGTAACACCGAAGGC
CCGGTTGTTCAGCGTGAACTGCCGAAACAGCTGCTGCCGGGTCACACCTTCAACATCGAAGCTGGTAAACAGGCTCTGCG
TAACATCAACTCTCTGGCTCTGTTCTCCAACATCGAAGTTAACccgcgg
CCTGATGAGATGAATGAGGGAAGCATAATAGTTGAAATTAAGCTCAAAGAGTTGGAGCAGAAATCAGCTGAAGTTAGTAC
AGAGTGGAGTATTGTTCCCGGGCGAGGAGGACGTCCGACTTTGGCTTCGCTGCAGCCGGGAGGGACTATTACTTTTGAAC
ATCGGAATCTGCAAGGATTGAATAGGTCACTTACTGGTTCAGTGACAACTAGCAACTTCTTGAATCCTCAGGATGATCTT
GCGTTTAAAATGGAGTATGCACATCCATATTTGGATGGTGTAGATAATCCACGGAACCGAACTCTCCGTGTAAGCTGCTT
CAATAGCCGAAAGCTGAGTCCAGTATTCACTGGAGGGCCGGGGGTGGATGAAGTGCCTTCAATATGGGTTGACCGTGCTG
GTGTAAAAGCTAATATCACTGAGAATTTTTCTCGTCAGAGTAAATTCACTTATGGATTGGTAATGGAAGAGATAATAACA
CGTGATGAAAGCAATCATATCTGTTCCAACGGTCAAAGAGTATTACCTAATGGAGCAATTAGTGCAGATGGACCTCCAAC
CACCCTTAGTGGTACTGGTATCGATAGGATGGCGTTTTTGCAGGCTAATATTACGCGGGATAACACAAGGTTTGTGAATG
GAACTATAGTTGGAAGCAGGAATATGTTCCAGGTAGATCAAGGCCTTGGCGTTGGCAGCAATTTCCCATTCTTTAACCGT
CACCAATTAACTGTGACAAAGTTTCTCCAATTGATGTCTGTGGAGGAAGGTGCCGGTAAATCACCACCTCCAGTGCTTGT
CCTCCATGGCCACTATGGCGGCTGTGTAGGTGACCTTCCAAGTTATGATGCTTTTACTCTCGGGGGTCCCTATTCTGTTA
GGGGTTACAACATGGGTGAGATTGGAGCAGCCAGAAACATCCTCGAGCTGGCAGCTGAGATACGTATACCTATTAAAGGT
ACGCACGTGTATGCCTTTGCAGAACATGGCACTGATCTAGGAAGTTCGAAAGATGTCAAGGGAAATCCGACTGTAGTCTA
TAGGCGAATGGGTCAGGGGTCCTCTTATGGTGCTGGTATGAAGCTTGGTTTAGTAAGAGCAGAATATGCCGTTGATCATA
ATTCAGGAACGGGTGCAGTATTTTTCCGTTT

Figure S- 7 Full-length sequence of the psToc75 after codon optimization
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1 M

44 N C 0.9

87 N C 0.7 133 E C 0.9

175 S C 0.9

218 M C 0.5 234 F E 0.8 276 R C 0.5 319 I H 1.0

2 R

45 N C 0.9

88 A C 0.6 134 P C 0.9

176 K C 0.6

219 E C 0.7 235 A C 0.4 277 Q C 0.7 320 R H 1.0

3 T C 0.8

46 D C 0.8

89 A C 0.4 135 K C 1.0

177 V H 0.6 220 G C 0.7 236 E C 0.6 278 E C 0.5 321 D H 1.0

4 S C 0.8

47 S C 0.7

90 A C 0.4 136 S C 0.9

178 E H 0.7 221 K C 0.7 237 S H 0.5 279 R E 0.4 322 R H 0.9

5 V C 0.7 48 F C 0.7

91 G C 0.5 137 E C 1.0

179 T H 0.9 222 T C 0.9 238 M H 0.5 280 E E 0.5 323 V H 1.0

6 I C 0.8

49 N C 0.7

92 G C 0.8 138 D C 0.9 180 Q H 0.8 223 N C 0.9 239 W C 0.7 281 Y E 0.5 324 Q H 1.0

7 P C 0.6

50 S C 0.6

93 G C 0.8 139 W C 0.9 181 D H 0.9 224 A C 0.9 240 E C 0.8 282 K E 0.6 325 S H 1.0

8 N C 0.8 51 S C 0.6

94 A C 0.8 140 D C 0.9 182 S H 0.8 225 D C 0.9 241 R C 0.7 283 R E 0.6 326 W H 0.9

9 R C 0.8 52 L C 0.7

95 G C 0.8 141 S C 0.9

183 F H 0.6 226 G C 0.9 242 A C 0.6 284 R E 0.5 327 Y H 0.9

10 L C 0.8

53 L C 0.6

96 G C 0.8 142 H C 0.9 184 L H 0.7 227 S C 0.9 243 D C 0.7 285 I C 0.5 328 H H 0.9

11 T C 0.8

54 K C 0.6

97 G C 0.9 143 E C 1.0

12 P C 0.7

55 T C 0.5

98 G C 0.9 144 L C 1.0 186 M H 0.6 229 G C 0.8 245 F C 0.6 287 S C 0.4 330 E C 0.6

13 T C 0.6

56 I H 0.4

99 G C 0.9 145 P C 0.9

14 L C 0.6

57 S H 0.5 100 G C 0.9 146 A C 0.9 188 S E 0.9

231 T E 0.5 247 C C 0.5 289 R C 0.7 332 Y C 0.9

15 T C 0.6

58 T H 0.6 101 S C 0.9 147 D C 0.8 189 L E 0.7

232 I E 0.6

16 T C 0.7

59 T H 0.5 102 S C 0.9 148 I C 0.8

190 K E 0.6

249 N C 0.7 291 C C 0.7

17 H C 0.9 60 V H 0.6 103 S C 0.9 149 T C 0.7

191 P C 0.9

250 V C 0.8 292 L C 0.7

18 P C 0.9

61 A H 0.7 104 S C 0.9 150 V C 0.6 192 G C 0.9

251 G E 0.5 293 L C 0.9

19 S C 0.8

62 V H 0.6 105 G C 0.9 151 L C 0.5 193 G C 0.9

252 L C 0.5 294 P C 0.9

20 R C 0.7 63 S H 0.6 106 G C 0.9 152 L C 0.7 194 V C 0.5

253 M C 0.8 295 T C 0.5

21 R C 0.7 64 S H 0.6 107 G C 0.9 153 G C 0.7 195 Y E 0.5

254 G C 0.9 296 S H 0.7

22 R C 0.9 65 A H 0.6 108 G C 0.9 154 R C 0.6 196 T C 0.4

255 Q C 0.9 297 V H 0.9

23 N C 0.9 66 A H 0.6 109 G C 0.9 155 L C 0.6 197 K H 0.9

256 S C 0.7 298 H H 0.8

24 D C 0.9 67 A H 0.8 110 G C 0.9 156 S C 0.7

198 A H 0.9

257 K C 0.8 299 E H 0.9

25 H C 0.5 68 S H 0.8 111 W C 1.0 157 G C 0.8 199 Q H 1.0

258 P C 0.7 300 E H 0.9

26 I C 0.5

69 A H 0.8 112 F C 1.0 158 F C 0.9

200 L H 1.0

259 V E 0.6 301 I H 0.8

27 T E 0.4

70 F H 0.8 113 N C 0.8 159 K C 0.9

201 Q H 1.0

260 E C 0.7 302 K H 0.8

28 T C 0.4

71 F H 0.8 114 G C 0.8 160 K C 0.5

202 K H 1.0

261 M C 0.7 303 D H 0.8

29 R C 0.5 72 L H 0.8 115 D C 0.9 161 Y E 0.8

203 E H 1.0

262 D C 0.8 304 M H 0.7

30 T C 0.7

73 T H 0.8 116 E C 0.9 162 K E 0.9

204 L H 1.0

263 P C 0.8 305 L H 0.5

31 S C 0.7

74 G H 0.8 117 G C 0.7 163 I E 0.9

205 E H 1.0

264 D C 0.8 306 A H 0.6

32 S C 0.6

75 S H 0.7 118 S C 0.6 164 S E 0.8

206 S H 1.0

265 M C 0.6 307 E H 0.6

33 L C 0.6

76 L H 0.6 119 F C 0.4 165 D E 0.9 207 L H 1.0

266 S C 0.8 308 Q H 0.5

34 K E 0.8

77 H C 0.5 120 W H 0.4 166 I E 0.9

208 A H 0.9

267 E C 0.8 309 G C 0.6

35 C E 0.7

185 D H 0.6 228 L C 0.9 244 R C 0.7 286 S E 0.5 329 E H 0.8
187 V E 0.9 230 L C 0.6 246 R C 0.5 288 A C 0.8 331 G C 0.7
248 I C 0.5 290 P C 0.7 333 A C 0.8

78 S C 0.6 121 S H 0.5 167 L E 0.9

209 T H 0.9

268 K C 0.6 310 R C 0.7

36 H E 0.6 79 P C 0.8 122 R H 0.5 168 F E 0.9

210 C H 0.7

269 E H 0.4 311 V C 0.8

37 L C 0.5

80 F C 0.9 123 I C 0.4

211 G C 0.6

270 K H 0.5 312 S C 0.9

38 S C 0.6

81 P C 0.8 124 L C 0.6 170 D C 0.5 212 M C 0.7

271 I H 0.5 313 A H 0.8

39 P C 0.9

82 N C 0.8 125 S C 0.7 171 R C 0.8 213 F E 0.7

272 E H 0.5 314 R H 0.9

40 S C 0.9

83 F C 0.8 126 P C 0.9 172 N C 0.8 214 E E 0.6

273 F H 0.3 315 L H 1.0

41 S C 0.9

84 S C 0.8 127 A C 0.8 173 K C 0.8

215 K E 0.5

274 F C 0.4 316 L H 1.0

216 V C 0.5

317 Q H 1.0

42 G C 0.9 85 G C 0.7 128 R C 0.8

169 F E 0.9

129 A C 0.9

Table S- 1 Secondary Structure
APSSP2
130 I C Predictionby
0.8
131 A C 0.8
Raghava Secondary Structure
Prediction, where each first column shows amino acid numbers
and 2nd column shows amino acid residues, corresponding secondary structure state (H 
Helix; E  Strand ; C  Coil ) and probability of correct prediction.
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335 A E 0.7

377 E C 0.7

420 P E 0.9

436 L E 1.0

478 L C 0.5

521 R E 0.6

537 F C 0.6

579 I E 0.7

336 Q E 0.6

378 G C 0.6

421 R C 0.9

437 K E 0.8

479 Q C 0.6

522 T E 0.6

538 T C 0.6

580 I E 0.5

337 V E 0.8

379 P H 0.5

422 P C 0.9

438 E E 0.7

480 G C 0.7

523 L E 0.7

539 G C 0.6

581 T E 0.7

338 V E 0.6

380 V H 0.7

423 D C 0.9

439 L C 0.5

481 L C 0.8

524 R E 0.7

540 G C 0.8

582 R E 0.5

339 N E 0.6

381 V H 0.7

424 E C 0.9

440 E C 0.5

482 N C 0.8

525 V E 0.8

541 P C 0.8

583 D C 0.7

340 F C 0.7

382 Q H 0.8

425 M C 0.9

441 Q C 0.4

483 R C 0.8

526 S E 0.8

542 G C 0.9

584 E C 0.8

341 G C 0.9

383 R H 0.8

426 N C 0.9

442 K C 0.5

484 S E 0.7

527 C E 0.6

543 V C 0.8

585 S C 0.8

342 N C 0.8

384 E H 0.7

427 E C 0.9

443 S C 0.4

485 L E 0.8

528 F E 0.8

544 D C 0.9

586 N C 0.8

343 L C 0.9

385 L H 0.7

428 G C 0.9

444 A E 0.7

486 T E 0.8

529 N E 0.7

545 E C 0.7

587 H C 0.7

344 N C 0.9

386 P H 0.8

429 S C 0.8

445 E E 0.8

487 G E 1.0

530 S E 0.6

546 V C 0.7

588 I C 0.7

345 T C 0.8

387 K H 0.7

430 I E 0.7

446 V E 0.9

488 S E 0.9

531 R E 0.5

547 P C 0.6

589 C C 0.8

346 R C 0.7

388 Q H 0.6

431 I E 0.9

447 S E 0.9

489 V E 0.9

532 K E 0.5

548 S C 0.6

590 S C 0.8

347 E C 0.6

389 L H 0.7

432 V E 1.0

448 T E 0.9

490 T E 0.9

533 L C 0.5

549 I E 0.6

591 N C 0.8

348 V E 0.9

390 L C 0.7

433 E E 0.9

449 E E 0.9

491 T E 0.9

534 S C 0.6

550 W E 0.6

592 G C 0.7

349 V E 0.9

391 P C 0.9

434 I E 0.8

450 W E 0.8

492 S E 0.5

535 P C 0.7

551 V E 0.6

593 Q C 0.7

350 C E 1.0

392 G C 1.0

451 S E 0.8

493 N C 0.5

552 D E 0.9

594 R C 0.7

351 E E 1.0

393 H C 0.9

452 I E 0.8

494 F E 0.5

553 R E 0.8

595 V C 0.6

352 V E 0.9

394 T C 0.5

453 V C 0.6

495 L C 0.7

554 A E 0.6

596 L C 0.5

353 V E 0.6

395 F C 0.9

454 P C 0.7

496 N C 0.7

555 G E 0.9

597 P C 0.6

354 E C 0.5

396 N C 0.9

455 G C 0.8

497 P C 0.6

556 V E 0.9

598 N C 0.7

355 G C 0.7

397 I H 0.9

456 R C 0.9

498 Q C 0.8

557 K E 0.9

599 G C 0.8

356 D C 0.8

398 E H 0.8

457 G C 0.9

499 D C 0.8

558 A E 0.7

600 A C 0.8

357 I C 0.7

399 A H 1.0

458 G C 0.8

500 D C 0.5

559 N E 0.9

601 I C 0.7

358 T C 0.7

400 G H 1.0

459 R C 0.8

501 L E 0.8

560 I E 0.9

602 S C 0.5

359 K C 0.8

401 K H 1.0

460 P C 0.7

502 A E 0.7

561 T E 0.8

603 A C 0.5

360 L E 0.8

402 Q H 1.0

461 T C 0.6

503 F E 0.8

562 E E 0.8

604 D C 0.6

361 S E 1.0

403 A H 1.0

462 L C 0.5

504 K E 0.8

563 N E 0.7

605 G C 0.9

362 I E 0.9

404 L H 1.0

463 A C 0.5

505 M E 0.6

564 F E 0.7

606 P C 0.9

363 Q E 1.0

405 R H 1.0

464 S C 0.5

506 E E 0.9

565 S C 0.8

607 P C 0.7

364 Y E 0.9

406 N H 1.0

465 L C 0.4

507 Y E 0.8

566 R C 0.9

608 T C 0.7

365 L E 0.9

407 I H 1.0

466 Q E 0.4

508 A E 0.4

567 Q C 0.9

609 T C 0.7

366 D C 0.5

408 N H 0.8

467 P C 0.5

509 H C 0.5

568 S C 0.8

610 L C 0.7

367 K E 0.3

409 S H 0.6

468 G C 0.6

510 P C 0.7

569 K C 0.5

611 S C 0.7

368 L C 0.7

410 L C 0.9

469 G E 0.5

511 Y C 0.8

570 F E 0.8

612 G C 0.7

369 G C 0.8

411 A C 1.0

470 T E 0.6

512 L C 0.5

571 T E 0.9

613 T C 0.9

370 N C 0.8

412 L C 0.8

471 I E 0.7

513 D C 0.6

572 Y E 1.0

614 G C 0.9

371 V E 0.6

413 F C 0.4

472 T E 1.0

514 G C 0.8

573 G E 1.0

615 I C 0.7

372 V C 0.8

414 S E 0.5

473 F E 0.9

515 V C 0.9

574 L E 0.9

616 D C 0.8

373 E C 0.6

415 N E 0.5

474 E E 0.7

516 D C 0.8

575 V E 0.9

617 R C 0.5

374 G C 0.7

416 I E 0.7

475 H C 0.5

517 N C 0.8

576 M E 0.8

618 M E 0.5

375 N E 0.5

417 E E 0.8

476 R C 0.7

518 P C 0.6

577 E E 0.9

619 A E 0.7

418 V E 0.9

519 R C 0.7

Table S- 1 Continued.
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620 F E 0.9

Figure S- 8 Secondary structure predict by PROF
E  Strand; HHelix
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Figure S- 9 Secondary structure prediction by PSIPRED
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Figure S- 10 Secondary structure prediction by JPred3
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Figure S- 10 Continued.
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Subject: Porter response to
Query_name:
Query_length: 809
Prediction: C  coil; H  helix; E  strand
MRTSVIPNRLTPTLTTHPSRRRNDHITTRTSSLKCHLSPSSGDNNDSFNSSLLKTISTTV
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCE
AVSSAAASAFFLTGSLHSPFPNFSGLNAAAGGGAGGGGGGSSSSGGGGGGWFNGDEGSFW
EECCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
SRILSPARAIADEPKSEDWDSHELPADITVLLGRLSGFKKYKISDILFFDRNKKSKVETQ
HHHCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEEEEEEEEECCCCCCCHHHH
DSFLDMVSLKPGGVYTKAQLQKELESLATCGMFEKVDMEGKTNADGSLGLTISFAESMWE
HHHHHHHECCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCEEEEEEECCCCE
RADRFRCINVGLMGQSKPVEMDPDMSEKEKIEFFRRQEREYKRRISSARPCLLPTSVHEE
HCCCEEEEEECCCCCCCCEEECCCCCCCEEEEEEECCCCCEEEEEEECCCCCCCHHHHHH
IKDMLAEQGRVSARLLQKIRDRVQSWYHEEGYACAQVVNFGNLNTREVVCEVVEGDITKL
HHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCEEEEEECCCCCCCCEEEEEEECCCCCEE
SIQYLDKLGNVVEGNTEGPVVQRELPKQLLPGHTFNIEAGKQALRNINSLALFSNIEVNP
EEEEEECCCCCCCCCCCHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHCCCCCEEEEEE
RPDEMNEGSIIVEIKLKELEQKSAEVSTEWSIVPGRGGRPTLASLQPGGTITFEHRNLQG
CCCCCCCCCEEEEEEEEEECCCCEEEEEEEEECCCCCCCCCEEEEEEEEEEEEECCCCCC
LNRSLTGSVTTSNFLNPQDDLAFKMEYAHPYLDGVDNPRNRTLRVSCFNSRKLSPVFTGG
CCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCCCCCCEEEEEEECCCCCCCEECCC
PGVDEVPSIWVDRAGVKANITENFSRQSKFTYGLVMEEIITRDESNHICSNGQRVLPNGA
CCCCCCCCEEEEECCEEEEEEEECCCCCCEEEEEEEEEEEEECCCCCCCCCCCCCCCCCC
ISADGPPTTLSGTGIDRMAFLQANITRDNTRFVNGTIVGSRNMFQVDQGLGVGSNFPFFN
CCCCCCCCEECCCCCCCEEEEEEEEEEECCCCCCCCCCCEEEEEEEEEEECCCCCCCEEE
RHQLTVTKFLQLMSVEEGAGKSPPPVLVLHGHYGGCVGDLPSYDAFTLGGPYSVRGYNMG
EEEEEEEEEEEEEEEEEECCCCCCCEEEEEEECCCECCCCCCCHEEEECCCCEEEEECCC
EIGAARNILELAAEIRIPIKGTHVYAFAEHGTDLGSSKDVKGNPTVVYRRMGQGSSYGAG
CCCCCCCEEEEEEEEEEECCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCEEEEEC
MKLGLVRAEYAVDHNSGTGAVFFRFGERF
CCCCCEEEEEEECCCCCCCEEEEEECCCC
Predictions based on PDB templates (seq. similarity up to 6.3%)
Query served in 2032 second
Figure S- 11 Secondary structure prediction by PORTER
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TPTLTTHPSRRRNDHITTRTSSLKCHLSPSSGDNNDSFNSSLLKTISTTVAVSSAAASAFFLTGSLHSPFPNFSGLNAAAGGGAGGGGGGSSSSGGGGGGWFNGDEGSF
WSRILSPARAIADEPKSEDWDSHEL
---------------EE-----EEEEE--------------HEEEEEEEEEE-------EEE------------------------------------------------------HHHHH------------PADITVLLGRLSGFKKYKISDILFFDRNKKSKVETQDSFLDMVSLKPGGVYTKAQLQKELESLATCGMFEKVDMEGKTNADGSLGLTISFAESMWERADRFRCINVGLM
GQSKPVEMDPDMSEKEKIEFFRRQE
-------EEE-------EEEEEEEE-------HHHHHHHHHHHH--------HHHHHHHHHHHHH-------EEEEEE------EEEEEE--------EEEEE------------EE------EEEEEEE---REYKRRISSARPCLLPTSVHEEIKDMLAEQGRVSARLLQKIRDRVQSWYHEEGYACAQVVNFGNLNTREVVCEVVEGDITKLSIQYLDKLGNVVEGNTEGPVVQRELPK
QLLPGHTFNIEAGKQALRNINSLAL
-------EEE-------EEEEEEEE-------HHHHHHHHHHHH--------HHHHHHHHHHHHH-------EEEEEE------EEEEEE--------EEEEE------------EE------EEEEEEE---FSNIEVNPRPDEMNEGSIIVEIKLKELEQKSAEVSTEWSIVPGRGGRPTLASLQPGGTITFEHRNLQGLNRSLTGSVTTSNFLNPQDDLAFKMEYAHPYLDGVDNPRNRT
LRVSCFNSRKLSPVFTGGPGVDEV
EEEEEEEEE-------HHHHHHHHH---------HHHHHHHHHHHHHHHHH----EEEEEE-------EEEEEEEEEE---EEEEEEEE-----------HHHHHHH----------HHHHHHHHHHHH---PSIWVDRAGVKANITENFSRQSKFTYGLVMEEIITRDESNHICSNGQRVLPNGAISADGPPTTLSGTGIDRMAFLQANITRDNTRFVNGTIVGSRNMFQVDQGLGVGS
NFPFFNRHQLTVTKFLQLMSVEEGAG
----EEEE--------EEEEEEEEEE----EEEEEEEE----------------EEEEEEEEE--------EEEEEEEE---------EEEEEEEEE-----------EEEEEEEEE----------------KSPPPVLVLHGHYGGCVGDLPSYDAFTLGGPYSVRGYNMGEIGAARNILELAAEIRIPIKGTHVYAFAEHGTDLGSSKDVKGNPTVVYRRMGQGSSYGAGMKLGLVRA
EYAVDHNSGTGAVFFRFGERF
---EEEEEEEEEEEEEEE----EEEEEEEEEEEEEE----------------------------------EEEEEEEEEEEE-----------EEEEEEEE----------EEEEEEEEEEEEEE-----EEEE----EEEEEEEE------------E----------------------EEEEEEEEEE---EEEEEEEEEEE------------------EEEEEEEEEE----EEEEEEEEE-----EEEEEEE----

Figure S- 12 Other ExPASy secondary structure program
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#POTRA domains

Amino acid
sequence and
residue number

Primer name

Strand

Length

Sequence 5’ -> 3’

#POTRA1

RPCL-LGNV
288-370

POTRA 1 FOR
POTRA 1 REV

+
-

27
24

GGT GGT CATATG AGG CCT TGT CTT TTG
GGT GGT CCCGGG AAC ATT ACC AAG

#POTRA2

TFNI-TGSV
393-500

POTRA 2 FOR
POTRA 2 REV

+
-

28
27

GGT GGT CATATG ACT TTT AAC ATT GAA GCT GG
GGT GGT CCCGGG CAC TGA ACC AGT AAG

#POTRA3

FLNP-TYGL
493-573

POTRA 3 FOR
POTRA 3 REV

+
-

27
25

GGT GGT CATATG TTC TTG AAT CCT CAG
GGT GGT CCCGGG CCC GGG CAA TCC ATA AGT G

# The design of these primers was due to the initial attempt to identify the regions of POTRA domains without
psToc75 transit peptide, and therefore were not tilized for any cloning.

Table S- 2 List of the primers for unadapted regions of psToc75
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